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The first and rate limiting step in steroid biosynthesis
from cholesterol, namely the side-chain cleavage of cholesterol,
was investigated in rat testqs.
1. A sensitive and quantitative method for the assay of
cholesterol side-chain cleavage is described. The procedures
developed for preparing subcellular fractions free of sperms;
fractionation of the heavy mitochondria and separation of the
steroid products formed from cholesterol on a single thin-layer
chromatogram plate are also presented.
2. The subcellular distribution of the cholesterol side-chain
cleavage enzyme system was investigated. This enzyme was
localized exclusively in the heavy mitochondrial fraction.
3. The phosphorylative and respiratory control capacities of
these intact testicular heavy mitochondria were measured.
Respiratory control ratios could be demonstrated only when
potassium phosphate, ethylenediamine tetraacetic acid and bovine
serum albumin (free of fatty acid) were present together. The
optimal requirements for these factors were investigated and
the results discussed.
4. The effect of various extra and intra-mitochondrial sources
of reducing equivalents on the sterol hydroxylase enzymic
activity were examined. The cholesterol side-chain cleavage
enzyme had an absolute requirement for NADPH. Certain Krebs
cycle intermediates were found to be effective electron donors
for the enzyme activity.
5. The optimum conditions for cholesterol side-chain cleavage
activity were investigated. These included the effect of varying
substrate concentrations (cholesterol and NADPH); different
buffer systems, varying the pH and increasing amounts of mito¬
chondrial protein. 1
6. The rate, total yield and nature of the steroid products
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formed from /j±- C/ cholesterol by testicular heavy mitochondria
ivere found to be greatly influenced by the type of electron
donor used (NADPH or isocitrate), as well as by various anions,
cations, nucleotides and bovine serum albumin.
7. The influence of inhibitors on the in vitro biosynthesis
of steroids in mitochondria were tested. Cyanoketone at low
concentrations (6 jiM) did not inhibit the cholesterol side-chain
cleavage activity but blocked the further metabolism of
pregnenolone to progesterone. Aminoglutethimide at 400 (iM
completely inhibited the conversion of cholesterol to pregnenolone.
These effects are discussed.
8. By difference spectroscopy it was demonstrated that rat
testes heavy mitochondria contain a complement of cytochromes
of the normal respiratory chain but the oxygen activating and
substrate binding component of steroid hydroxylation reactions -
cytochrome P450 - could not be demonstrated as the CO-binding
pigment. Using ficoll fractionated heavy mitochondria and certain
specific lipophilic amines a method was developed for the
detection and measurement of testicular mitochondrial cytochrome
P450. Aminoglutethimide was bound only to mitochondrial cyto¬
chrome P450, whereas metyrapone interacted with both the
mitochondrial and microsomal cytochrome P450. This fact suggested
that the mitochondrial cytochrome P450 is quite different from
the cytochrome P450 found in the microsomes. The amount of
high and low spin cytochrome P450 was estimated and the effect
of changes of pH and the effect of steroids on cytochrome P450
binding was studied.
9. Treatment of intact rats with cycloheximide resulted in a
significant decrease in the conversion of cholesterol to
pregnenolone as well as the amount of cholesterol bound to the
mitochondrial cytochrome P450. The significance of these
findings are discussed.
10. Whether the seminiferous tubules were capable of de novo
steroid biosynthesis from cholesterol was studied using
subcellular fractions from interstitial tissue and seminiferous
tubules dissected out from rat testes. On the basis of cholest¬
erol side-chain cleavage activity and cytochrome P450 spectral
evidence it was established that the interstitium is the only
testicular tissue capable of de novo steroid synthesis from
cholesterol. The seminiferous tubules appear to lack the
necessary oxygenase enzyme systems.
11. Preliminary observations are presented which suggest the
existence of an alternative route of steroid biosynthesis from
cholesterol. The possible significance of these observations
are discussed.
(i)
ABBREVIATIONS USED IN THE TEXT
ACTH - Adrenocorticotrophic hormone
ADP - Adenosine 5'-diphosphate
AMP - Adenosine 5'-monophosphate
ATP - Adenosine 5'-triphosphate
BSA - Bovine serum albumin
Cyclic AMP - Adenosine 3',5'-cyclic monophosphate
CSCC - Cholesterol side-chain cleavage
cpm - Counts per minute
DHA - Dehydroepiandrosterone
DOC - Deoxycorticosterone
EDTA - Ethylenediamine tetra-acetic acid
EGTA - Ethyleneglycol-bis(p-amino-ethyl ether)
N^N'-tetra acetic acid
EPR - Electron paramagnetic resonance
FAD - Flavin adenine dinucleotide
FSH - Follicle-stimulating hormone
G-6-P - D-Glucose-6-phosphate
GDC - Gas-liquid chromatography
GSH - Reduced glutathione
HCG - Human chorionic gonadotrophin
ISP - Iron sulphur protein
in - Luteinizing hormone
MAD - 17a-Methyl androst-5-ene-3(3 ,17|3-diol
NAD(H) - Nicotinamide adenine dinucleotide (reduced)
NADP(H) - Nicotinamide adenine dinucleotide phosphate
(reduced)
PMS - Pregnant mare serum
TLC - Thin-layer chromatography
Tris - 2-Amino-2-hydroxy methylpropane-1,3-diol
(ii)




















Dihydrotestosterone: 17(3 -hydroxy-5a-andr os tan-3-one
Epiandrosterone: 3(3-hydroxy-5a-androstan-17-one
Epitestosterone: 17a-hydroxyandrost-4-ene-3-one
(20S) -20-Hydroxycholesterol: cholest-5-enc-3|3 ,20a-diol
(22R) , 22-Hyaroxycholesterol: cholest-5-ens-3(3 ,22 (R)-diol
(20R,22R) -20,22-Dihydroxycholesterol: cholest-5-ene-3(3 ,
20a,22(R)triol
17a-Hydroxypregnenolone : 3(3 ,17a -dihydroxypregn-5-ene-20-one
11(3 -Hydroxyproges terone: 11(3 -hyoroxypregn-4-ene-3 ,20-dione
17a-Hydroxyprogesterone: 17a-hyaroxypregn-4-ene-3,20-dione
Oestradiol-17(3 : oestra-1,3,5 (10)-triene-3 ,17(3-diol
Oestrone: 3-hydroxyoestra-1,3,5 (10)-triene-17-one































NATURE AND NUMBER OF TESTICULAR ANDROGENS
HISTOLOGY OF THE TESTIS IN RELATION TO
STEROIDOGENESIS
STEROID BIOSYNTHETIC PATHWAYS FROM CHOLESTEROL
Cleavage of cholesterol side-chain
Intermediate compounds in the conversion of
cholesterol to pregnenolone




Multiplicity of cytochrome P450
Mechanism of function of cytochrome P450
CONVERSION OF PREGNENOLONE TO TESTOSTERONE
Pathways
Enzymes related to testosterone biosynthesis
INVOLVEMENT OF STEROID SULFATES IN TESTOSTERCNE
BIOSYNTHESIS
OESTROGEN BIOSYNTHESIS BY TESTIS









AIMS OF PRESENT STUDY
GENERAL INTRODUCTION
The testis is an extremely complex organ ivhich is
comprised of many different types of cells, each having its
oivn metabolic and physiological function. This has been one
of the major obstacles in the study of the testis.
Although in some respects knowledge of the endocrinology
of the testis has advanced more rapidly than that of other
endocrine organs, the information on the biochemistry of
steroidogenesis is comparatively sketchy. Many of the
concepts concerning the regulation of steroid biosynthesis in
the testis are assumed to be similar to that of the other
steroidogenic organs viz adrenal and ovary, on which extensive
research has been?done.
The testis serves two distinct but related functions in
the reproductive life of the adult male, namely the germinal
function of providing sex cells and the endocrine function of
secreting hormones, principally androgens - namely testoster¬
one, androstenedione and dehydroepiandrosterone. These
hormones are necessary for the maintenance of spermatogenesis
and fertility (Ludwig, 1950; Clermont & Morgentaler, 1955;
Davis et al., 1965; Tuleisnik et al., 1966; and Ellis &
Berliner, 1969) and development of male accessory reproductive
organs and the male secondary sexual characteristics (Walsh
et al., 1934; Wood & Simpson, 1961; Clermont & Harvey, 1967).
Early in foetal life, the secretions of the testis play an
important role in the development of the male genital tract
(Goldman et al., 1966a,b; Goldman, 1970). The testis however
cannot achieve or maintain normal function without the support
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of the pituitary gland (Greep et al . , 1936; Greep & Fevold,
1937), the principal mediators being follicle-stimulating
hormone (FSH) and interstitial cell stimulating hormone (ICSH)
(Clermont & Harvey, 1967).
1.1 NATURE AND NUMBER OF TESTICULAR ANDROGENS
The testis secretes three main C^ steroids testosterone,
androstenedione and dehydroepiandrosterone (DHA). The
evidence that testosterone and androstenedione are true
testicular hormones is unquestionable but evidence that DHA
is secreted by the testis remains indirect (Eik-Nes & Hall,
1965a). In man it appears that testosterone is secreted by
the testis alone but that the adrenal and testes secrete both
DHA and androstenedione (Gurpiae et al., 1965). In addition,
a small amount of DHA is converted to testosterone and
androstenedione in peripheral tissues (Morton & Tait, 1967).
Although cyclic activity has long been recognized as
characteristic of the female reproductive organ, comparable
cycles are less evident in the male. However, seasonal changes
in the function of the testis are well known (Hall & Eik-Nes,
1962; Ewing et al., 1965; Niemi & Kormano, 1965). In man
the secretion of androgens show diurnal changes (Resko &
Eik-Nes, 1966).
Of the androgens, testosterone and androstenedione are
considerably more potent than DHA. (Dorfman & Shipley, 1956).
However, certain qualitative differences have been observed,














FIG. 1.1 DIAGRAMMATIC SECTION THROUGH THE TESTIS
f
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than on the seminal vesicles when compared with testosterone.
Cn the other hand testosterone and androstenedione are approxi¬
mately equally potent as inhibitors of the adenohypophysis in
rat, while DHA is approximately half as potent (Dorfman &
Shipley, 1956). Androstenedione, although a potent anabolic
agent, appears to be a weak androgen compared to testosterone,
particularly in ruminants (Mann et al., 1960) where much of it
is metabolized by red blood cells to the inactive epitestosterone
(Lindner, 1961a).
Recently Eaulieu (1970) suggested that testosterone per se
is not the active compound. In the target cells testosterone
was transformed into derivatives androstanolone and androst-
anediol, the active hormones. The effects of those metabolites
on the secondary sex organs were different but the summation
of their action reflected that of testosterone.
1.2 HISTOLOGY OF THE TESTIS IN RELATION TO STEROIDOGENESIS
The mature testis, which is enclosed within a sac called
the tunica albuginea, is basically made up of two distinct
functional parts (Fig. 1.1 shows a diagrammatic section
through the testis):
(1) The seminiferous tubules which consist of
(a) basement membrane formed by a single layer
of epithelial cells.
(b) Several layers of germinal cells at various
stages of development. The development and
maturation of these cells proceed from the






















PATHWAYS OF STEROID BIOSYNTHESIS FROM CHOLESTEROL
► MAJOR PATHWAY
> PROPOSED ALTERNATIVE PATHWAY
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towards the lumen, where the formed spermatozoa
are passed along into the excretory ducts,
(c) Sertoli cells - these are tall columnar, pillar-
shaped nongerminal supporting cells which are
evenly distributed in the seminiferous
epithelium and around which the spermatocytes
and spermatids are arranged. In man there are
two types of Sertoli cells (Johnsen, 1969).
(2) The interstitial tissue which occupies the inter
tubular spaces contain clusters of large polyhedral
cells - the "Leydig cells" (or interstitial cells),
around blood vessels. Interspersed among these
clusters are macrophages and stem cells. Leydig
cells differ from species to species not only in
number and size but also in certain ultrastructural
features (Fawcett et al., 1969; Christensen & Gillim,
1969) .
It is now fairly well established that the Leydig cells
of the testis are the principal source of testicular steroids.
Evidence for t his was obtained from a number of different
direct and indirect observations such as (a) histochemical
localization of the 3(3- and 17(3-hydroxy steroid dehydrogenases
in these cells (Wattenberg, 1958; Baillie et al., 1966);
(b) x-irradiation of the testis - this treatment completely
damaged the spermatogenic germ cells. The remaining histo¬
logically intact Sertoli cells and Leydig cells were apparently
capable of maintaining the weight of accessory sex organs such
as seminal vesicles and prostate - the indices of the in vivo
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produced and secreted androgens (Schoen, 1964; Inano &
Tamaoki, 1968a; Abbott, 1959); (c) ability of interstitial
cell tumors to produce androgens from several precursors
in vitro (Dominguez et al., 1958; Gual et al., 1962; Inano
et al., 1968); (d) by a fluorescent antibody technique
using antibodies against steroid-bovine serum albumin conjugates
(Woods & Domm, 1966); (e) by immunological inactivation of
endogenous LH (Wakabayashi & Tamaoki, 1966) and (f) by direct
biochemical measurement of the in vitro ability of manually
separated interstitial tissue and seminiferous tubules to
metabolize progesterone (Christensen & Mason, 1965), cholesterol
(Hall et al., 1969) and endogenous precursors (Van der Vusse
et al., 1973) into androgens.
In addition to the interstitial cells the Sertoli cells
have also been reported to be involved in steroid production
(Christensen & Mason, 1965; Lacy, 1967; Ellis, 1969; Lacy
& Pettit, 1970; Bell et al., 1968, 1971). However, the
contribution was considerably smaller than that of the inter¬
stitial cells (Christensen & Mason, 1965)„ The functional
significance of these findings remains uncertain.
Another relevant histological feature of the testis
which is of physiological significance is the presence of
well developed lymphatics between the seminiferous tubules
and the Leydig cells (Fawcett et al., 1970). The seminiferous
tubules are not penetrated by blood vessels but are nourished
by lymph formed in the peritubular spaces or exuded by
capillaries applied to their basement membrane. It appears
that part of the androgens secreted by the Leydig cells are
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released into the testicular lymph and this probably provides
a mechanism by which these hormonal secretions exert a local
influence on target cells within the seminiferous tubules
(i.e. in the maintenance of spermatogenesis) and on adjacent
^structures such as the epididymus (Lindner, 1969; Mason &
Shaver, 1952).
It has been estimated that in ram, the concentration of
testosterone in the lymph was about two thirds of the level
in spermatic venous blood and five to ten times higher than
that in peripheral venous or arterial blood (Lindner, 1966).
1.3 STEROID BIOSYNTHETIC PATHWAYS FROM CHOLESTEROL
The role of;cholesterol as the physiological obligatory
precursor of all steroid hormones seems now well established
(Krum et al., 1964; Menon et al., 1965a). One exception to
this generalization, however, has been reported: triparanol,
i.e. l-/p ((3-diethylaminoethoxy) phenyl/7-!-(p-tolyl) -2-
(p-chlorophenyl)-ethanol, which by inhibiting the reduction
of the double bond in the side chain of desmosterol
(Avigan et al., I960) prevents the conversion of acetate to
cholesterol, did not block the biosynthesis of
testosterone from acetate in slices of rabbit testis in vitro
(Hall, 1964). Therefore, it was suggested that desmosterol
could act as a precursor of steroid hormones in the testis.
1.3.1 Cleavage of cholesterol side-chain
In common with other steroidogenic organs like the ovary
and adrenals, in testes the biosynthesis of steroids from
cholesterol was shown (see Fig. 1.2) to involve the splitting
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of the side chain of cholesterol resulting in the formation
of the ^21 steroid, pregnenolone and the 6 carbon side-chain
fragment, isocaproic aldehyde isolated as the acid (Toren
et al., 1964). This scission was postulated to involve
hydroxylated cholesterol intermediates (Menon et al., 1965b;
Hall & Young, 1968; Kobayashi & Ichii, 1967). The enzyme
system (the cholesterol side-chain cleavage enzyme) catalysing
this conversion of cholesterol to pregnenolone was localized
in the mitochondrial fraction of the testis and found to have
an absolute requirement for NADPH and molecular oxygen (Toren
et al., 1964; Drosdowsky et al., 1965). This reaction has
been suggested to be the rate limiting step in steroid
biosynthesis and the site most likely to be affected by trophic
hormones - LH and HCG (Menon et al♦, 1965a; Hall & Young,
1968; Hall, 1966; Hall & Eik-Nes, 1962; Eik-Nes & Hall, 1965a).
In addition to the above pathway, the existence of an
alternative pathway involving the direct conversion of
cholesterol to DHA without the intermediary formation of
pregnenolone has been reported (Jungmann, 1968a,b) . This
by-pass step (see Fig. 1.2) was reported to involve the
cleavage of a C fragment of the side chain of cholesterol
O
(2-methylheptan-6-one). However, the reaction could not be
confirmed (Hochberg et al., 1971; Burstein et al., 1971).
1.3.2 Intermediate compounds in the conversion of cholesterol
to pregnenolone
Information on the mechanism of transformation of
cholesterol to pregnenolone has been based mainly on studies
on the adrenal cortex. The exact nature of the intermediates
and their sequence of formation remains unclear.
OH
FIG.1.3POSTULATEDPA HWAYSFORCHOLES ROLC NVE SI NOPR GNENOLONEIENDOCRINEORGA S INVOLVINGHYDROXYLATEDCH LESTEROLINT RM IATE(S)(afterBurstein&Gut,1969)
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The pathway most commonly postulated for the conversion
of cholesterol to pregnenolone in steroid-producing organs
has been reported to involve two hydroxylated derivatives of
cholesterol, (20S)-20-hydroxycholesterol and (2CR,22R)-20,
22-dihydroxycholesterol (Shimizu et al., 1961, 1962;
Constantopoulos et al., 1962; Constantopoulos & Tchen, 1961;
Staple et al. , 1956). Evidence for this hypothesis has
generally been indirect. The studies of Koritz and Hall
(1964), Hall and Koritz (1964a) and Simpson and Boyd (1967a)
cast some doubt on whether the hypothesis was a valid
mechanism for the conversion of cholesterol to pregnenolone.
These workers were unable to demonstrate that (20S)-20-hydroxy¬
cholesterol was formed from cholesterol in vitro. Hall and
Koritz (1964b) proposed that multienzyme complexes may exist,
in which there occurs transfer of a product from one enzyme
to the next without release of the intermediate into the
medium. Recently, Burstein et al. (1970a,b)& Burstein & Gut
(1969, 1971) have provided kinetic evidence that (22R)-22-
hydroxycholesterol and not the 20S isomer is the more usual
first intermediate in the process of the side-chain oxidation
of cholesterol. They also suggested that formation of (22R)-
22-hydroxycholesterol may apparently be by-passed in a
concerted one-step production from cholesterol of the (20R,22R)-
20,22-dihydroxycholesterol which then yields pregnenolone.
Recently the involvement of 20a-hydroperoxide of
cholesterol in the cholesterol side-chain cleavage process
has been strongly implicated by Van Lier and associates
(Van Lier & Smith, 1970a,b; Van Lier & Kan, 1971): they
3
presented evidence for the incorporation of H from
3
cholesterol-1,2- H into 20a-hydroperoxy-cholesterol and
demonstrated that this compound was readily converted to
(20R,22R)-20,22-dihydroxycholesterol in an anaerobic enzymic
reaction by adrenal mitochondria. The triol formed was then
converted to pregnenolone by a much sloxver reaction which
required oxygen and NADPH. Kraaipoel et al. (1974) proposed
that a 20-22 cyclic peroxide of cholesterol may be an inter¬
mediate in cholesterol side-chain cleavage. However, this
compound has not been isolated.
Lieberman et al. (1969), Luttrel et al. (1972) and
Hochberg et al. (1974), suggested the existence of free radical
or ionic intermediates in the transformation of cholesterol to
pregnenolone.
R^CH —» * R^C-0-0. > R^C-O. Fragmentation^R^,C=Q + R.
1.3,3 Components of the cholesterol side-chain cleavage
multi-enzyme
In testis comparatively little is known about the components
of the cholesterol side-chain cleavage enzyme system. Since
this testicular hydroxylase system is a mixed function oxidase,
(i.e. involves the insertion of one atom of oxygen into the
substrate with the other oxygen atom being reduced to water
in the presence of an electron donor-NADPH), it has been
assumed to be similar to those of other steroid-forming organs.
Most mammalian steroid mixed oxidases are associated with
membranes within the cell, being located usually in the mito¬
chondrial or microsomal subcellular compartments. The
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cholesterol side-chain cleavage enzyn;e activity of all
steroidogenic organs has been localized in the mitochondrial
fraction (Sulimovici & Boyd, 1969). The particulate nature
of these enzymes has made their solubilization and purification
difficult to achieve. Omura et al. , (1966) reported the
fractionation of the adrenal mitochondrial steroid 11(3-
hydroxylase into three components - flavoprotein (diaphorase),
iron sulphur protein (ISP) and cytochrome P450. Boyd and
co-workers and other investigators accomplished a partial
purification of the cholesterol side-chain cleavage system
from mitochondria of adrenal cortex (Simpson & Boyd, 1967b;
Bryson & Sweat, 1968), rat ovary (Sulimovici & Boyd, 1968a)
and human placenta (Mason & Boyd, 1971). The enzyme appeared
similar in all three tissues in that it could be resolved into
an NADPH diaphorase, the iron sulphur protein and cytochrome
P450. Furthermore, the adrenal mitochondrial cytochrome P450
associated with cholesterol side-chain cleavage was separated
from the cytochrome P450 associated with 11|3-hydroxylase
activity (Jefcoate et al., 1970).
In testis, however, several attempts to solubilize the
cholesterol side-chain cleavage enzymes have been unsuccessful
(Green, 1963; Drosdowsky et al., 1965). Machino et al. (1969)
failed to demonstrate the presence of cytochrome P450 in the
testicular mitochondrial fraction from rat.
1.3.3.1 Role of components
The role of the flavoprotein in the electron transport
chain appeared to be to catalyze the reduction of the non-heme
iron protein by NADPH (Omura et al., 1966). The flavoprotein
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associated with 11|3-hydroxylase system was found to have a
molecular weight of about 60,000 and to contain FAD as its
prosthetic group.
Adrenodoxin, the iron sulphur protein (ISP) isolated from
adrenals (Suzuki & Kimura, 1965; Kimura & Suzuki, 1965;
Omura et al., 1965) and having a molecular weight of about
22,000 was shown to contain two atoms of iron and two moles
of labile sulfur per mole of protein. The iron atoms were
reduced in the presence of NADPH thus suggesting that they
play an important role in the catalytic function of this
protein (Omura et al., 1965; Watari & Kimura, 1966). Ohno
et al. (1967) demonstrated the existence of a similar non-heme
iron protein (testodoxin) in pig testis. Testodoxin, when
substituted for adrenodoxin, also served as an oxidation-
reduction component in the electron transfer system of adrenal
hydroxylase.
Cytochrome P450, the hemoprotein possessing protoheme
as a prosthetic group (Omura & Sato, 1964a,b) was demonstrated
to be the terminal oxidase of the NADPH - requiring hydroxylase
systems. This hemoprotein acted as the oxygen-activating
enzyme as well as the substrate binding site (Estabrook et al.,
1963; Omura et al., 1966). Reducing equivalents originating
from pyridine nucleotides served as the primary source of
electrons for the reduction of cytochrome P450 prior to the
activation of oxygen for substrate hydroxylation. The inter¬
relationship of components involved in cholesterol hydroxy¬




NADPH Fp ISP P450
pregnenolone .... (1)
1.3.3.2 Cytochrome P45Q
The hemoprotein pigment cytochrome P450 was so called
because of the intense absorption band at 450 nm produced by the
carbon monoxide derivative of the reduced hemoprotein (Omura
& Sato, 1964b). Cytochrome P450 has been detected in a large
number of tissues of mammals and other animals such as fish,
birds, amphibians (Ichikawa & Yamano, 1967) and house flies
(Ray, 1967). Bacteria (Conrad et aL., 1965; Cardini &
Jurtshuk, 1970), yeast (Linenmayer & Smith, 1964) and pea
seedling buds (Russell, 1971) have also been shown to contain
cytochrome P450. In mammals, cytochrome P450 occurs in the
lungs, liver, intestinal mucosa, kidney, pituitary and
steroidogenic organs. These hemoproteins catalyse the
oxidative metabolism of a broad spectrum of organic compounds
(Estabrook et al., 1972a,b). Cytochrome P450 from different
sources showed substrate specificity depending on the needs
of the cell and source. The basis for the substrate speci¬
ficity is not known. Certain differences in chemistry and
function of cytochrome P450 could be observed by changes in
the location of the spectral absorption maximum of the carbon
monoxide derivative of reduced cytochrome P450 - which varied
from 446 nm to 453 nm as well as the characteristics of the
low spin form of the ferric hemoprotein as determined by EPR
spectrometry.
TABLE 1.1
PROPOSED CLASSES OF CYTOCHROME P45Q
1. ADRENAL MITOCHONDRIA
1. membrane bound P450
1 soluble iron-sulfur protein
? soluble flavoprotein
2. LIVER MICROSOMES
12. membrane bound P450
3 membrane bound b^
1 membrane bound flavoprotein
3. BACTERIAL SYSTEM
1 soluble P450
1 soluble iron sulfur protein
? soluble flavoprotein
(after Estabrook etal., 1972b)
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1.3.3.3 Multiplicity of cytochrome P450
The existence of different forms and types of cytochrome
P450 has been demonstrated.
Depending upon the presence of various compounds capable
of functioning as substrates or inhibitors of hydroxylation
reactions ferric cytochrome P450 has been shown to exist in
a variety of forms - reversible transitions between low and
high spin states (Tsai et al., 1970; Peterson, 1971; Cammer
et al., 1966). Optical and electron paramagnetic resonance
spectral studies demonstrated the presence of at least three
forms of the ferric state. These are a) the high spin form
of the ferric hemoprotein observed in the presence of one
class of substrate (Type I); b) the low spin form observed
in the absence of substrate and c) a low spin form obtained
when compounds such as aniline, pyridine or metyrapone inter¬
acted with the hemoprotein (Type II) (Remmer et al., 1966).
Like hemoglobin or myoglobin, ferrous cytochrome P450
could reversibly form distinguishable complexes with oxygen
and carbon monoxide (Ishimura et al., 1971; Gunsalus et al»,
1971; Estabrook et al., 1971a).
In addition the cytochrome P450's have been observed to
differ depending on their localization within the cell, the
nature of the primary electron donor, and the structural
organization requisite for their function. Three general
classes of cytochrome P450 have been distinguished as shown
in Table 1.1.
(1) Adrenal mitochondrial type: This type of cytochrome
P450 required the presence of an iron-sulfur protein as a









FIG. 1.4 POSTULATED PATHWAYS OF ELECTRON TRANSFER OCCURRING
ON MICROSOMES DURING THE REDUCTION AND OXIDATION
OF CYTOCHROME P450
Valence of heme iron of cytochrome P450 is indicated
by the charge associated with Fe.
Fp = different flavoproteins
S = organic substrate to be hydroxylated
(after Hildebrandt & Estabrook, 1971)
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dehydrogenase and cytochrome P450 (Harding et al . , 1966;
Omura et al., 1966; Cammer & Estabrook, 1967a). Here the
membrane-bound cytochrome P450 exists in a 1:1 stoichiometry
with the soluble iron-sulfur protein which in turn reacts
with the readily soluble flavoprotein, NADPH-adrenodoxin
reductase (see Fig. 1.5).
(2) Liver microsomal type - typifying the cytochrome
P450 associated with the endoplasmic reticulum. Associated
with this type of hemoprotein no iron-sulfur protein has been
found to exist (Baron et al., 1972). Hildebrandt and
Estabrook (1971) suggested that cytochrome b^, as well as the
flavoprotein, NADPH-cytochrome C reductase, may function in
the capacity of electron donor. In this case, cytochrome P450
was reported to exist in a non-equivalent stoichiometric
relationship with a second hemoprotein cytochrome b<_ and at
least two flavoprotein dehydrogenases, NADPH-cytochrome C
reductase and NADH-cytochrome b,_ reductase (Estabrook et al 0 ,
1971b).
It has been postulated as shown in Figure 1.4 that
flavoprotein reductase or an unknown intermediate X
participates by donating the first electron required for the
reduction of cytochrome P450 resulting in the formation of
reduced cytochrome P450 (Masters et al., 1971). Whereas
cytochrome b,_, reduced by either the NADH or NADPH flavo¬
protein dehydrogenase serves as the donor of the second
electron required for the reduction of the oxy-ferrous

























FIG. 1.5 A PROPOSED SCHEME FOR THE CYCLIC REDUCTION
AND OXIDATION OF CYTOCHROME P450 DURING
INTERACTION WITH A SUBSTRATE AND OXYGEN
(after Estabrook et al., 1973)
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(3) Bacterial system - typified by the cytochrome P450
observed in the bacterium Pseudomonas putida. The bacterial
system was composed of soluble proteins, readily isolated and
purified. The bacterial cytochrome P450 was similar to the
cytochrome P450 containing electron transport system present
in mitochondria (Peterson, 1970). In this case the flavo-
protein dehydrogenase was able to function with either NADPH
or NADH (Cushman et al ., 1967).
1.3.3.4 The mechanism of function of cytochrome P450
During the last few years a generalized scheme was
proposed (Estabrook et al., 1971c, 1972a,b, 1973) describing
the interaction of cytochrome P450 with its substrates oxygen
and an organic substance (drug, steroid etc.) as well as with
electron transport carriers necessary for its reduction.
Direct evidence for the reactions proposed and some of the
intermediates postulated were provided from studies with
purified bacterial cytochrome P450 (Gunsalus et al., 1973;
Ishimura et al., 1971; Griffin & Peterson, 1972). Experiments
with the adrenal and liver cytochrome P450's are consistent
with the proposed scheme. The cyclic reaction of cytochrome
P450 involve at least six steps as shown in Figure 1.5.
Step 1. An organic substrate (S) reacts with the low
spin form of the ferric (Fe ) cytochrome P450 to form a high
spin ferric substrate complex (Fe3+)f>H. This interaction is
reversible.
Step 2. The ferric-substrate complex of cytochrome P450
undergoes a one electron reduction to form the ferrous-
substrate complex of the pigment (F
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Step 3. The ferrous substrate complex interacts
reversibly with molecular oxygen to form an oxy-ferrous-
2 +
substrate complex (Fe -O^.S), called oxycytochrome P450,
the nature of which remains undefined.
In the presence of carbon monoxide, a competition for
oxygen binding occurs resulting in the formation of the CO
adduct of reduced cytochrome P450, characterized by an
absorbance band in the blue portion of the spectrum with a
maximum at about 450 nm.
Step 4. The oxycytochrome P450 presumably then interacts
with an electron transfer component undergoing a second one-
electron reduction, forming an unidentified intermediate.
The intermediate could be a superoxide anion ferrous substrate
complex or a hydroperoxide derivative of ferric-substrate
complex of cytochrome P450.
Step 5. Presumably through an internal rearrangement,
one atom of the bound molecular oxygen is introduced as a
hydroxyl group into the substrate molecule with the concomitant
formation of water.
Step 6. The hydroxylated product dissociates from the
ferric cytochrome P450 regenerating the uncomplexed low spin
form of the ferric hemoprotein.
1.4 CONVERSION OF PREGNENOLONE TO TESTOSTERONE
1.4.1 Pathways
Over the past ten years a considerable amount of data
has been published on the biosynthesis of androgens from






















FIG. 1.6 SUGGESTED PATHWAYS OF TESTOSTERONE BIOSYNTHESIS
FROM PREGNENOLONE IN TESTICULAR TISSUE IN VITRO
AND IN VIVO ~
I. 30-Hydroxysteroid dehydrogenase;
II. A 5_ a4_Hydroxysteroid isomerase;
III. 17a-Hydroxylase;







testosterone production have been established mainly by
results obtained by in vitro experiments and some confirmed
by in vivo studies.
As shown in Figure 1.6 there are two major pathways to
testosterone from pregnenolone. The dominant pathway (the
4-ene pathway), which utilizes 4-ene-3-cxo intermediates viz
progesterone, 17a-hydroxyprogesterone and androstenedione was
demonstrated clearly in vitro in the testes of rats (Shikita
et al., 1964; Shikita & Tamaoki, 1965a; Tamaoki & Shikita,
1966b; Bell & Vinson, 1968; Lynn & Brown, 1958; Slaunwhite
& Samuels, 1956; Slaunwhite & Burgett, 1965), other rodents
(Tamaoki & Shikita, 1966a; Murota et al., 1965; Inano et al..
1967a), rabbit (Tamaoki & Shikita, 1966), monkeys (Sharma
et al. , 1967) and boars (Kahnt et al., 1961); while the
alternative pathway which involves the transformation of 5-ene-
3y3-hydroxysteroid intermediates such as 17a—hydroxy-
pregnenolone and DHA to testosterone, has been demonstrated
in vivo in dogs (Eik-Nes & Kekre, 1963; Ibayashi et al.,
1965).
Although the occurrence of this DHA pathway has been
inferred for testes of rats (Ibayashi et al., 1965; Bedrak
et al. , 1973; Slaunwhite & Burgett, 1965), mouse (Ellis &
Berliner, 1965; Grosso & Ungar, 1964), rabbit (Hall et al.,
1964), canine (Eik-Nes & Hall, 1965b), porcine, bovine (Kahnt
et al. , 1961) and human foetus (Acevedo et al., 1961; Ellis &
Berliner, 1969), the evidence remains indirect (Eik-Nes &
Hall, 1965b; Eik-Nes, 1971). Opinions differ concerning the
existence of the pathway and its significance in the bio¬
synthesis of testosterone specially in rat testicular tissue
(Shikita et al., 1964; Tamaoki & Shikita, 1966a). The
inability to demonstrate the pathway in vitro has been
attributed to the loss of enzymes during the in vitro studies
(Ellis & Berliner, 1969).
A connection between the two pathways involving the
conversion of 17a-hydroxypregnenolone to 17a-hydroxyprogesteron
has been observed in vivo in canine testis (Hagen & Eik-Nes,
1964). The importance of this pathway is not known. Hoivever,
it is of interest to observe that the formation of the
progestational hormone - progesterone is by-passed.
Progesterone has been reported to inhibit spermatogenesis
(Erricsson & Dutt, 1965).
The conversion of DHA to testosterone can occur via two
routes involving as an obligatory intermediate (a) androstene-
dione (Eik-Nes, 1969) or (b) androstenediol - another steroid
with the 5-ene-3f3-hydroxy configuration. The involvement of
androstenediol has been observed in the in vitro conversion
of DHA to testosterone by testes of certain species, e.g.
rabbit (Rosner et al., 1964), monkey (Hoschoian & Brownie,
1967) and humans (Rosner & Macome, 1970) . A.ndrostenediol was
observed in canine spermatic vein blood and its increase after
LH administration reported (Yamaji et al., 1968). In rat, no
evidence was obtained for androstenediol as an intermediate
in testosterone biosynthesis (Tamaoki & Shikita, 1966a; Ellis
& Berliner, 1969). However, in heat acclimatized rat testis,
androstenediol was demonstrated as an obligatory intermediate
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in the biotransformation of DHA to testosterone (Bedrak et al.,
1973). In this respect the results of Dufau et al. (1971b)
are of interest. They found that peritubular cell monolayers
cultured from rat seminiferous tubules were able to convert
DHA. and androstenediol into androstenedione and testosterone.
1.4.2 Enzyme related to testosterone biosynthesis
The conversion of pregnenolone to testosterone requires
five enzymic reactions 17a-hydroxylation, lyase (desmolase),
3|3-hydroxysteroid dehydrogenation, 5-ene-3-oxo-steroid
isomerization and 17a-hydroxysteroid dehydrogenation. It was
demonstrated by cell fractionation studies that the enzymes
catalyzing these reactions were concentrated mainly in the
smooth surfaced microsomal fraction, i.e. smooth endoplasmic
reticulum (Christensen & Gillim, 1969; Inano et al., 1970;
1967a,b; Shikita & Tamaoki, 1965; Shikita et al., 1964).
The supernatant (105,000 x g) although essentially devoid of
these five enzymic activities was capable of stimulating the
conversion of pregnenolone to testosterone. This stimulation
was not related to the generation of reduced pyridine
nucleotides.
5-ENE-3P-HYDROXYSTEROID DEHYDROGENASE AND ISOMERASE
In co-operation with isomerase,5-ene-3(3-hydroxysteroid
converts pregnenolone to progesterone, androstenediol to
testosterone and also DHA to androstenedione in the presence
of NADP or NAD (Goldberg et al.. 1964; Slaunwhite & Burgett,
1965; Tamaoki & Shikita, 1966b; Wattenberg, 1958). The
isomerase which transforms 5-ene-steroid to 4-ene-steroid was
stimulated by NAD and NADH (Oleinick & Koritz, 1966). Indirect
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evidence based on HCG stimulation suggest that two different
3(3-hydroxysteroid dehydrogenases exist. The enzyme catalyzing
the conversion of pregnenolone to progesterone was reported
to be stimulated by HCG in immature animals (Inano & Tamaoki,
1966) whereas the dehydrogenase which transformed DHA to
androstenedione was not affected (Frowein, 1973).
Although these above transformations were generally
regarded as irreversible, it has proved possible under certain
conditions to reverse the reaction pregnenolone —•> progesterone
(Rosner et al., 1965; Ward & Engel, 1966). The physiological
significance of this reversal remains unknown.
17a-HYDROXYLASE. This enzyme catalyzes an irreversible
reaction requiring NADPH as cofactor and molecular oxygen
(Lynn & Brown, 1958; Inano et al., 1967b). One atom of
oxygen is inserted as the 17a-hydroxy group of the steroid
molecule (Nakano et al., 1968). Like other mixed function
oxidases, this hydroxylation involves cytochrome P450 (Inano
et al., 1970; Betz & Michels, 1973a,b).
C-17,20 LYASE which converts 17a-hydroxyprogesterone to
androstenedione by the cleavage of the side-chain, plays a
very important role in the production of C steroids (androgens)
from steroids (pregnene steroids). Like hydroxylases the
lyase also requires molecular oxygen and NADPH (Nakano et al.,
1966, 1967). This enzyme is not inhibited by cyanide or
catalase (Lynn & Brown, 1958).
17(3-HYDROXYSTEROID DEHYDROGENASE is responsible for the
last step in the course of testosterone production, i.e. the
reduction of the 17-ketone of androstenedione to the 17(3 —
hydroxy group. The enzyme catalyzes a reversible reaction
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which favours the reduced steroid-testosterone (Samuels, 1952).
The preferred cofactor is NADP. The equilibrium of the 17(3-
hydrogenation is greatly influenced by the ratio of NADPH:NADP.
1.5 INVOLVEMENT OF STEROID SULFATES IN TESTOSTERONE
BIOSYNTHESIS
Steroid sulfates have generally been reported as excretion
by-products of steroid metabolism but there are an increasing
number of reports suggesting that steroid sulfates may play
an important role in steroid production in testis.
Dehydroepiandrosterone sulfate occurs in human peripheral
blood as the predominant C^Q steroid (Baulieu, I960) and it
was suggested that circulating DHA sulfate may be used by
the testis in the synthesis of testosterone (Aakvaag et al. ,
1964; Dorfman & Ungar, 1965). Dixon et al. (1965) reported
that DHA and testosterone were converted to their respective
sulfates after incubation with normal human testes and the
DHA sulfate (3(3-yl sulfate) was converted to testosterone
sulfate (17(3-yl sulfate). After incubation with human
feminizing Leydig cell tumor, the production of 3(3 ~yl sulfates
of pregnenolone, 17a-hydroxypregnenolone and DHA were observed
(Pierrepoint et al., 1966). Recently, Raheja and Lucis (1970)
reported that human testis failed to convert DHA-sulfate to
free testosterone or free DHA in vivo. But in vitro, DHA
sulfate was transformed to free DHA, testosterone and
androstenedione. Aakvaag et al. (1964), after perfusing
canine testes with labelled DHA sulfate, detected labelled
testosterone in the spermatic venous effluent and perfused
tissue. The discrepancies in these observations have been
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FIG. 1.7 PROPOSED PATHWAYS OF ANDROGEN SYNTHESIS AND
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In rat testes, it was demonstrated that free steroids
such as aadrostenedione and testosterone were produced from
sulfated precursors— 17a-hydroxypregnenolone sulfate (Neher
& Kahnt, 1965) and DHA sulfate (Burstein & Dorfman, 1963).
A soluble extract of rat testes was able to transform DHA
and estradiol-17|3 to their respective 3-yl-sulfates (Payne &
Mason, 1965a,b). The testicular steroid 3j3-sulfatase activity
was found to be associated with the microsomal fraction
(Payne & Jaffe, 1970; Burstein & Dorfman, 1963). Payne and
Mason (1965a) observed that in rat the in vitro conversion of
DHA sulfate to androstenediol-3-sulfate occurred four times
more rapidly than that of DHA to androstenediol. The relative
conversion by the microsomal preparations of DHA. sulfate and
androstenediol sulfate to testosterone and aadrostenedione
in the presence of NAD, NADP and NADPH suggested that androstene-
diol-3-sulfate was the preferred precursor (Payne & Jaffe,
1970). On the basis of the 5a-reduced steroids isolated as
additional products of both sulfated substrates and the kinetic
studies (Payne et_al., 1969; Notation & Ungar, 1969a), a
general scheme for pathways of androgen synthesis involving
sulfated steroids was proposed (Payne & Jaffe, 1970) as shown
in Figure 1.7. It was suggested that the steroid sulfatases
may act as control enzymes providing a regulatory mechanism
for release of free steroids which could then be further
metabolized to active hormone (Payne et al., 1969; Payne &
Kelch, 1973). 5a-Androstane-3|3 ,17|3-diol the major distant
metabolite of androstenediol-3-sulfate and a potent inhibitor
of the testicular steroid sulfatase (Payne et al., 1969) may
act by feedback inhibition to control the amount of
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testosterone synthesized. Eased on their response to gonado-
trophins, the steroid sulfatase activity in seminiferous
tubules was shown to be different from those of the interstitial
tissue. The enzymic activity in the latter tissue was
suggested to be under the control of both LH and FSH (Payne
& Kelch, 1973), confirming the initial observations of
Notation and Ungar (1968), that HCG administration in vivo
to rats increased the in vitro steroid sulfatase activity.
Although the contribution from steroid sulfates were small
and highly variable, it was suggested to be an auxiliary
biosynthetic route (Notation & Ungar, 1969b). Whether
cholesterol sulfate can act as a precursor in this pathway
remains to be demonstrated.
1.6 ESTROGEN BIOSYNTHESIS BY TESTIS
It has been known for some time that adult men excrete
steroids with a phenolic A-ring in the urine. Until recently
only indirect and conflicting evidence existed for the
production and secretion of estrogens by mammalian testis
(Leach et al. , 1956; Fishman et al., 1967). Dynamic studies
suggested that more than half the production rate of estradiol
in blood was derived by peripheral aromatization of secreted
testosterone (Longcope et al., 1969; Baird et al., 1969a).
It was also claimed by other investigators that all the
circulating estrogen in men could be accounted for by extra-
glandular production (Lipsett, 1970; MacDonala, 1967, 1971).
More recently estradiol was measured in higher concentrations
in spermatic than in peripheral venous blood of men confirming
that the testis secreted estrogens (Kelch et al., 1972;
















ESTRADIOL - 17/S ESTRONE
FIG. 1.8 PREDOMINANT PATHWAYS OF ESTROGEN BIOSYNTHESIS IN
EQUINE TESTES
The width of arrows is proportional to activity.
> = more than one step may be involved. All
the participating enzyme systems were localized in the
microsomal fraction.
(After Bedrak & Samuels, 1969; Oh & Tarnaoki, 1971)
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Estrogens have been detected and their concentration
measured in testicular tissue of humans (Goldzieher & Roberts,
1952; Anliker et al., 1957), horse (Beall, 1940; Raeside,
1969), and foetal sheep (Attal, 1969). The conversion of
radioactive precursors to estrogens in vitro have been
reported in testes of man (Axelrod, 1965; Sharma & Gabrilove,
1971), rabbit (Rabinowitz, 1956, 1958) and rat (Inaba et al.,
1967; Ficher & Steinberger, 1971). However, Pierrepoint
et al. (1967) could not show a significant conversion of
pregnenolone or DHA and De Jong et al. (1973) of testosterone,
androstenedione or DHA to estrogens in testes of normal dog
and rat respectively. Eik-Nes (1967) demonstrated the in vivo
conversion of radioactive androstenedione to estrone and
estradiol during perfusion of dog testis.
The histochemical demonstration of estrone in Leydig
cells (Ashbel et al. , 1951) and the studies in which HCG was
used to stimulate testis, strongly suggest that testicular
estrogens were secreted by Leydig cells (Maddock & Nelson,
1952; De Jong et al., 1973). On the other hand, the
feminizing influence of Sertoli cell tumors (Witschi &
Mengert, 1942; Huggins & Moulder, 1945; Berthrong et al.,
1949; Teilum, 1949; Lewis & Stockard, 1950) together with
other indirect evidence has led to the view that estrogens
arise from Sertoli cells (Lacy et al., 1968; Lacy & Pettitt,
1970; Bass et al., 1973).
The biosynthesis of estrogens in equine testes has been
established in vitro (Bedrak & Samuels, 1969; Oh & Tamaoki,
1970). Figure 1.8 shows that estrone is produced from
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androstenedione through 19-hydroxyandrostenedione and then
19-oxo-androstenedione. The aromatizing enzymes (19-hydroxy-
lase and aromatase) were found to be concentrated in the
microsomal fraction of the equine testis (Oh & Tamaoki, 1971,
1973) .
1.7 REGULATION OF ANDROGEN BIOSYNTHESIS
1.7.1 Hormones
It has generally been observed that of the anterior
pituitary hormones, only luteinizing hormone (LH) regulates
the Leydig cells and the production of androgens in the testis
(see Eik-Nes, 1964a). Recently, evidence based on the binding
of radioiodinated LH (De Kretser et al., 1971) and radioimmuno¬
assay (Moudgal et al., 1971) conclusively demonstrated that
LK specifically binds to Leydig cells. Follicle stimulating
hormone (FSH), which mainly affects spermatogenic activity
(Dorrington et al., 1972), was observed to increase testosterone
synthesis in vitro (Hall & Eik-Nes, 1962) but this effect was
suggested to be due to contamination by traces of LH (Mason
& Savard, 1964; Moyle et al., 1971). Currently, there is
accumulating evidence that prolactin - a predominantly female
hormone may also influence androgen biosynthesis in the testis
(Bartke, 1971; Hafiez, 1971; Musto & Hafiez, 1972). The
two placental gonadotrophins, human chorionic gonadotrophin
(HCG; Brady, 1951; Hall & Eik-Nes, 1962) and pregnant mare
serum (PMS; Eik-Nes & Hall, 1965b) stimulate the secretion
of androgens by the testis, probably in a manner similar to
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LH; but unlike LH, HCG has been reported to also increase
the activities of microsomal 17oc-hydroxysteroid}C—17^ 20 lyase
(Schoen & Samuels, 1965) and 3(3—hydroxysteroid dehydrogenase
(Shikita & Hall, 1967)0 It has been demonstrated that LH does
not increase the conversion of pregnenolone to testosterone
but primarily enhances the oxidation of cholesterol to
pregnenolone in the mitochondria (Hall, 1966).
The mechanism of LH action in the testis is not clear.
Based on ovarian and adrenal studies, there are several ways
in which the trophic hormone could effect the metabolism of
cholesterol by the mitochondria. The rate of pregnenolone
production could be limited by controlling the availability
of the various substrates for cholesterol side-chain cleavage
namely:-
(a) NADPH - by affecting the cytoplasmic glucose
6-phosphate dehydrogenase activity (Koritz & Peron
1958; Savard & Casey, 1964; Haynes, 1958;
McKerns, 1969), mitochondrial nucleotide trans-
hydrogenase or malic enzyme (Simpson et al., 1972).
(b) Cholesterol - by affecting synthesis or mobilization
of cholesterol from cell stores (Behrman & Armstrong
1969; Behrman & Greep, 1972; Trzeciak & Boyd,
1973) or the synthesis of a "labile protein factor"
(Garren et al., 1965; Simpson et aL1972).
(c) Oxygen - by altering the blood flow to the organ
(Ellis, 1961, Wurtman, 1964).
(d) The accumulation of pregnenolone could result in
product inhibition of cholesterol metabolism
(Koritz & Hall, 1964a,b; Koritz & Kumar, 1970).
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Current concepts suggest that in part LH stimulates the
accumulation of cyclic AMP which in turn promotes steroido¬
genesis via intermediary factor(s) (Robison et al., 1971;
Moyle et al., 1971).
1.7.2 Nucleotides
Until recently the evidence for cyclic-AMP being the
mediator in the action of trophic hormones on steroidogenesis,
in testis, were generally indirect. In as much as cyclic-AMP
and its di'outyryl derivative have been shown to stimulate
steroidogenesis when added to rat testicular slices (Sandler
& Hall, 1966); whole testis (Connell & Eik-Nes, 1968;
Dufau et al., 1971b, 1972; Rommerts et al., 1972), or to
mouse Leydig cell tumors (Moyle et al., 1971) or administered
via the spermatic artery of anaesthetized dogs (Eik-Nes, 1971,
1967); it has been widely accepted that the LH-induced
testosterone biosynthesis is mediated by cyclic-AMP (Robison
et al., 1971). Eik-Nes (1969) demonstrated by infusion
experiments that the effect of cyclic-AMP on the rates of
secretion of testosterone was very specific since administration
of 5-AMP, 2',3'-AMP or 3'-AMP had no effect on testosterone
secretion. It was observed that the trophic stimulation of
cyclic-AMP accumulation in testis (Murad et al., 1969; Kuehl
et al., 1970; Eik-Nes, 1971; Dorrington et al., 1972) was
not due to inactivation of cyclic-AMP phosphodiesterase but
an augmented synthesis of cyclic AMP from ATP by adenylcyclase
localized in the nuclear membrane of the testicular tissue
(Murad et al., 1969; Pulsinelli & Eik-Nes, 1970; Eik-Nes,
1971). More recently, direct experimental evidence to support
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the view for cyclic AMP being the second messenger (Robison
et al. , 1971) in the trophic stimulation of steroidogenesis
in testis, was provided. Van der Molen and co-workers
(Rommerts et al., 1972; Cooke et al., 1972a) demonstrated
that in HCG stimulated rat testes and isolated interstitial
tissue, the increase in testosterone production was preceded
by increase in cyclic-AMP levels. LH, HCG but not FSH
increased the cyclic AMP content in rat Leydig cell prepara¬
tions (Cooke et al., 1972a,b; Moyle & Ramachandran, 1973)
and mouse tumor Leydig cells (Moyle & Ramachandran, 1973).
LH failed to stimulate cyclic AMP synthesis in the seminiferous
tubules.
The mechanism for the role of cyclic AMP in steroidogenesis
is obscure and some of the evidence conflicting. It has been
reported that LH acts at the site involved in the hydroxy-
lation of cholesterol (Menon et al., 1965a). However,
Pulsinelli u Eik-Nes (197o) reported that testicular mitochondria
will not enhance the conversion of endogenous or exogenous
cholesterol to pregnenolone in the presence of cyclic-AMP.
Furthermore, it has been observed that higher concentrations
of trophic hormone were required for maximal stimulation of
cyclic-AMP accumulation and the amount of cyclic AMP synthesized
was far in excess of that needed for maximal stimulation of
steroidogenesis. The stimulation of cyclic-AMP synthesis
was readily terminated by dilution of the LH whereas the




Prostaglandins occur in and are synthesized in the
testis (Carpenter & Wisman, 1970; Michael, 1973). The
significance of these findings are not clear and evidence of
the action of prostaglandin in testes are conflicting. In
other steroidogenic organs, prostaglandin for example
stimulated steroidogenesis (Speroff & Ramwell, 1970)
probably via cvclic-AMP (Marsh, 1970). In minced testes
from normal rats the addition of prostaglandin was observed
to increase the formation of cyclic-AMP. In contrast, Kuehl
et al . (1970) reported that prostaglandin E^ and E^<x will not
promote the accumulation of cyclic-AMP from ATP in homogenates
of rat testes. Eik-Nes (1969) observed that the infusion of
large amounts of prostaglandin E^ via the spermatic artery
of dogs increased the secretion of testosterone. This finding
was attributed to a possible increased blood flow in the
testis (Bergstrom, 1967; Eik-Nes, 1964b).
1.7.4 Serotonin and melatonin
Ellis al» (1972) suggested that serotonin and
melatonin may be involved in the normal regulation of
testicular function in rats. Serotonin and melatonin were
both found to non-competitively inhibit the 17cc-hydroylase
and 17a-hydroxy-pregnene-C-17?20 lyase activities. In
addition it was observed that serotonin increased and
melatonin reduced the 17(3-hydroxysteroid dehydrogenase
activity.
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1.8 INFLUENCE OF AGS ON TESTICULAR STEROIDOGENESIS
A considerable body of evidence has accumulated showing
that the testes of foetal and immature rats produce androgenic
substances and that this capacity varies with the growth and
differentiation of the Leydig cells both pre- and post-
natally. In rats the Leydig cells rapidly multiply and
differentiate from day 15 of foetal life (when the cells are
clearly distinguished) until day 19 when the cells reach the
climax of their quantitative development (Roosen-Runge &
Anderson, 1959; Niemi & Ikonen, 1963). This phase is then
followed by a drastic regression or de-differentiation of the
Leydig cells until day 4 after birth, when the cells are
virtually absent. From about the fourth post-natal week,
concomitant with the appearance of the first spermatids, a
second generation of Leydig cells differentiate and develop
to the adult level by the third month (Roosen-Runge & Anderson
1959; Niemi & Ikonen, 1963, 1966; Clegg, 1966; Hitzeman,
1962; Niemi & Kormano, 1964). The appearance of this second
generation of Leydig cells coincides with the secretion of
gonadotrophins shortly before puberty (Niemi & Ikonen, 1961,
1962). In mouse only a single generation of Leydig cells
has been reported to occur (Baillie, 1961, 1964).
1.8.1 Foetal testes
The influence of steroid androgens on mammalian sexual
differentiation has been well documented by biological
experiments (Jost, 1965; Price & Oritz, 1965; Goldman, 1970)
and the presence of testosterone and other neutral steroids
in foetal testis demonstrated (Attal, 1969; Huhtaniemi et al.
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1970). Although there are some conflicting reports, in
general, at about the time Leydig cells first appear, the
foetal testes acquire certain steroidogenic enzymes and can
convert pregnenolone to androgens - the predominant androgen
being testosterone. During this period differentiation of
the genital ducts occur. The presence of the enzymes required
for the conversion of pregnenolone via progesterone to
androstenedione and testosterone have been established by
several investigators (Acevedo et al., 1963; Bloch, 1964,
1967; Liosett & Tullner, 1965; Noumura et al., 1966; Serra
et al., 1970). It has also recently been reported that rat
foetal testes possess the enzymes necessary for de novo
synthesis of testosterone from acetate (Warren et al.. 1972,
1973; Serra et al., 1970).
In rat, the ability of foetal testes to metabolize
radioactive acetate and radioactive pregnenolone to labelled
testosterone could not be detected before 15.5 days of
intrauterine existence (Warren et al., 1972, 1973; Bloch
et al., 1971). However, testosterone formation from
progesterone was demonstrated as early as 13.5 days of
gestation (Noumura et al., 1966) and a small amount of
pregnenolone conversion to progesterone at 14.5 days (Bloch
et al., 1971). The observation that testes at 14.5 days of
foetal age formed no radioactive testosterone when incubated
in vitro with radioactive acetate or pregnenolone supported
the lack of enzymes needed for testosterone biosynthesis from
these precursors before 15.5 days of foetal life (Warren
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et al., 1973) and suggested that the main precursors utilized
in the production of androgens by 13.5-14.5 day foetal
testes may not be acetate or pregnenolone but progesterone
derived from maternal blood (Grota & Eik-Nes, 1967; Warren
et al., 1973). From day 15 after gestation, the steroid
biosynthetic activity as well as testicular testosterone
levels in the foetal rat was observed to increase sharply
and to reach a maximum on day 18. This activity was maintained
at the same high level up to a few hours after birth, when a
precipitous drop was recorded (Noumura et al., 1966; Warren
et al., 1973). The factors responsible for regulating
testosterone synthesis in the foetal testes are currently
unknown but maternal or placental gonadotrophins are assumed
to be involved.
1.S.2 Post-natal testes
Information in literature indicates that post-natal
testes at different stages of development produce different
steroids and show a characteristic change in the pattern of
the enzymes. These changes appear to be a reflection of the
post-natal regression and prepubertal redifferentiation of
the Leydig cells.
In a systematic study using rat testes at different
stages of development, Steinberger and Ficher (1968, 1969)
demonstrated a biphasic character of the capacity of
differentiating testes to convert progesterone to testosterone.
A high rate of conversion, equal to and possibly higher than
that obtained with testicular tissue from an adult animal,
PROGESTERONE
Dihydrote stosterone
FIG. 1.9 POSTULATED PATHWAYS OF PROGESTERONE METABOLISM IN
TESTICULAR TISSUE CHARACTERISTIC OF IMMATURE RATS
Thick arrows indicate the relatively major pathway of
steroid conversion. All the enzymes involved were








was observed in testes from newborn rats (Steinberger & Ficher,
1S68; Noumura et al. , 1966). The rate diminished progressively
as the testes developed reaching essentially zero at the age
of 20 days. With further development, the capacity for
testosterone synthesis gradually increased, reaching high
levels in 90 days (Steinberger & Ficher, 1968; Inano et al.,
1967c). Resko et al. (1968) and Knorr et al. (1970) found
that testosterone levels in plasma and testicular tissue of
rats followed a similar biphasic pattern.
The pattern of formation of androstenedione was similar
to that of testosterone. However, androstenedione appeared
earlier than testosterone in the course of sexual maturation
and resulted in an androstenedione/testosterone ratio of
greater than 1. As the testis developed, the conversion
rate to testosterone increased, while androstenedione formation
did not change significantly, causing a reversal in the ratio
(Inano et al., 1967c; Hashimoto & Suzuki, 1968). Such a
transition from androstenedione to testosterone dominance has
also been observed in guinea pig (Snipes et al., 1965; Becker
& Snipes, 1968) and bull (Lindner, 1961b; Lindner & Mann,
I960)o The enzyme responsible for converting androstenedione
to testosterone thus appears to arise late in the course of
the differentiation of the Leydig cells in post-natal life.
The testes of 20-day-old rats, while not capable of
accumulating testosterone, metabolized progesterone very
efficiently to two major 5a-reduced c steroids, androsterone
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and androstanediol (Steinberger & Ficher, 1969; Coffey et al.,
1971) (see Fig. 1.9). Androstanediol was reported to appear
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earlier (at day 13) than androsterone (at day 17) (Ficher &
Steinberger, 1971). A number of other investigators
(Sylianou et al., 1961; Nayfeh et al., 1966; Ficher &
Steinberger, 1968, 1971; Inano et al., 1967c; Yamada &
Matsuraoto, 1974) also demonstrated the conversion of suitable
precursors to 5a-reduced androgens by testicular tissue from
immature rats. As the capacity for converting progesterone
to testosterone diminished with progressive maturation of the
testes, the formation of androsterone gradually increased and
reached a peak at the time when testosterone was detected in
only trace amounts. As maturation of the testes progressed
further and progesterone conversion to testosterone increased,
the formation of the 5a-reduced steroids diminished.
Hall et al. (1969) reported that in vitro conversion of
cholesterol to androgens by isolated Leydig cells from testes
of rats aged 20 days was less than with cells from mature
animals.
Inano et al. (1967c) investigated the enzyme pattern of
immature rat testes and observed that the concentration of
3(3-hydroxysteroid dehydrogenase, 17a-hydroxylase, C—17?20-
lyase and the 17|3-hydroxysteroid dehydrogenase gradually
increased between the ages of 20 and 60 days post-natal and
levelled off at the time approaching maturity. In contrast, the
4-ene-5a-reductases (pregn-4-ene and androst-4-ene-5a—
reductases sharply increased between days 20 and 30 and then
dropped rapidly between days 40 and 60. This disappearance
was observed to coincide with a sharp increase in the growth
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rate of the seminal vesicles and prostate (Lindner, 1968).
4
The predominance of the catabolic pathway (A -5-reductases)
appears to be characteristic for certain stages in the develop¬
ment and maturation of the testis. Thus testicular tissue of
post-nata.l rats of all ages contain the enzymes involved in
the biosynthetic pathways from progesterone to androgens - a
functional capacity acquired during foetal life and retained
in post-natal life. The process of differentiation therefore
appears to involve mainly induction or suppression of the
ring A reductase system which regulates the accumulation and
catabolism of testosterone, rather than with enzymes dealing
with the synthesis of the androgen from progesterone.
The physiological significance of 5a-reductase activity
during differentiation of the androgen biosynthetic pa.thways
remains to be determined. The cell type containing the 5a-
reductase system and the factors which regulate this enzymic
activity are also not known. However, it has been suggested
that the high serum FSH levels observed in the immature rats
may play a role in the increased reductase activity (Coffey
et al. , 1971). Swerdloff et al. (1971) demonstrated that
serum LH levels were only slightly lower and FSH levels two
to three times higher in immature than in mature rats. FSH
levels were maximal at 35 days of age and low at about 50 days
of age corresponding with the decline in reductase activity.
Recently, Rivarola and Podesta (1973) reported that androstanediol
was the main in vitro metabolite of testosterone and was found
in high concentrations only in the isolated seminiferous tubules
of immature 20-26 day old rats but not in the mature ones.
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1.9 AIMS OF PRESENT STUDY
Although the pathways related to the synthesis of
androgens in testes have been demonstrated there is compara¬
tively little information on the biochemistry of steroidogenesis„
The first step in steroid biosynthesis, namely the hydroxylation
of cholesterol, has been suggested to be the rate-limiting step
and the site most likely to be affected by trophic hormones,
hence special interest has been attached to this reaction.
Many of the concepts are assumed to be similar to those of the
adrenal gland or ovaries from which much of the thinking and
speculation has evolved. The aim of the present study therefore
was to investigate and characterise the properties of the
cholesterol side-chain cleavage reaction in rat testes in the
following way:
(1) To evolve a sensitive and quantitative method for the
assay of the enzymatic activity.
(2) To re-investigate the subcellular localization, cofactor
requirements and optimal conditions for cholesterol side-
chain cleavage activity.
(3) To investigate whether cytochrome P450, the oxygen
activating and substrate binding component of hydroxy¬
lation reactions is present in testes mitochondria and to
establish whether this enzyme component participates in
cholesterol side-chain cleavage activity.
(4) To attempt to establish whether the seminiferous tubules
and Leydig cells are both capable of de novo steroid
biosynthesis from cholesterol.
(5) To attempt to investigate the mode and site of action of
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In this chapter the techniques which form the basis for much
of the work presented in subsequent sections will be described.
2.1 TISSUE SOURCE
Testes from normal rats of the Wistar strain were used.
The rats were bred in the Clinical Endocrinology Unit, Medical
Research Council, Edinburgh. Unless otherwise stated, each
experiment consisted of a group of 8 to 12 animals - all of
the same age. The rats were killed by a blow on the head
followed by cervical dislocation. The testes were then
quickly removed via a ventral approach, dissected away from
the adhering epididymis and superficial fat, and placed in
ice cold isotonic KC1. Subsequent fractionation procedures
were carried out at 4°C.
2.2 SUBCELLULAR FRACTIONATION
Gonads thus obtained within 20 minutes of the death of the
animals were washed several times with isotonic KC1, (until
free of adhering blood) and finally rinsed in homogenizing
medium. The testes were weighed and the tunica albuginea (sac)
and testicular artery carefully removed. The remaining
tissue was then homogenized in three volumes (vol/gm wet
weight) of medium consisting (unless stated otherwise) of 250 mM
sucrose-0.2 mM EDTA and 10 mM Tris (final pH 7.4) (Medium H).
The homogenization was carried out using a loose-fitting Potter-
Elvehjem type teflon pestle - glass homogenizer„ The teflon
pestle was motor driven and the glass homogenizer kept on ice to avoid
TABLE 2.1
CELL FRACTIONATION PROCEDURE
hashed Fresh Rat Testes
Decapsulated




Resuspended in 2 vol.
medium H
Centrifuged 470 x g/lO mins.
, 1



















Resuspended in medium H
















(washed in Medium H)
SUPERNATANT
(Cytosol)
(All fractionation procedures were carried out at 4°C)
- 38 ~
heatingc No more than 8 passes of the pestle were made.
This crude homogenate was then subjected to differential
centrifugation as outlined in Table 2.1. The pink homogenate
was centrifuged at 470 x g av. for 10 minutes in an M.S.E.
High Speed 18 centrifuge to sediment the nuclei, seminiferous
tubular fragments, unbroken cells, cell debris and sperms.
The pale supernatant was carefully decanted and retained while
the pellet was re-suspended in 2 volumes of medium H and
centrifuged again at 470 x g for 10 minutes. The resulting
pellet was discarded, and the supernatant was combined with
that of the first centrifugation and recentrifuged at 360 x g
for 20 minutes. This low speed centrifugation was necessary
to remove most of the remaining spermatids, sperm tails and
heads and other cellular fragments. This 'cell and fragment
free' supernatant was carefully removed with a Pasteur pipette
and then centrifuged at 6,000 x g for 20 minutes to sediment
the 'heavy mitochondria' (HM). The thin white film at the
top of the tube was first aspirated off and the inner walls
wiped. The supernatant fluid was decanted and retained, while
the packed light brown heavy mitochondrial pellet was washed
three times by re-suspending in medium H (with gentle strokes
by hand in a loose-fitting Teflon-glass homogenizer) and then
resedimented at 10,000 x g for 10 minutes. This washed heavy
mitochondria was suspended in Medium H giving a protein con¬
centration of between 8 to 10 mg/ml. The light mitochondria
(proba.bly consisting of mitochondria, broken mitochondria and
heavy microsomes) was separated from the 6,000 x g supernatant







• •• • » •
o ix \>»v»
. * ••• •• •,
• % •





FIGURE 2.1 Diagrammatic representation of the fractionation
achieved after centrifugation of crude heavy
mitochondria on a discontinuous 3-10% ficoll
density gradient.
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supernatant was removed and further centrifuged at 105,000 x g
in a Beckman UTtracentrifuge for 1 hour, yielding a white micro¬
somal pellet and pale pink supernatant (cytosol). Both the
light mitochondrial and microsomal fractions were washed once
and suspended in medium H. This subcellular fractionation
procedure was carried out between O to 5°C.
2.3 FURTHER FRACTIONATION OF HEAVY MITOCHONDRIA
In an attempt to obtain a clean homogeneous mitochondrial
preparation rich in cholesterol side-chain cleavage activity,
the crude heavy mitochondrial fraction obtained by differential
centrifugation (section 2.2), was subjected to density gradient
centrifugation on ficoll. The following operations were
carried out at 4°C.
Using a 60 ml centrifuge tube, 8 to 10 ml of the heavy
mitochondrial fraction suspended in medium H, was carefully
layered over a discontinuous ficoll density gradient consisting
of 14 ml each of 10% (bottom), 6% (middle) and 3% ficoll (top):
the ficoll was dissolved in medium H in order to maintain
isotonicity. After centrifugation at 10,000 x g for 1 hour
in a Beckman swing-out rotor (Model S.W. 25.2) five clearly
discernible particulate fractions were obtained. These
heavy mitochondrial sub-fractions (HMF) were designated, as
indicated in Figure 2.1 (in order, from the top) as:-
HMF 1 - a white light turbid layer corresponding to medium H
and separated by a thin clear layer from
HMF 2 - a broa.d white dense turbid layer corresponding to
3% ficoll.
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HMF 3 - a broad yellowish brown layer corresponding to 6%
ficoll.
HMF 4 - a floating brownish narrow band at the interface
between the 6% and the almost clear 10% ficoll layers,
and
HMF 5 - the dark brown hard packed pellet at the bottom of
the tube.
These fractions were carefully removed separately with the
aid of a Pasteur pipette and retained. All the fractions were
diluted with, or suspended in medium H and then centrifuged
at 12,000 x g in an M.S.E. High Speed 18 centrifuge for 15
minutes. This process was repeated once more to wash off the
ficoll. The final pellets of the different fractions were
again suspended in medium H.
It was observed (see Chapter 3 section 3) that most of
the cholesterol side-chain cleavage activity occurred in
fractions 4 and 5. However, only fraction 5 was collected
routinely and used for the studies on cholesterol side-chain
cleavage and related aspects of testes metabolism.
Ficoll - a nonionic synthetic high polymer of sucrose
and epichlorohydrin (Mol. wt. 400,000 ± 100,000) was chosen
for the fractionation of heavy mitochondria because it provides
high density solutions of low viscosity and osmotic pressure.
2.4 DETERMINATION OF CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
THE BASIS OF THE ASSAY
The reaction being studied can be written simply as
follows:-
TABLE 2.2
COMPOSITION OF ROUTINELY USED INCUBATION MEDIA
Medium A Final Molarity (mM)




Tris buffer pH 7.5 50
Potassium chloride 20
Potassium phosphate buffer, pH 7.5 10
EDTA (pH 7.0) 0.3
Bovine serum albumin (fatty acid free) 0.15% (wt/vol)
Electron Source
1. DL Isocitrate 5




Glucose-6-phosphate dehydrogenase 0.2 I.U.
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This reaction can be followed by measuring the conversion of
cholesterol either to the steroid products or to isocapro-
aldehyde. The enzymic assay used throughout this study was
•—> 14 ~7 ~ 14 -n
based on the conversion of added /_4- C/ cholesterol to /A- C/
steroid products, the electrons being supplied either by
isocitrate or extramitochondrial NADPH generating system (see
Table 2.2). The activity was therefore expressed as the
/— 14 —
percentage conversion of /_A- C/ cholesterol to the labelled
steroid products.
2.4.1 Incubation procedure
Immediately before use aliquots of ^4-^0/ cholesterol
(58 nCi/mg) were subjected to thin-layer chromatography on
silica gel G using di-isopropyl ether:petroleum ether (boiling
point 60-80°C):acetic acid (75:35:2 by vol.) as solvent
system to remove any auto-oxidation products. The radio-acti.ve
area corresponding to the authentic reference cholesterol spot
was eluted from the plate with redistilled acetone.
Heavy mitochondria (0.5 mg protein) were incubated in a
final volume of 200 p1 (in 10 x 75 mm test tubes) in either
medium A or B (Table 2.2) together with either DL isocitrate
+
5 mM or an extra-mitochondrial NADPH generating system (NADP
5 mM, glucose-6-phosphate 40 mM and glucose-6-phosphate
dehydrogenase 0.2 I.U.) as electron source. The reaction was
14 ~~7
initiated by the addition of 200,000 cpm of /A- C/ cholesterol
TABLE 2,3
EXTRACTION PROCEDURE
Incubation reaction terminated by addition of
3 vol.* ethyl acetate : methanol (1:1) mixture


















mixed with 2 vol. distilled
water and 20 vol, chloroform
pooled
Centrifuged
(to separate the layers)
























Applied to TLC plate
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(approx. 2 \ig) in 2 p. 1 acetone. Incubations were carried out
37°C in an atmosphere of air using a Dubnoff incubator with
constant shaking. The period of incubation varied as indicated
in the text but was usually 1.5 or 2 hours. The enzymic
reaction was terminated by the addition of 600 p. 1 of ethyl-
acetate : m ethanol (1:1) containing 3 p.g each of the following
carrier standard steroids and sterols:- pregnenolone, dehydro-
epiandrosterone (DHA), androstenediol, progesterone, 17a-hydroxy-
pregnenolone , androstenedione, testosterone, 17a-hydroxy-
progesterone, cholesterol, 20a-hydroxycholesterol and cholesterol
oleate (representing cholesteryl esters). Tubes were sealed
and kept at -20°C until extraction. Control samples were
complete reaction mixtures either stopped at zero time or
incubated with a boiled enzyme fraction (i.e. enzymic preparation
denatured by placing the tubes in a water bath for 2 minutes).
Unless stated otherwise, all incubations were routinely
carried out in duplicate.
2.4.2 Extraction procedure
The extraction procedure is outlined in Table 2„3. The
denatured protein precipitate was sedimented using a bench
centrifuge. The clear supernatant was removed with a fine
tipped Pasteur pipette and reserved in a glass stoppered conical
centrifuge tube. The pellet was broken up and extracted 4 times
with 4-00 ill of hot (approx. 50°C) solvent mixture consisting of
acetone: ethyl acetate: methanol (2:1:1). The supernatants
were combined, 4^0 distilled water added mixed and then
extracted with 4 ml chloroform. After a thorough mixing, the
layers were separated by centrifugation. The upper aqueous
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and'any remaining precipitate at the interface was carefully
removed and transferred to the original incubation tube which
contained the final pellet now suspended in 600 p. 1 ethyl ether:
methanol (5:1), and mixed. This mixture was re-extracted
(twice) with 1.5 ml of chloroform and centrifuged. The lower
organic layer was removed with a Pasteur pipette and pooled
with the main organic fraction in the conical centrifuge tube
and stored under nitrogen at -20°C. The remaining upper
aqueous layer and denatured protein band were discarded. Just
before thin layer chromatography, any remaining aqueous layer
was removed with a fine tipped Pasteur pipette and the organic
extract taken to dryness under a stream of nitrogen at 45°C.
This entire extraction procedure was carried out in two
tubes - the original incubation tube and the extraction conical
glass centrifuge tube. No significant amount of material was
lost during the procedure. Recoveries could be monitored at
each stage and any radioactivity remaining re-extracted if
necessary. Under these conditions recoveries werecomplete
(see Table 2.6).
2.4.3 Thin layer chromatography of organic extract
To separate the steroids, thin layer chromatography was
performed at room temperature (21-23°C). The inner walls of
the TLC chamber were lined with filter paper to increase
saturation for a more even migration of steroids and solvent
across the plates. Thin layer glass plates (5 x 20 cm or
10 x 20 cm) precoated with silica gel P~254, layer thickness
0.25 mm were used. The extracts were dissolved twice
successively in each of the following solvents: a) chloroform
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b) chloroform : methanol (2:1) c) acetone : ethyl acetate:
methanol (2:1:1) and d) ethyl ether : chloroform: methanol
(2:2:1), and spotted on the TLC plate 1.5 cm from the bottom
and near the left hand edge (i.e. plates were divided into
two vertical lanes). Non-radioactive steroid standards were
applied at the other edge (right hand) of the same plate.
The chromatoplates were developed in di-isopropyl ether :
petroleum spirit (b.pt. 60-80°C) : acetic acid (80:35:2 v/v),
three or four times (as indicated) in the same direction with
air drying for one minute between each run.
After chromatography, the 3 -oxo-4-ene steroids were located
under 254 nm U.V. light and marked. Then the side with the
radioactivity was masked off xvhile the opposite edge of the
plate bearing the reference steroids was visualized by spray¬
ing with a freshly prepared mixture of sulfuric acid: methanol
(2:1 v/v). The heat generated by this solution was sufficient
to ensure colour development without warming at 110°C. All
radioactive peaks were detected by scanning the plates under
a Panax windowless, gas flow, Geiger-Muller type radio-
chromatogram scanner (Panax Equipment Ltd., System E.Olll/
P7900A). A carrier gas mixture of 98% argon and 2% propane
was employed.
It was initially observed that lipid like material in
testicular extracts from large incubations of l.O ml or more,
interfered with the spotting and mobility of steroids on the
precoated chromatoplates. Several preliminary attempts to
remove the interfering material by treating the extracts with
1% petroleum ether (40-60°C) and 80% ethanol, ethanolic
TABLE 2.4
EFFECT OF SILICA GEL F254 ON RADIOACTIVE COUNTING
EFFICIENCY












1 5,311 ± 50 5,232 ± 145 5,296 ± 81
2 11,798 ± 102 11,785 ± 99 11,675 ± 130
3 49,331 ± HO 49,403 ± 189 49,469 ± 95
4 105,096 ± 111 104,920 ± 160 104,898 ± 405
5 150,728 ± 257 150,802 ± 210 150,698 ± 380
Five sets of estimations were performed with different
amounts of cholesterol as indicated. Each set
containing the same quantity of radioactivity throughout
the different experiments.
In experiment A cholesterol was added directly
into scintillation vials and counted
2
B Silica gel equivalent to 6cm from the
TLC plate was added to vials containing
cholesterol and counted.
C cholesterol was spotted on TLC
plates and silica gel then scraped into
vials and counted by liquid scintillation
spectrometry.
TLC plates were obtained from E. Merck, Darmstadt, Germany,
precoated with silica-gel F254 (layer thickness C.25 mm).
The mean values represent the averages of six samples per set
± standard deviation of this mean.
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MgCl^ or column chromatography were not satisfactory. These
procedures all resulted in loss of radioactive compounds
(20-30%). This problem was overcome by the use of the micro-
incubation system of 200 jil final volume described above.
No further preliminary purification of the extracts was necessary,,
2.4.4 Measurement of radioactivity
TLC plates were lightly sprayed with water (this allows
the gel to be scraped off as a flake rather than powder) and
the radioactive zones corresponding to the radioactive peaks
and standard steroids were scraped directly into vials, dried
in a warm oven and then suspended in 10 ml of scintillation
fluid consisting of 4 gm 2,5-diphenyloxazole (PPO) and 30 mg
1,4-bis-(5-phenyloxazoly-2-)-benzene dissolved in 1 litre of
dry toluene containing 2% redistilled methanol. The radio¬
activity of the samples were assayed in a Packard Tricarb
liquid scintillation spectrometer, model 314-Ex. Samples were
counted until the standard deviation of the counts obtained
was below 1% of the mean. Under the conditions employed, the
14
counting efficiency for the C isotope was 82%.
2
It was ascertained that up to 6 cm of silica gel could
be added to the scintillation solution without impairing the
counting efficiency as s'noivn in Table 2.4. These results
confirm previous observations of Mitton (1967) with silica
gel H and Robinson (1971) with silica gel G. In routine assays
the area of silica gel scraped into each vial did not exceed



























































































2.4.5 Recovery of /A- C/ products throughout the
experimental procedure
— 14 —
This was ascertained by adding the /A- C/ steroids and
sterols listed in Table 2.5A, to a series of six incubation
tubes containing medium B and heavy mitochondria. Further
metabolism of these added compounds was prevented by the
immediate addition of ethyl acetate:methanol (1:1) and the
'incubates' then subjected to the same procedure previously
described for extraction, TLC, scanning and counting.
At different stages of the extraction procedure (Table 2.6)
samples were taken and their radioactivity estimated by liquid
scintillation counting. Aqueous layers were taken to dryness
and the protein pellets digested with 500 p1 soluene (Packard
Instruments Co.) before the addition of scintillator fluid.
The results in Table 2.6 show that recovery after extraction
ivas greater than 95%.- Table 2.5B shows that the ratio of
labelled compounds estimated after TLC and scintillation
counting were similar to that added initially. This indicates
that when losses did occur they would not affect the calculations
of the cholesterol side-chain cleavage activity when this was
expressed as the percentage of /A-^ £/ cholesterol converted
to /_A- C/ steroid products. Most of the loss which could
occur could be due to the material being left in the
centrifuge tube when the plates were spotted.
2.5 PROCEDURES USED IN THE IDENTIFICATION OF STEROID PRODUCTS
2.5.1 Chemical conversion
A. OXIDATION: To the dried steroid extract was added 0.5 ml
of a 5% solution (w/v) of chromic acid in glacial acetic acid.
TABLE2.6























After 4 hours at room temperature 2 ml of water was added and
the steroid extracted twice with 4 ml chloroform:ether (1:1).
The washed extracts were pooled, concentrated and spotted on
TLC plates.
B. REDUCTION: The steroid samples dissolved in 500 p. 1 methanol
was incubated with 5 mg sodium borohydride for 1 hour. 1.0 ml
water was then added followed by a few drops of hydrochloric
acid to decompose the unreacted borohydride. The steroids
were extracted with chloroform and the extracts washed twice
with water before being submitted to TLC.
C. ACETYLATION: 200 p. 1 of a mixture of pyridine-acetic
anhydride (1:1 v/v) was added to the sample of the dry steroids.
After an overnight incubation at room temperature under N^,
the reaction was terminated by the addition of 200 p.1 methanol.
This mixture was evaporated to dryness under a stream of
nitrogen. The steroids were then extracted with chloroform:
methanol (3:1) and submitted to TLC.
2.5.2 Enzymatic conversion
Steroids were incubated with a steroid-3[3-ol dehydrogenase
preparation from Pseudomonas testosteroni and an excess of NAD
for 30 minutes at 37°C. The incubation system consisted of
200 ^il Tris buffer pH 7.5 (50 mM) , 50 p 1 of steroid 3(B-ol
dehydrogenase and 10 p1 NAD (2 mM). Steroids were added in
acetone (3 pi). Reaction was terminated by the addition of
methanol:acetone (1:2) and the steroids extracted as previously
described (section 2.4.2).
Steroid 3(3-ol dehydrogenase ivas prepared by homogenizing
50 mg of dried cell preparation of Pseudomonas testosteroni
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(Type I) in 5 ml of 20 mM Tris buffer, pH 7.5. After 1 hour
at 5°C, the suspension was centrifuged at 20,000 x g for
10 minutes and the supernatant used without further purification
(Marcus & Talalay, 1956).
To check for recoveries in all the above studies, controls
were run using authentic /4-^Q7 steroids diluted with cold
steroid standards treated identically as the extracted radio¬
active compound under investigation.
2.6 ASSAY FOR 33-HYDROXYSTSROID DEHYDROGENASE ACTIVITY
The assay procedure was essentially the same as that
described for cholesterol side-chain cleavage except that
A-14C7 pregnenolone (specific activity 55.7 mc/mM) was used
__ 1 A _
instead of /4- *C/ cholesterol as substrate. The TLC plates
were usually developed four times. Activity is expressed as
the percentage conversion of /4-^4c7 pregnenolone to radioactive
steroid products which are progesterone, 17a-hydroxyprogesterone,
androstenedione,and testosterone.
.;.y_" v, ';r . /a -
Before use /4- 0/ pregnenolone was nitrified by TLC in
jmPmm soIVeht sand VI (see Table 3.4, page 69). The
radi oactive area cor responding to the authentic reference spo't
*Lr . Vvi*:"-■ *. 'fL '• ' >*7":',V ■ - ? ALi' 1/4 A"CoV •*'
was eluted-from the silica-gel with redistilled acetone.
2.7 ASSAY FOR CHOLESTEROL ESTERASE (HYDROLYTIC) ACTIVITY
When this activity was determined in heavy mitochondria
the assay conditions were exactly the same as for cholesterol
side-chain cleavage, except that cholesterol oleate
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(specific radioactivity 46 |iCi/mg) was used instead of /A-^~ c/
_ 24 ~7
cholesterol. TLC plates were developed twice. [A- C/Cholesterol
oleate was purified before use by TLC in a manner similar to
24 —
that described for /A- C/ cholesterol (see section 2.4.1).
2.8 DETERMINATION OF ENDOGENOUS FREE AND ESTERIFIED CHOLESTEROL
2.8.1 Extraction and separation of cholesterol and cholesterol
esters.
Testicular fractions equivalent to 4 mg protein were
— 24 —
extracted as described for steroids (section 2.4.1). /A- C/
Cholesterol (5,OOO cpm approx. O.Ol (ig) and /A-^c/ cholesterol
oleate (5,000 cpm approx. O.Ol p.g) were added as internal
standards (for recovery corrections and as markers) just before
extraction. For TLC separation, plates were prepared with
silica gel G without binder (a slurry of silica gel G in
distilled water was spread on glass plates and thennactivated
at about HO°C for 1 hour). The plates were developed twice
in the di-isopropyl ether solvent system (see section 2.4.2).
The zones containing the radioactive peaks corresponding
to cholesterol (near the middle of the plate) and cholesterol
oleate (solvent front) were scraped from the glass plate.
The silica gel powder thus obtained was packed into small
columns over glass wool and the sterols eluted successively
with 15 ml each of mixtures of chloroform:ethyl acetatermethanol
(3:1:1) and ethyl ether:methanol (3:1). The eluted samples
were taken to dryness under nitrogen.
TABLE 2.7














2.8.2 Hydrolysis of cholesterol esters
Hydrolysis of cholesterol esters was achieved by the
procedure described below. To the samples of cholesterol
ester dissolved in 1 ml acetone: methanol (1:1), 50 p. 1
saturated KOH solution in 50% methanol was added and the tube
incubated at 37°C for 2 hours. The solution was then neutral¬
ised with HC1 and extracted with 4 ml chloroform, twice. The
chloroform extracts were washed three times with 1 ml water
and then evaporated to dryness under nitrogen. This hydrolyzed
material was purified by TLC and eluted from absorbant as
described above. Under these conditions 90-95% of cholesterol
esters were hydrolyzed.
Both samples of cholesterol (i.e. free cholesterol and
that obtained after hydrolysis of ester) were dissolved in
redistilled acetone. Small aliquots were taken for radioactive
measurements by liquid scintillation spectrometry to check for
recoveries during the above extraction procedures. (Final
recoveries of 93-96% were obtained.) To the remainder of the
sample, dehydro-epiandrosterone was added as an internal
standard to correct for losses during gas-liquid chromatography.
Suitable aliquots of each sample were injected into the gas-
liquid chromatography column, described' below.
2.8.3 Gas liquid chromatography
Gas liquid chromatography was carried out on a Pye 104
gas chromatograph equipped with a hydrogen flame ionization
detector. A glass column silanized with dichloro-dimethyl
silane, 1.75 metres long and 4 mm i.d. containing 3% QF1 as
♦
FIGURE 2.2 A typical gas liquid chromatogram tracing showing
the separation of cholesterol and dehydroepiandro-
sterone. Column: 1.75 metres x 4 mm I.D. glass
packed with 3% QF1 on 100-200 mesh Gas Chrom Q.
Column temperature: 240°C. NT2 flow rate 30 ml/min
at 30 lb/sq.in. A standard mixture containing
cholesterol (1.6 ng) and DHA (0.8 ng) in 4 |il of
acetone was injected onto the column. (Actual
weight ratio 2:1.) Arrow indicates the point of
injection of the sample mixture. The observed
peak height ratio of cholesterol/UHA = 1.06.
Detector: flame ionization at 2 x 10 AFS.
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stationary phase with 100-2CO mesh Gas Chrom Q (Applied
Sciences Lab. Inc., Pennsylvania, U.S.A.) as column support
was employed. The column oven temperature was kept at 240°C,
and the injection port temperature 3C)0°C. High purity nitrogen
was used as carrier gas at a flow rate of 30 ml/min. Gas
chromatographic retention times were measured from the initial
excursion of the recorder pen upon injection of the sample to
the maximum pen response of the eluted sample component. The
retention times of dehydro-epiandrosterone was 9 minutes and
of cholesterol 15 minutes (Table 2.7). A typical gas chromato¬
graphic tracing is shown in Figure 2.2.
Solutions made up of known ratios of cholesterol and DHA
were subjected to gas liquid chromatography and the ratios of
the observed peak heights calculated. Figure 2.3 shows a
typical calibration curve produced from known ratios by weight
of cholesterol and DHA. To measure the amount of cholesterol
in an unknown sample, known amounts of DHA were added to the
sample and the actual amount of cholesterol present determined
from the peak height ratios obtained. 2 ^g cholesterol and
1.3 ng DHA produced a full scale deflection on the gas chromato¬
graphic trace.
2.9 PROTEIN ESTIMATION
The amount of protein in the subcellular fractions were
routinely determined by the method of Lowry et al. (1951)
using a solution of bovine plasma albumin (fraction V) as
standard.
FIGURE 2.3 A typical gas liquid chromatographic calibration
curve constructed for assay of cholesterol on
3% QF1. The actual weight ratio of cholesterol/
DHA (the internal standard) in the solution is
plotted against the ratio of the observed heights
of the peaks of the steroids produced on GLC.
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2.10 DETERMINATION OF RESPIRATORY CONTROL AND ADP;Q RATIOS
Oxygen uptake was determined essentially as described
by Estabrook (1967). The apparatus consisted of a Clark
membrane-covered oxygen electrode inserted into a closed
lucite chamber designed to exclude air. The polarographic
measurements were performed at 30°C in a magnetically stirred
solution which consisted of lOO mM sucrose, 20 mM KC1 and 25 mM
Tris buffer pH 7.5 (Basic Incubation Medium). In addition to
this basic incubation medium variable amounts of potassium
phosphate, ethylene glycol-bis-((3-aminoethyl ether) -N^N"*" tetra
acetic acid (EGTA) , ethylene diamine tetra, acetic acid (EDTA) ,
MgCl^ and bovine serum albumin (free of fatty acid) were added
as indicated in the text or legends to tables and figures.
Mitochondrial protein concentration was 1-2 mg. The final
volume of the medium was 3.0 ml. The substrate, unless other¬
wise stated was 5 mM succinate. The concentration of ADP
employed was either 0.083 mM or 0.166 mM. These additions
were made in 5-10 fil aliquots. The respiratory control ratios
(RCR) were calculated as described by Chance and Hess (1959)
and ADP/O ratios determined as defined by Chance and Williams
(1955b).
Each data point shown in figures and tables represents
the mean of at least two determinations. Each experiment
was repeated twice with different groups of rats all of the
same age.
The oxygen content of the complete incubation medium H
was calibrated by using sub-mitochondrial particles supplemented
with limiting amounts of NADH as recommended by Estabrook (1967)
and was found to be 243 jxM at 30°C.
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The oxygen consumed by the electrode itself over an
average experimental period of 15-20 minutes was less than
1% of the total oxygen present in the 3.0 ml reaction medium.
Back diffusion of oxygen from the atmosphere into the solution
xvas negligible and the amount of oxygen introduced in the




1. A method for the isolation of rat testicular mitochondria
which is essentially free of sperms and sperm fragments is
described.
2. A procedure for the fractionation and purification of the
heavy mitochondria on a discontinuous ficoll density gradient
was developed.
3. A micro-procedure for the assay of the following enzymatic
activities are presented:-
(a) Cholesterol side-chain cleavage activity based on
the conversion of C? cholesterol to steroid
products.
(b) Steroid 3(3-hydroxysteroid dehydrogenase activity
based on the conversion of pregnenolone to
labelled steroids.
(c) Cholesterol esterase activitj/ based on the enzymatic
hydrolysis of /4-^c/ cholesterol oleate to C~f
cholesterol„
4. The procedures for incubation of the enzyme source with
the radioactive substrate; the quantitative extraction of
the resulting labelled products and their subsequent separation
by TLC on a single plate are described.
5. Endogenous free and esterified cholesterol were determined
by GLC using a column containing QF1.
6. The use of the Clark electrode to measure respiratory control
and ADPrO ratios is also described.
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PRELIMINARY STUDIES ON THE CHOLESTEROL
SIDE-CHAIN CLEAVAGE ENZYME SYSTEM
In this section the subcellular distribution of the
cholesterol side-chain cleavage enzyme complex and the nature
and characteristics of the organelles involved will be
presented. In addition the development of the systems used
for the separation of the steroids formed from cholesterol
during in vitro incubations will be discussed.
3.1 SUBCELLULAR DISTRIBUTION OF THE ENZYME ACTIVITY
The subcellular distribution of cholesterol side-chain
cleavage enzyme was determined by subjecting freshly
homogenized testes to differential centrifugation as described
in Chapter 2 (Section 2.2; Table 2.1). Four subcellular
fractions were obtained viz:- (a) a particulate fraction
sedimenting between 470-6,OGO x g/20 minutes (washed three
times) termed "Heavy mitochondrial" fraction. (b) The material
sedimenting between 6,000-11,000 x g/l5 minutes (twice washed)
termed "Light mitochondrial" fraction. (c) "Microsomal"
fraction - endoplasmic reticulum sedimenting between
11,000-105,000 x g/hour (washed once) and (d) Supernatant
(cytosol) - the fluid remaining after centrifugation at
105,000 x g/hourc
Aliquots of these fractions equivalent to 0.4-0.6 mg of
protein were seoarately incubated with cholesterol
at 37°C for 2 hours in medium B (see Table 2.2) in the
HM
LM Micr Supn Control
I 1 I 1 t 1 I 1
TYPICAL SUBCELLULAR DISTRIBUTION OF CHOLESTEROL SIDE-
CHAIN CLEAVAGE ENZYME SYSTEM AFTER DIFFERENTIAL
CENTRIFUGATION
HM = Heavy mitochondrial fraction (470-6,000 x g/20 min)
LM = Light mitochondrial fraction (6,000-11,000 x
g/l5 min)
Micr = Microsomal fraction (11,000-105,000 x g/60 min )
Supn = Supernatant fraction remaining after 105,000 x
g/60 min)
Control = Boiled heavy mitochondria.
Aliquots of the above fractions (0.5 mg/tube) were
incubated with cholesterol at 37°C for 2 hours
in medium B in the presence of extramitochondrial
NADPH-generating system. Similar results were obtained
with isocitrate as the electron source.
- 56 -
presence of either DL isocitrate or extramitochondrial NADPH
generating system as the electron source. The cholesterol
side-chain cleavage activity was then assayed as previously
described (see section 2.4.1-2.4.4). The results in Figure 3.1
show that all the cholesterol side-chain cleavage enzyme
activity is localized exclusively in the heavy mitochondrial
fraction of rat testes. The light mitochondrial fraction
and the cytosol fraction were found to be completely devoid
of cholesterol side-chain cleavage activity. This observation
is in accord with the general view that the cholesterol
oxygenase enzyme resides in the mitochondria of all steroid
producing tissues (see Sulimovici & Boyd, 1969).
3.2 INFLUENCE OF CHEMICAL AMD PHYSICAL TREATMENTS OF THE
TESTICULAR HEAVY MITOCHONDRIA UPON CHOLESTEROL
SIDE-CHAIN ACTIVITY
The cholesterol side-chain cleavage activity in rat
testes mitochondria was found to be relatively low - the
percentage conversion to steroids being of the order of
2-6% of the added labelled cholesterol. In adrenal and
ovaries very much higher conversions (20-50%) have been
obtained. The low activity in the testes could be attributed
to the presence of large amounts of endogenous substrates.
With a view to improving the cholesterol side-chain
cleavage activity the rat testes heavy mitochondria were
subjected to the different chemical and physical treatments
described below.
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Acetone powder: washed heavy mitochondria (suspended in
2 volumes distilled water) were added dropwise to 20 volumes
of acetone (at -40°C) with continuous stirring. The
precipitated material was filtered using a Buchner apparatus,
washed with 3 volumes of acetone (at -20°C) followed by
4 volumes of ether (at -20°C). The material was finally dried
in a vacuum desiccator. This testicular mitochondrial
acetone powder was suspended in 0.25 M sucrose-10 mM Tris
pH 7.5 (at concentration of 10 mg/ml) and centrifuged at
105,000 x g for 60 minutes. The resulting supernatant and
pellet and a combined mixture of these two fractions were
assayed for cholesterol side-chain activity using NADPH
generating system (in medium A) as source of electrons. None
of these fractions showed any significant enzyme activity.
(<0.3%). The addition of BSA to the suspending medium before
acetone treatment, or to the dried acetone powder and/or to
the assay medium, or extraction with 0.1 M ICC1 or 0.05 M
phosphate buffer pH 7.0, did not result in the recovery of
cholesterol side-chain cleavage activity.
Ultrasonication: the heavy mitochondrial fraction suspended
in Tris buffer pH 7.4 was subjected to ultrasonication for
five periods of 2 minutes duration with intervals for cooling,
using an M.S.E. ultrasonic disintegrator. The suspension was
cooled in ice throughout the sonication process. After
centrifugation at 105,000 x g for 30 minutes, the supernatant,
the pellet and the mixed fractions were found to be devoid of
cholesterol side-chain cleavage activity. Exogenous NADPH
generating system was used as the electron source. Addition
of BSA before sonication had no effect.
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Freezing and Thawing: heavy mitochondria suspended in Tris
buffer pi I 7.5 was frozen in a bath of methanol and solid
carbon dioxide and then thawed in a water bath. This
procedure was repeated 5-10 times. After this treatment no
cleavage enzyme activity was observed in either the pellet
or supernatant fluid obtained at 105,000 x g/BO minutes.
*
All these procedures proved unsuccessful. In each case
cholesterol side-chain cleavage activity was <5% of that
present in an equivalent amount of original 'native' heavy
mitochondria.
These observations are similar to those of Drosdowsky
et al. (1965). These authors were unable to solubilize
this enzyme complex by using such methods as dialysis against
n-butanol, and addition of egg or beef lecithin to acetone
powder. The failure in solubilizing the cholesterol side-chain
cleavage enzyme emphasizes the labile nature of this enzyme
complex from testes in contrast to the stability of the
corresponding enzyme complexes in bovine adrenal (Contantopaulos
& Tchen, 1961; Simpson & Boyd, 1966), hog adrenal (Ichii
et al. , 1967), bovine corpus luteum (Ichii et al., 1963),
human placenta (Morrison et al., 1965; Mason & Boyd, 1971)
and immature rat ovarian tissue (Sulimovici & Boyd, 1968b).
3.3 DISTRIBUTION OF CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
AFTER FICOLL GRADIENT CENTRIFUGATION
Unlike the corpora lutea and adrenal cortex which are
almost entirely composed of steroid forming cells only 3-5%


























































FIG. 3.2 TYPICAL SUBCELLULAR DISTRIBUTION OF CHOLESTEROL SIDE-
CHAIN CLEAVAGE ACTIVITY AFTER FICOLL GRADIENT
FRACTIONATION OF TESTICULAR HEAVY MITOCHONDRIA
Heavy mitochondria obtained after differential centri-
fugation were further subfractionated by density
gradient centrifugation on 0-10% ficoll as described
in the text. Cholesterol side-chain cleavage activity
in each fraction was assayed using medium A and an
NADPH-generating system (see Chapter 2). Similar
results were obtained with isocitrate as the electron
donor.
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Mason, 1965). By virtue of the heterogeneous cellular nature
of the organ, the bulk of mitochondria derived from whole
testes would not only be non-steroidogenic but also of different
kinds and sizes. Differential centrifugation, as described
above, achieved an initial separation of the mitochondria
into a fraction rich in cholesterol side-chain cleavage
activity (heavy mitochondria) and a fraction (light mito¬
chondria) not containing the enzyme activity. A further
fractionation of the heavy mitochondrial fraction was achieved
by centrifuging the cholesterol side-chain cleavage enzyme
rich fraction through a 3-6-10% discontinuous ficoll gradient
as described in Chapter 2.3. The five subfractions thus
obtained were assayed for cholesterol side-chain cleavage
activity. A typical result presented in Figure 3.2 shows that
most of the enzyme activity is located in the heavy sedimenting
subfraction 5 (HMF5). Subfraction 4 and subtraction 3, both
contained some cleavage activity but accounted for less than
15% of the total activity in HMF5 (see Table 3.1 and Figure
3.2). A.s the mitochondria from subfraction 3 and 4 had a
lower "apparent" relative specific activity, only HMF5 was
used as source of the cleavage enzyme. Subfractions 1 and 2
did not exhibit any cholesterol side-chain cleavage activity.
Based on cholesterol side-chain cleavage activity and specific
cytochrome P450 content (see Chapter 5) such a fractionation
generally resulted in a 2-4-fold purification over the
original 'native' heavy mitochondria.
TABLE 3.1
PROTEIN DISTRIBUTION PATTERN OP' SUBCELLULAR










1 3 (1.2) 6 (14) )
> 60 (94)
2 65 (27) 30 (68) J
3 48 (20) 5 (11) 4 (6)
4 16 (7) <1 (2) 0
5 HO (45) 2 (5) 0
After ficoll gradient centrifugation each subtraction xvas
carefully removed, diluted with medium H up to 50 ml and
centrifuged at 15,000 x g for 20 minutes. The pellet was
suspended in a small known volume of medium H and the protein
content measured by the Lowry procedure. Figures in ( )
indicates the percentage of total protein applied on the
gradient.
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3.3.1 Behaviour of subcellular fractions on ficoll gradient
Table 3.1 shows a typical protein distribution pattern
obtained when heavy mitochondria, light mitochondria and
microsomal fraction of testes were each subjected to ficoll
gradient. Most of the protein from the heavy mitochondrial
fraction was recovered in the cholesterol side-chain cleavage
rich subfraction 5. This fraction accounted for approximately
45% of the protein applied on the gradient. Most of the
remaining protein was distributed between subfractions 2 (27%)
and 3 (20%). Light mitochondria consisted mainly of a fraction
corresponding to subfraction 2 of heavy mitochondria.
Microsomes, on the other hand, occupied the region corresponding
to sucrose and the 3% ficoll layers, (i.e. subfractions 1 and 2)
as one broad, white diffuse layer, i.e. subfractions 1 and 2
were not distinguishable.
These results show that heavy mitochondria, although a
distinct fraction, contains material with characteristics
similar to light mitochondria and microsomes and these
contaminants can be readily separated by the 3-lC% ficoll
gradient.
3.3.2 Further fractionation of heavy mitochondria subfraction 5
Since the enzymatically active HMF5 sedimented as a pellet,
the suitability of this fraction for further subfractionation
was examined. After centrifuging HMF5 at 10,000 g for 60
minutes through a second discontinuous gradient consisting
of 6%, 10%, 15% and 20% ficoll, three fractions \vere obtained
corresponding to 10%, 15% and 20% ficoll layers. Most of the
protein was found in the 15% layer. Cholesterol side-chain
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cleavage enzyme activity was present in all the three layers.
The apparent specific activities of the three fractions were
similar. These observations suggest that the mitochondria
from rat testes capable of steroidogenesis are not uniform in
size and density. Since this second gradient fractionation
did not appear to be much of an improvement over the first
0-10% ficoll gradient fractionation, further fractionation
studies were not pursued.
3.4 DETERMINATION OF RESPIRATORY CONTROL AND ADP;O RATIOS
It is known that in mammalian systems respiratory control
and coupled oxidative phosphorylation cannot be demonstrated
unless the mitochondria are intact.
It was initially observed that mitochondria incubated
in a media consisting of sucrose KC1-triethanolamine-potassium
phosphate and MgCl^ (Simpson et al., 1972b) or 250 mM sucrose -
10 mM potassium phosphate, did not exhibit any respiratory
control. Since the demonstration of respiratory control
(expressed as a ratio of the maximum rate of oxygen uptake
in the presence of ADP /state 3/ to that obtained when ADP
was absent /stat© 4/ is usually regarded as the most sensitive
indicator of mitochondrial integrity, the conditions and
composition of the incubation medium required to induce
coupling were investigated.
3.4.1 Composition of medium required to induce coupling
Washed heavy mitechondria were prepared as previously
described from testes of 17 week old male rats and homogenized
in 250 mM sucrose. These mitochondria were incubated in the




























FIGURE 3.3 Composition of the incubation medium necessary to
induce coupled mitochondria.
Testis were homogenized in 0.25 M sucrose and
washed heavy mitochondria prepared. To the 'basic
incubation medium' the following compounds were
added as indicated:-
Potassium phosphate buffer pH 7.4 (10 mM), EDTA
(1 mM), EGTA (1 mM), Mg++ (5 mM) and BSA (0.5% w/v).
Respiratory control ratios were measured as
described in the text using succinate as substrate.
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EDTA (l mM), EGTA (1 mM) or BSA (0.5%) were added either
individually or in different combinations. The effect of
these compounds on respiratory control are shown in Figure 3.3.
It was observed that mitochondria were coupled only when all
three factors, potassium phosphate, EDTA and BSA were present
together - in an "all or none" type of effect. With other
combinations no appreciable respiratory control was obtained.
These specific requirements hint at a complex relationship
between the factors involved.
2+
The addition of 2-5 mM Mg to the above coupled system
completely depressed respiratory control (as shown in Figure
3.3, Experiment F) so that the ADP/O ratio was unmeasurable
(i.e. completely uncoupled the mitochondria). This observation
contrasts with those reported for pig corpora lutea (Robinson,
1971) and superovulated rat ovaries (Arthur & Boyd, personal
2 "J*
communication) in which the presence of exogenous Mg was
required for coupling. A further addition of EDTA (up to
2+
10 mM) to these Mg uncoupled mitochondria, failed to relieve
the inhibition. This effect might be explained as follows:-
2 +
a potent Mg dependent ATPase present in the heavy mitochondria
was reconverting the ATP formed back to ADP which thereby
continued to stimulate the oxygen uptake. The ATPase activity
of these mitochondria was therefore measured by a modified Gctnori
(1942) procedure (Rebello et al ., 1969). It was found that
2+
Mg stimulated the ATPase activity two-fold. The mean rate
of inorganic phosphate released from ATP was 3.5 |imoles/mg
protein/hour. This was increased to 8.1 inmoles Pi released/mg
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2+ 2 +
protein/hour by 5 mM Mg . Similar effects of Mg on
oxidative phosphorylation were observed in rat adrenal
mitochondria (Purvis et al., 1968; Sauer & Mulrow, 1969;
Simpson et al., 1972). Sauer and Mulrow (1969) suggested
2 +
that this Mg stimulated ATPase may be extramitochondrial.
However, when mitochondria purified on ficoll gradient (HMF5)
was used instead of heavy mitochondria, a similar uncoupling
2 +
effect of Mg , to those described above was obtained.
Therefore, if the ATPase activity represents contaminants
(microsomal or lysosomal), then these contaminants may be
closely associated with the mitochondria. Vanha-Perttula
(1971) reported that rat testes mitochondria, compared to
other testicular subcellular fractions, was rich in acid
phosphatase activity. In addition, Pressman and Lardy (1956)
observed that adrenal mitochondrial ATPase activity was
stimulated by fatty acids and that this activation was a
mitochondrial membrane effect. In view of the abundance of
fatty acids in the testis (Carpenter, 1971; Davis et al.,
1966) the depression of respiratory control may not be due
2+
solely to the stimulation of ATPase by Mg
3.4.2 Effect of varying concentrations of potassium phosphate,
EDTA and BSA on respiratory control ratio
The optimal concentration of potassium phosphate, EDTA
and BSA required for the display of maximal respiratory
control by rat testis mitochondria were investigated.
The observations on respiratory control ratio of several
preliminary experiments indicated that irrespective of the









0 2 h 6 8 10
mg BSA/ml incubation medium
Effect of varying amounts of potassium phosphate and BSA on
mitochondrial respiratory control ratios.
Testes were homogenized in 0.25 M sucrose. RCR were measured
as described in the text after suspending the washed heavy
mitochondria (2 mg protein) in 'basic incubation medium'
containing EDTA (0,3 mM) and:-
FIG. 3.4 BSA (0.155 w/v) and varying concentration of
potassium phosphate.
FIG. 3.5 Potassium phosphate (10 mM) and varying amounts of
BSA (fatty acid free).
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250 raM sucrose plus 10 mM Tris (pH 7.4), 250 mM sucrose plus
1 mM EGTA (pH 7.4) , or 250 mM sucrose plus Tris 10 mM plus
0.3 mM EDTA (pH 7.4) the results obtained with either heavy
mitochondria or ficoll fractionated mitochondria (HMF,.) were
essentially similar provided potassium phosphate, EDTA and
BSA were all present in the incubation medium. The results
presented below were typical of those observed.
A. The effect of different concentrations of potassium
phosphate on respiratory control is shown in Figure 3.4. The
optimal concentration of potassium phosphate was found to be
lO mM. Increasing the concentration beyond this maximum led
to a decrease in the respiratory control ratios. This effect
resembles substrate-enzyme inhibition. The reason for this
phenomenon is not clear. It may in part be related to
energized phosphate binding (Packer & Utsumi 1969; Allmann
etal. 1970a). It is well established that the respiration of
tightly coupled mitochondria is strikingly dependent on the
presence of inorganic phosphate and the phosphoryl acceptor
system-ADP.
B. The effect of varying amounts of BSA on mitochondrial
respiratory control ratios presented in Figure 3.5 shows that in
the absence of BSA the mitochondria were uncoupled. Respiratory
control was however induced by the presence of small amounts of
BSA 0.05%. Maximal values were obtained with BSA concentrations
of 0.1-0.5%. Higher amounts (1%) had an inhibitory effect.
These observations suggest that in addition to the well
established protection against fatty acid induced inhibition
of mitochondria respiratory control (Allmann et al., 1970a;
Bjorntorp et al., 1964) BSA may have direct
FIGURE 3.6 "Uncoupled
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FIG. 3.6 Effect of different concentrations of EDTA and EGTA
on mitochondrial respiratory control ratio.
Testes were homogenized in 0.25 M sucrose. Washed
heavy mitochondria (2 mg protein) were suspended in
'basic incubation medium' plus potassium phosphate
buffer (10 mM), BSA (0.1%) and varying concentrations
of EDTA or EGTA.
FIG. 3.7 Same as Fig. 3.6 except that in this experiment
testes were homogenized in 0.25 M sucrose containing
EfiTA (1 mM) .
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mitochondrial structural effects (Helinski, 1960; Strehler,
1966). Harding et al. (1968) and Satre et al. (1969) showed
that the cristae of adrenal mitochondria, isolated in a
sucrose medium free of albumin, were in the orthodox
(uncoupled) configuration.
C. The variation of RCR with EDTA concentrations is
illustrated in Figure 3.6. The minimum amount of EDTA which
produced maximal respiratory control, in the absence of an
additional chelator in the homogenizing medium, was 0.4 mM.
Above this minimum concentration (i.e. 0.4-1 mM) respiratory
control appeared to remain constant. When mitochondria were
isolated from testes homogenized in 250 mM sucrose-1 mM EGTA,
a further addition of EDTA in the incubation medium was still
essential. The results in Figure 3.7, while qualitatively
similar in pattern to Figure 3.6, show a lowered minimum
requirement for EDTA of 0.2 mM. EGTA (1 mM) could not be
substituted for EDTA. EDTA protects the mitochondria against
++




The effect of the specific Ca chelating agent (EGTA)
in the homogenizing medium, in lowering the effective minimum
concentration of EDTA necessary to produce maximum respiratory
control could be attributed to the removal of Ca ion. If
initially no EGTA was present then the amount of EDTA in the
incubation medium would be expected to be higher - to remove
both Mg2 + and Ca2+ (Settlemire et al., 1968). Ca2+ ion which










250mMsucrose(5) 250mMsucrose+1EDTA(5) 250mMsucrose+1EGTA( )
2.4±0 2 2.5±0 2 2.5±0 3
2.3±0. 2.4±O 2 2.5±O 2
1.4±0.2 2.5±0 3
1.3±0.2 2.4±0 3
Reactionconditi nsweresimilarthosedescribedforFigu3.8,su ci at wasthesubstrateused.Resultsarxpre semean±SEM;numof determinationsareinpare th sis.
- 66 -
respiratory control by inducing the mitochondria to the
orthodox configuration through the generation of non-
esterified fatty acids (Allmann et al., 1970a). Allmann
et al. (1970a,b) observed the existence of a critical balance
between Mg^+ and Ca^ .
The respiratory control ratios of freshly prepared
mitochondria were not significantly affected by the variations
in the composition of the homogenizing medium. However, it
was observed that the presence of EGTA in the homogenizing
medium appeared to affect the stability of the mitochondria
to storage at 0-4°C for several hours and its ability to show
respiratory control. Data presented in Table 3.2 illustrates
this point. Testes mitochondria isolated in a sucrose medium
containing 1 mM EGTA were much more stable to storage (up to
48 hours at least) compared to those containing EDTA or no
chelator. The reason for these results is not clear. It
, +
could xn part be attrxbuted to the loss of endogenous K .
2+
The removal of limited amounts of Mg by EDTA increased the
+ +
Na uptake and K loss. In contrast, EGTA, which has a high
2+ 2+
affinity for Ca , does not remove Mg and does not result
+
in the loss of endogenous K (Settlemire et al., 1968). On
the basis of the above results the composition of medium B
(Table 2.2) was arrived at. This medium was used in both
the studies on ADP/O ratios and mitochondrial steroidogenesis.
3.4.3 Oxidative, phosphorylative and respiratory control
capacities of rat testis heavy mitochondria
The polarographic determination of ADP:0 and respiratory
control ratios were carried out in 3.0 ml of medium B as
described in Chapter 2, section 2.10.
0.2 ml TESTES HEAVY MITOCHONDRIA ( HMF5 )
FIG. 3.8 ILLUSTRATION OF RESPIRATORY CONTROL IN TESTICULAR
HEAVY MITOCHONDRIA
The numbers below the traces refer to the rate of
oxygen utilization in micro atoms of oxygen per
minute. Conditions used were similar t.o those
described in Chapter 2.10
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A typical polarographic trace is shown in Figure 3.S.
After adding mitochondria the addition of succinate increased
the rate of oxygen utilization from the low level, attributable
to endogenous substrates to the ADP-deficient state (state 4).
The subsequent addition of limiting amounts of ADP caused a
three-fold increase in the rate of respiration (state 3).
After conversion of the added ADP into ATP, as indicated by
the cut-off in the polarographic trace, the respiratory rate
returned to the low level indicative of the ADP deficient
state (state 4). Respiratory rates could be stimulated to
the same extent by further additions of ADP. These classical
state 4- state 3 transitions in response to ADP are character¬
istic of intact, well preserved mitochondria (Chance, 1956).
The ADPrO ratios, i.e. the amount of ADP phosphorylated
divided by the amount of oxygen used during this process,
were calculated as shown in Figure 3.8.
The ADP:0 and respiratory control ratios and the rates
of oxygen utilization in the presence (state 3) or absence
(state 4) of ADP observed in a typical heavy mitochondrial
preparation isolated from rat testes are summarized in Table 3.3.
Testes heavy mitochondria were able to oxidize various tri¬
carboxylic acid cycle intermediates, with succinate being
oxidized at the highest rate. Malate, which was less effective,
was a much better substrate than isocitrate. The respiratory
rates of the three Krebs cycle intermediates tested were
dependent on the presence (state 3) or absence (state 4) of
added ADP. By contrast NADPH or NADH were not oxidized to
any appreciable extent by the mitochondria even in the
TABLE3.3



































RespiratorycontrolratiosandADPiOr tiosweredete minedadesc ib dinCh pter2. Reactionconditi nsweresimilarthosesh wninFigure3.8.I1washehe vy mitochondriawasused,inallotherexperimentsfic llfractionatedhe vymitochondria5 (HMF,_)wasused.Resultarexpressemean±S.E.M.;numb rofdetermin tionsar inparenthesis.
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presence of ADP. Had these mitochondria been permeable to
exogenous nucleotides, the rate of oxygen uptake would have
increased. These observations attest to the biochemical
"intactness" of these mitochondria.
The respiratory and phosphorylative activities of the
heavy mitochondria and ficoll purified mitochondrial fraction 5
were found to be similar.
2 +
With succinate as substrate the addition of Mg
completely uncoupled the mitochondria, as discussed earlier,
by markedly stimulating state 4 oxygen uptake so that ADP:0
ratios were unmeasurable.
The low ADP:0 and respiratory control ratios observed in
this study with testicular heavy mitochondria compared to
reported values for liver does not appear to be unusual.
Similar low ratios, especially with succinate as substrate,
have been reported in other steroidogenic tissues: bovine
adrenal cortex (Cammer & Estabrook, 1967), porcine corpus
luteum (Robinson, 1972), rat adrenal (Purvis et al., 1968;
Sauer & Mulrow, 1969). The observations in this study on
testes mitochondria closely resemble those of rat adrenal
(Sauer & Mulrow, 1969). In both cases the low ADPrO and
2 +
respiratory control ratios were sensitive to Mg ions;
2+
omission of Mg from the incubation medium increased the
values.
3*5 IDENTIFICATION OP THE PRODUCTS OF CHOLESTEROL OXIDATION
3.5.1 Thin layer chromatography
Cholesterol metabolism by mitochondria isolated from
most steroidogenic tissues, including the corpus luteum
TABLE3.4
SOLVENTYST MSINVES IGATEDFORTHEPARATION OFINTERMEDIATESTESTOSTERONESYNTH SIS
5?°*°fSOLVENTRatio I=Chloroform:Ethanol99:1 II=Benzene:Etha ol96:4 III=Cyclohexane'.Ethylac t te50:50 IV=Chloroform'.Acetone90:10 V=Benzene:Acetone80:20 VI=Toluene:Metha ol92:8 VII=Di-isopropylether:Petroleumether(60°-80°C):«o-3r-2Glacialaceticid"
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(Robinson & Stevenson, 1971), adrenal cortex (Simpson & Boyd,
1967a) and the placenta (Mason & Boyd, 1971), resulted in the
formation of only two major products, pregnenolone and
progesterone. Hoivever, "heavy mitochondria" prepared from
the rat testes catalysed the formation of a number of steroid
— 14 ~7
products from /4- C/ cholesterol when an NADPH generating
system was used as a source of reducing equivalents. The total
yield of steroid products formed was low, usually not more
than 5% of the added ,/4-^C/7 cholesterol used. The necessity
therefore, to reduce procedural losses of compounds during
routine analysis prompted the development of a suitable
technique for extraction of t he steroids from testicular
incubates (described in Chapter 2.4.2, Table 2.3). Since
most of the chromatography systems described were suited to
the separation of only a few steroids from the biological
extracts, a reproducible system for separating the multiple
steroid intermediates in testosterone biosynthesis from
cholesterol on a single TLC chromatoplate was developed.
A number of different solvent systems (listed in Table 3.4)
were investigated using authentic steroids and silica-gel
GF254 precoated glass plates (0.25 mm layer thickness). The
conditions for TLC were the same as described in Chapter 2,
section 2.4.3. Because of the multiple developments the Rf
values were not reproducible from run to run. However,
provided the plates were each developed the same number of
times the relative migration values (relative to progesterone,
i.e. R progesterone) were very reproducible (± 0.5). Hence
the results were expressed as
TLC OF STEROID MIXTURE IN DI-ISOPROPYL ETHER-


















FIGURE 3.9 Trace of a typical TLC resolution of steroids in
di-isopropyl ether:petroleum ether (BP 60-30°C) :
glacial acetic acid (80:35:2) developed four times.
Silica gel GF 254 precoated plates (E. Merck) were
used. Shaded spots are steroids visualized under
u.v. Unshaded spots are steroids located after




„ Miqration distance of soot „
R proaesterone = — T~- ^T-—I 7 1 x lOOMigration distance of progesterone
The resolution achieved with the different solvent
systems are shown in Table 3.5.A. It can be seen that the
best separation was obtained in solvent mixture VII di-iso-
propyl ether : petroleum ether (BP 60°-80°C): glacial acetic
acid (80:35:2 by vol.). Two developments in this solvent
system gave moderately good resolution of the steroid mixture,
but separation was much improved by four consecutive develop¬
ments (Table 3.5.B). Cholesterol esters, cholesterol,
20a-hydroxycholesterol, pregnenolone, dehydroepiandrosterone
and progesterone were all very well separated from each other
and from the 4-ene-3-oxo steroid group, 17a-hydroxyprogesterone,
testosterone and androstenedione (as depicted in Figure 3.9).
These latter three steroids, which were poorly resolved when
visualized with ultra violet light,could be delineated if
14
C-labelled steroids were run and their distribution examined
by means of a radiochromatogram scanner. The separation of
dehydroepiandrosterone as a discrete spot from pregnenolone
and progesterone, with which it otherwise very closely
overlapped, was of particular importance in view of the role
of dehydroepiandrosterone as a possible intermediate in the
alternative route in testosterone biosynthesis from cholesterol
(Jungmann,1968).
The complete separation of the multiple steroids by this
system VII was slow since each run took 2 hours (i.e. a total
development time of 8 hours). However, an equivalent
separation of the intermediate steroids involved in testoster¬
one formation from cholesterol, was not obtained with any of
TABLE3.5
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the other solvent systems tried, or with those reported in
literature (Stahl, 1965; Levin et al., 1969). Furthermore,
the separation of the steroid mixture on one TLC plate
during routine investigations greatly reduced the loss of
accuracy and eliminated the use of tedious recovery techniques
involving elution and rechromatography in different solvent
systems, which would have been necessary if incomplete
resolution was obtained.
Examples of the use of this method for the separation
of steroids extracted from rat testicular heavy mitochondria
after incubation with /_4- C/ cholesterol and different
electron donors are depicted in Figure 3.10. It can be seen
that when electrons for cholesterol side-chain cleavage were
supplied by an NADFH generating system many products were
formed. The radioactive peaks shown in the radiochromatogram
(Trace 1) correspond with the authentic standards pregnenolone,
progesterone, testosterone, 17oc~hydroxyprogesterone, andros-
tenedione and cholesterol esters, run on the same plate and
visualized as described in Chapter 2. All these steroid
products are known intermediates in testosterone biosynthesis.
When isocitrate was the electron source pregnenolone and
progesterone were the major products (Trace 2). Trace 3 shows
+
that when NADP was added together with isocitrate, the
pregnenolone formed was converted to progesterone and another
4-ene- 3-oxo-steroid (testosterone). Finally, in the presence
of cyanoketone, an inhibitor of 3(3-hydroxysteroid dehydro¬
genase, pregnenolone was the only significant labelled product
of cholesterol metabolism (Trace 4). It is of interest to
1. NAOPH GENERATING SYSTEM
2. ISOCITRATE
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FIGURE 3.10
Typical traces of Thin layer radio-
chroniatogram scans of extracts from
incubated testicular "heavy mitochondria"
Heavy mitochondria were incubated with
^/4-^^C/cholesterol in the presence of
an electron source and other compounds
(see below) and the steroids formed
extracted and separated by TLC in
solvent VII as described in text. The
radioactive steroids formed from
cholesterol were located by scanning
the developed plates under a Panex
windowless gas flow, Geiger-Muller type
radiochromatogram scanner. A carrier
gas mixture of 98% argon and 2% propane
j
was employed. The radioactivity of
) each zone was subsequently determined
by liquid scintillation spectrometry.
Trace 1 NADPH generating system
2 DL-isocitrate
3 DL_isocitrate plus NADP+
4 DL isocitrate plus cyanoketone
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note that in all the above examples there was no detectable
radioactive peak corresponding to dehydroepiandrosterone.
The above observations indicate that the rat testes heavy
mitochondrial fraction possess in addition to the cholesterol
desmolcise, other enzymes involved in the further metabolism
of pregnenolone and progesterone.
Solvent system VII described in this study was a
modification of that previously described by Simpson and Boyd
(1967) for the separation of postulated intermediates in
cholesterol oxidation to pregnenolone in adrenal cortex and
that used by Manners et al. (1969) for separating the products
of fat digestion.
Although solvent systems I-VI were unsatisfactory for
these testicular studies, they were adequate for the separation
of a few steroids when present in the biological extracts.
The separation of some of the steroids from mixtures achieved
by these solvents are summarized in Table 3.6.
3.5.2 Derivative formation
A large number of identical incubations were carried out
to provide sufficient material for analysis and identification
of the products. After TLC in solvent VII, the radioactive
areas on the chromatoplate corresponding to standard pregneno¬
lone, progesterone, cholesterol oleate (individually) and
testosterone, androstenedione and 17a-hydroxyprogesterone
(as a group) were scraped off, packed into small columns and
eluted as described in Chapter 2.8.1. The extracts were







(a) Pregnenolone, progesterone and androstenediol
T (b) 17a(0H)-progesterone, androstenediol, testos¬
X
V terone, androstenedione or progesterone.
' (c) DHA, androstenediol and androstenedione
(a) Pregnenolone, progesterone and androstenediol
or testosterone
II (b) Progesterone, 17a-hydroxyprogesterone,
androstenediol and androstenedione
(c) DHA, androstenedione and testosterone
(a) Progesterone, 17a-hydroxyprogesterone and
III testosterone
(b) Androstenedione and testosterone
(a) Progesterone, pregnenolone, androstenediol
and testosterone
IV (b) DHAj androstenediol, testosterone and
androstenedione or progesterone
(c) 17a-hydroxyprogesterone, androstenediol ,
progesterone and androstenedione
(a) Pregnenolone, progesterone and testosterone
or androstenediol
v (b) Pregnenolone, androstenedione, testosterone
V or androstenediol
(c) 17of-hydroxyprogesterone , androstenedione,
testosterone and androstenediol
(d) Progesterone, DHA and testosterone or
androstenediol
(a) Pregnenolone, androstenediol, 17a-hydroxy-
progesterone, testosterone and progesterone
or androstenedione
VI (b) DHA, testosterone, androstenedioi and
androstenedione or progesterone
(c) Testosterone , 17a-hydroxyprogestorone,
17a-hydroxypregnenolone and androstenedione
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1. Pregnenolone and Progesterone
The identity of these steroids was confirmed by
(a) rechromatoaraphy in solvent systems I, II, IV, V and VI
(see Table 3.5A). In all instances the radioactive material
behaved as homogeneous fractions having identical chromato¬
graphic mobilities with those of the corresponding standards -
pregnenolone and progesterone. 90-95% of the radioactivity
applied on the thin layer chromatoplate was recovered in the
peaks. There was no significant radioactivity in the area
corresponding to androstenediol. Androstenediol separated
from progesterone in these solvents.
(b) On oxidation with chromium trioxide (see Chapter 2.5.1A)
pregnenolone was converted to an ultra violet light absorbing
spot which behaved like progesterone in all TLC systems examined.
Progesterone remained unchanged.
(c) On acetylation (see Chapter 2.5.1C) only pregnenolone
acetate was formed.
In both the above cases 85-90% of the radioactivity was
recovered in the converted compounds after TLC. Authentic
steroid controls too gave similar results.
(d) Enzymatic conversion with steroid 3(3-ol dehydrogenase.
Pregnenolone and progesterone were separately incubated with
a steroid 3|3-ol dehydrogenase preparation from Pseudomonas
testosteroni as described in Chapter 2.5.2. After extraction
and TLC, all the radioactivity of pregnenolone was recovered
in the ultra violet spot corresponding to authentic progest¬




These 4-ene- 3-oxo-steroids, which were not easily
distinguished after TLC in system VII, were clearly separated
by TLC in either solvent system II or VI. The accumulation
of steroids in this group was found to vary depending on the
age of the rats and conditions of incubation used (as discussed
in Chapter 4). In most cases, testosterone and androstenedione
(Ratio 3:1) were the major steroids isolated after incubation
of mature testes with C? cholesterol and either NADPH or
isocitrate plus NADP . System VI also clearly separated
17ct-hydroxypregnenolone from the above 4-ene- 3-oxo-steroids.
However, no significant radioactivity was observed in the
region corresponding to authentic 17a-hydroxypregnenolone.
(b) Oxidation
After oxidation and TLC in system VI, it was observed
that androstenedione remained unchanged, whereas testosterone
was converted to androstenedione. Under the oxidation
conditions described only 50% of both the authentic
17a-hydroxyprogesterone (control) and isolated steroid were
oxidized to testosterone.
(c) Reduction
After reduction and TLC, testosterone was found unchanged,
whereas androstenedione was converted to testosterone. The
radioactive compound exhibited the same mobilities as the
authentic steroids in solvent systems II and VI.
(d) Acetylation
After acetylation and TLC in solvent system V and VI,
testosterone acetate formed was well separated from the
unreacted androstenedione and 17a-hydroxyprogesterone0
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3.6 CHOLESTERYL ESTERS - TLC SEPARATION
»*?
Occasionally an additional radioactive peak was obtained
from the mitochondrial incubations (using NADPH generating
system. Rats 7-9 weeks) which migrated close to the solvent
front in solvent system VII and corresponded to cholesterol
esters (as represented by standard cholesterol-oleate or
-palmitate or -linolenate). This fraction sometimes accounted
for as much as 2% of the radioactive cholesterol added. The
conditions which resulted in the esterification of cholesterol
were not investigated. However, it was observed that when
cholesterol esters were formed, cholesterol side-chain
cleavage activities were low.
The cholesterol ester fraction from several plates were
pooled, eluted and the extracts concentrated under nitrogen,
as previously described, and aliquots taken for analysis.
(a) Hydrolysis
Aliquots of the ester fraction were hydrolysed with
methanolic KOH, as described in Chapter 2.8.2, and the extracts
submitted to TLC in solvent system VII and IV. 92% of the
radioactivity migrated as a single peak corresponding to
standard cholesterol, thus confirming this fast moving fraction
as consisting mainly of cholesterol.
(b) Fractionation of cholesterol esters by TLC
Insight into the nature of the esters of cholesterol was
achieved by TLC on silver nitrate-impregnated silica gel plates.
This procedure separated the various cholesterol esters




































SOLVENT: BENZENE HEXANE (1:1)
2 RUNS 22°C
FIGURE 3.11 TRACE SHOWING A TYPICAL TLC RESOLUTION OF
CHOLESTEROL-ESTERS
The upper 15 cm portion of preprepared silica-
gel GF254 plates were impregnated with silver
nitrate. Plates were developed twice in benzene
hexane (1:1). Cholesterol esters were located
under u.v. after spraying with 0.05% rhodamine
6G in methanol.
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employed is a modification of that described by Morris (1963)
and Goodman and Shiratori (1964).
Pre-prepared silica-gel F254 plates, 0.25 mm layer
thickness and size 5 x 20 cm were used. The upper 15 cm of
the plates were impregnated with silver nitrate by dipping
the plates in 90% methanol saturated with silver nitrate for
30 seconds (for better reproducibility) and air dried. The
area of the plate 4 cm from the line of origin was left
untreated. The isolated cholesterol ester extract and standard
cholesterol esters representing different degrees of unsatura-
tion (see Figure 3.11) were spotted and the plates developed
twice at room temperature in benzene:hexane (1:1). The
separated components were located under ultra violet light
after spraying with 0.05% rhodamine 6G in methanol. The
compounds appeared as orange spots against a greenish-yellow
background. The results illustrated in Figure 3.11 show that
the different classes of cholesterol fatty acid esters were
clearly resolved from each other, cholesterol and cholesteryl
acetate. The radioactivity was found to be fairly evenly
distributed among the different classes of esters.
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SUMMARY
1. The subcellular distribution of the cholesterol side-chain
cleavage enzyme system was investigated. This enzyme system
was localized entirely in the heavy mitochondrial fraction.
/
Light mitochondria, microsomes and supernatant were completely
devoid of any cholesterol side-chain scission activity.
2. Fractionation of the heavy mitochondrial preparation was
achieved by discontinuous density gradient centrifugation using
0-10% ficoll. The heavy sedimenting fractions contained most
of the cholesterol side-chain cleavage activity. This
fractionation resulted in a 3-4-fold purification over the
crude heavy mitochondria.
3. The phosphorylative and respiratory control capacities
of the testicular heavy mitochondria were measured. They
indicated that the mitochondria prepared were biochemically
intact. Respiratory control ratios could be demonstrated only
ivhen potassium phosphate, EDTA and BSA were all present together„
++ '
Mg uncoupled the mitochondria. The optimal requirements
for these factors were investigated and are discussed.
4. A procedure employing multiple development, one-dimensional
TLC in Di-isopropyl ether:petroleum ether:glacial acetic acid
(80:35:2) solvent system and silica gel F254 preprepared
glass plates, was developed for resolving the multiple mixture
of intermediate steroids in testosterone biosynthesis from
cholesterol. Other systems investigated were not suitable.
5. A modified TLC procedure for fractionating cholesterol
esters according to their degree of unsaturation is presented.
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Not only were the different classes of cholesterol fatty acid
esters resolved from each other but als^o separated from
cholesterol and cholesterol acetate.
6. Identification of the steroid products formed from
cholesterol was based on the following criteria:-
(a) Identical mobilities of the metabolites with those
of authentic steroid standards on TLC developed in
different solvent mixtures.
(b) Identical chromatographic behaviour with those of
authentic steroids after reactions such as
(1) acetylation with acetic anhydride in pyridine;
(2) oxidation with chromic acid in acetic acid;
(3) reduction with borohydride in methanol;
(4) enzymatic conversion using purified microbial
enzyme preparations.
CHAPTER 4
SOME CHARACTERISTICS OF THE CHOLESTEROL SIDE-CHAIN
CLEAVAGE REACTION OF RAT TESTIS
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SOME CHARACTERISTICS OF THE CHOLESTEROL SIDE-CHAIN
CLEAVAGE REACTION OP RAT TESTIS
In this chapter the studies on the effect of different
nucleotides, Krebs cycle intermediates, metal ions, reducing
agents and inhibitors, on the rate of cholesterol side-chain
cleavage and the nature of steroid products are presented.
Also discussed are the optimal conditions for cholesterol
side-chain cleavage.
4.1 REQUIREMENT OF CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
FOR NADPH
Washed rat testes heavy mitochondria were incubated in
medium A (see Chapter 2, Table 2.2) for 2 hours at 37°C in
the presence or absence of different nucleotides as indicated
in Figure 4.1. The results show that in the absence of a
reducing source no side-chain cleavage of cholesterol occurred.
NADPH (supplied by an extra mitochondrial generating system
+
consisting of 2.5 mM NADP , 40 mM glucose-6-phosphate and
glucose-6-phosphate dehydrogenase) was the most efficient
electron donor. NADH was only one-tenth as effective as
+ +
NADPH. NAD was totally ineffective. Neither NADP alone
nor NADP in the presence of glucose-6-phosphate could support
cholesterol side-chain cleavage activity, suggesting that
these mitochondria did not possess glucose-6-phosphate
dehydrogenase activity. The 40-50% inhibition of the NADPH
supported side-chain cleavage activity by NADH might be
H NO ADDITIONS
H GLUCOSE 6.P.(40 mM) + GLUCOSE 6.P. DEHYDROGENASE (0.2 I.U.)
(GENERATING SYSTEM)
hi NADP+ (2.5mM)
H NADP+ (2.5mM) + GLUCOSE 6.P (40mM)
NADP+ (2.5mM) + GENERATING SYSTEM
NAD (5 mM)
NADH (5 mM)
NADH (5 mM) + NADP (2.5mM) +
GENERATING SYSTEM
2 4 6
[4 - 14cJ CHOLESTEROL CONVERSION (V.)
FIGURE 4.1 REQUIREMENT OF NADPH FOR CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY
Washed heavy mitochondria (0.45 mg protein/tube)
were incubated with ,/4-^C/' cholesterol (200,000
c/m) in medium A for 2 hours with nucleotides
and generators as shown.
The bars represent the mean and SEM of four
separate experiments, each involving duplicate
determinations. Rats used were of the same age
group (10 weeks old). Generating system (extra-
mitochondrial) consisted of 40 mM glucose-6-
phosphate and 0.2 I.U. glucose-6-phosphate
dehydrogenase.
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explained if it was supposed that electrons were lost via
the respiratory system when NAD(H) was available (see Figure
9.1). It might also be explained if testes heavy mitochondria
were like the mitochondrial preparation from immature rat
ovary, in possessing an NAD - dependent 5-ene-3j3-hydroxysteroid
dehydrogenase which converts pregnenolone to progesterone
(Sulimovici & Boyd, 1969). The presence of NADH xvould there¬
fore influence the equilibrium of the enzyme causing the
accumulation of pregnenolone. This explanation seems unlikely
as it was observed that in rat testis pregnenolone is removed
+
by conversion to androgens via an NADP -dependent pathway
(Shikita & Tamaoki, 1965; also see Chapter 8).
The results obtained do not agree in every respect with
those of other workers in the field. Dorfman and co-workers
(Menon et al.. 1967; Drosdowsky et al., 1965; Toren et al..
1964) reported that their mitochondrial preparation from rat
testis contained glucose-6-phosphate dehydrogenase activity;
■f +
NADP plus glucose-6-phosphate or NADP alone supported the
cholesterol side-chain cleavage reaction. NAD was found to
be half as effective as NADH. Glucose-6-phosphate dehydro-
enase, although primarily localized in the interstitial
cells (Niemi & Ikonen, 1962; Ito, 1966; Blackshaw &
Elkington, 1970) is a cytoplasmic enzyme. Therefore, it is
possible that the mitochondrial preparations in the above
mentioned reports were contaminated with cytoplasmic proteins.
N A D P + CONCENTRATION (mM)
FIGURE 4.2 EFFECT OF INCREASING NADP(H) CONCENTRATIONS ON
CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
Washed heavy mitochondria ficoll fraction 5
(0.4 mg protein) was incubated at 37°C for
2 hours in medium A with cholesterol,
generating system (glucose-6-phosphate 40 mM
and glucose-6-phosphate dehydrogenase 0.2 I.U.)
and varying concentrations of NADP . Rats were
14 weeks old.
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4.2 EFFECT OF INCREASING NADPH CONCENTRATIONS ON THE RATE
OF CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
Depending on the type of steroidogenic tissue increasing
NADPH concentrations appears to have different effects on
cholesterol side-chain cleavage. Thus Satoh et al. (1966)
and Yago et al. (1967a) found that excess NADPH above 1 mM
inhibited the side-chain cleavage in some adrenal cell preparation:
• "1"
while high NADP concentrations (5-10 mM) stimulated the reaction
in bovine corpus luteum (Uzgiris et al. , 1971).
The effect of varying concentrations of NADP(H) on
cholesterol side-chain cleavage in washed heavy mitochondria
ficoll fraction 5, prepared from rat testes are shown in Figure
4.2. It can be seen that cholesterol side-chain cleavage
activity increased sharply until NADP(H) concentration was 1.8 mM.
At higher concentrations NADP(H) became increasingly inhibitory.
However, with unwashed heavy mitochondria as shown in Figure
4.3 the optimal concentration for NADP(H) \\ras much higher
(2.5 mM). NADP(H) at 5 mM was only slightly inhibitory. This
difference in the inhibitory concentrations of NADP(H) between
the crude and purified mitochondrial preparations could be due
to the presence of phosphatases (and probably other hydrolytic
enzymes) found to be present in the crude mitochondrial prepara-
tions. The presence of nicotinamide to protect the NADP from
hydrolytic activity or the titration of NADPH (i.e. addition of
0.8 mM aliquots of NADPH to the incubation medium at 20 minute
intervals to keep the concentration constant) did not result
in an increase in cholesterol side-chain cleavage activity
0
ADDITIONS
NADP+ (mM) 0 1 . 5 2. 5 5 10 5 ( 5 ) Titrated
NIACINAMIDE (mM) - - 5
FIGURE 4.3 EFFECT OF UNWASHED MITOCHONDRIA ON OPTIMAL NADPH
REQUIREMENTS FOR CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY
Unwashed heavy mitochondria (5,000 x g ppt) was
incubated under similar conditions to that of
Figure 4.2.with varying amounts of NADPH. In one
tube marked "titrated" 0.8 mM aliquots of NADP
was added at 20 minute intervals. In another tube
5 mM niacinamide was included. Rats were 10 weeks
old.
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(see Figure 4.3). The,concentrations of glucose-6-phosphate
and glucose-6-phosphate dehydrogenase used were sufficient
to completely reduce 10 mM NADP+ in 3 minutes.
4.3. EFFECT OF VARYING THE AMOUNT OF RADIOACTIVE SUBSTRATE-
/4-14c/ cholesterol on cleavage activity
Washed heavy mitochondria were incubated in medium A,
in the presence of an NADPH generating system. The incubations
— 14 —
were started by the addition of varying amounts of /4- C/
cholesterol and continued for 1.5 hours at 37°C. Cholesterol
side-chain cleavage activity was estimated as described in
Chapter 2, section 2.4. The results in Figure 4.4 show that
_ 14 _
the amount of £.4- C/ steroid products formed was proportional
to the amount of radioactive substrate added. The total
percentage conversion of cholesterol was constant
under these experimental conditions. This relationship is
probably a reflection of the abundant endogenous cholesterol
present in these preparations. The total cholesterol content
of heavy mitochondria, measured by GLC (see Chapter 2.8) was
33 ± 8 ng/mg protein, (85.27 ± 20.67 nmole per mg protein •
mean ± standard deviation of lO determinations; rats 10-15
weeks old). Of this total, esterified cholesterol accounted for
less than 10%.
4.4 INFLUENCE OF VARIOUS COMPOUNDS ON THE NADPH SUPPORTED
CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
Washed testicular heavy mitochondria were incubated for
2 hours in medium A with ^4-^C/ cholesterol, extra mitochondrial
—I 1 , r-
100 200 300 400
[• ■ ,4c] CHOLESTEROL INCUBATED (cpm x 1000)
FIGURE 4.4 THE EFFECT OF INCREASING THE CONCENTRATION OF
^/4_14C7 CHOLESTEROL ON THE CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY
The solid line represents steroid products
formed, the dotted line is the activity expressed
as the percent conversion of cholesterol.
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NADPH generating system (see Table 2.2) and different factors,
Cholesterol side-chain cleavage was assayed in the usual
manner (see section 2.4). The results are illustrated in
Figure 4.5. Cyanide increased cholesterol side-chain
cleavage activity (10%) probably by preventing NADPH removal
via pyridine nucleotide transhydrogenase. ATP inhibited the
side-chain cleavage activity by 30% and BSA (fatty acid free)
by 65%. Ca++ in the presence of cyanide, almost doubled the
-f- 4*
enzymic activity. These effects of ATP, BSA and Ca can be
explained on the basis of mitochondrial integrity and membrane
permeability. ATP, at certain concentrations, prevents the
cyclical low amplitude swelling and contraction characteristic
of intact mitochondria. Mitochondria in such contracted
states as well as intact mitochondria are known to be
virtually impermeable to NADPH (Hirschfield & Koritz, 1964;
Lehninger, 1965). Yago et al. (1967) reported that exogenous
NADPH was a poor source of reducing equivalents for the
cholesterol side-chain cleavage reaction in intact bovine
corpora lutea. Bovine serum albumin (BSA) as demonstrated
in Chapter 3.4.2.2 was found to have a protective effect on
mitochondrial integrity (Peron & McCarthy, 1968; Sauer &
Mulrow, 1969). Thus BSA could inhibit cholesterol side-chain
cleavage activity by reducing the permeability of the
mitochondrial membrane to externally generated NADPH. There
are various theories for the effect of Ca ions. Ca
causes swelling of the mitochondria (Lehninger, 1965) and







additions: none kcn ca + kcn atp bsa
FIGURE 4.5 INFLUENCE OF VARIOUS COMPOUNDS ON NADPH SUPPORTED
CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
For each experiment the corresponding controls
were included. Controls consisted of the complete
incubation mixture with effectors but without
generating system. Results presented are corrected
values, i.e. experimental minus control values.
The concentration of KCN was 2 mM, Ca 2 mM,
ATP 5 mM and BSA (fatty acid free) 1% (w/v).
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chain cleavage enzymes# Ca ions could also enhance the
cleavage of cholesterol to pregnenolone by activating the
adenyl cyclase (Sayers et al., 1972); by stimulating the
effect of cyclic AMP on steroidogenesis (Rubin et al.. 1972;
Haksar & Peron, 1972; Hermier & Jutisz, 1969) or by directly
effecting the cholesterol side-chain cleavage enzyme system
(Simpson et al., 1974), The observations in this present
study appear to be compatible with the view that agents which
induce mitochondrial swelling stimulate the conversion of
cholesterol to pregnenolone, while those which decrease
swelling inhibit this conversion,.
The labelled steroid products formed from cholesterol
in the presence of extra mitochondrial NADPH generating system
were testosterone, androstenedione, 17a-hydroxyprogesterone,
progesterone and pregnenolone.
Under the incubation conditions described above no
-f+
metal other than Ca could be shown to stimulate cholesterol
side-chain cleavage activity. The addition of Mn , Mg ,
Co , EDTA and EGTA each at 10 mM concentrations, had no
significant effect.
4.5 EFFICIENCY OP KREBS CYCLE INTERMEDIATES IN SUPPORTING
CHOLESTEROL SIDE-CHAIN CLEAVAGE REACTION
In view of the possible relative impermeability of
mitochondria to NADPH (Yago et_al., 1967) and also because of
the possible effect of phosphatases on NADP+and glucose-6-








^4 - 14C] CHOLESTEROL CONVERSION (•/.)
SURE 4.6 COMPARATIVE EFFICIENCY OF KREBS CYCLE INTERMEDIATES
IN SUPPORTING CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY
Washed heavy mitochondria (0.45 mg protein)were
incubated in medium A for 2 hours at 37°C in the
r- 14 -7
presence of £4- C/ cholesterol and the different
electron donors. The NADPH generating system
"f"
consisted of NADP (1.5 mM); glucose-6-phosphate
40 mM and glucose-6-phosphate dehydrogenase 0.2
I.U. Krebs cycle intermediates were 5 mM each.
Results are mean ± standard deviation of 8 duplicate
determinations.
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The ability of substrates other than extra mitochondrial
NADPH, namely intermediates of the tricarboxylic acid cycle
(TCA), to donate electrons and support steroids 11(3 -hydroxy-
lation has been extensively documented in adrenal cortex
mitochondria by several groups (Brownie & Grant, 1954; Sweat
& Lipscomb, 1955; Harding et al., 1965; Cammer & Estabrook,
1967; Peron & McCarthy, 1968; Kahnt & Wettstein, 1951) but
not so well studied for cholesterol side-chain cleavage.
The effect of three TCA intermediates - DL isocitrate
L-malate and succinate were compared with the externally
generated NADPH with regard to their ability to support the
cholesterol side-chain cleavage reaction in the testis.
The results are shown in Figure 4.6. All three TCA intermediates
\
tested supported cholesterol side-chain cleavage. Isocitrate
was a more effective electron donor than either malate or
succinate. In comparison to the extramitochondrially
generated NADPH, isocitrate was better and malate just as
efficient in supporting cholesterol conversion, whereas
succinate was only half as effective. Under the above assay
conditions, with the Krebs cycle intermediates as electron
donors, the products accumulating were mainly pregnenolone
and progesterone. The 3-oxo -4-ene- steroid group — testosterone
androstenedione and 17a-hydroxyprogesterone - accounted for
less than 0.4% of the radioactivity of cholesterol
added.
These results are comparable with those concerning
steroid hydroxylations in mitochondria of adrenal cortex
(Peron & McCarthy, 1968) and corpus luteum (Robinson &
TABLE4.1
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Stevenson, 1971) in that some TCA intermediates were apparently-
more efficient electron donors than the exogenous NADPH. In
contrast, in the earlier work on testis (Menon et_al., 1967)
and placenta (Mason, 1970) it was reported that the TCA
intermediates were less efficient than NADPH in supporting
cholesterol side-chain cleavage activity.
The relative efficiency of the various TCA intermediates
in supporting cholesterol side-chain cleavage activity,
reported by other investigators, in different steroid producing
tissues is presented in Table 4.1 and is compared with that
obtained in this present study with rat testes.
Because isocitrate was found to be the most efficient
of all electron donors studied and in particular because
it yielded only pregnenolone and progesterone as steroid
products, it was chosen as the electron source (i.e. intra
mitochondrial NADPH generating system)in the assay for
cholesterol side-chain cleavage.
4.6 FACTORS INFLUENCING THE ISOCITRATE SUPPORTED CHOLESTEROL
SIDE-CHAIN CLEAVAGE ACTIVITY
The influence of nucleotides, BSA, cations and anions
on the isocitrate supported cholesterol side-chain cleavage
reaction was investigated. The results presented in Figure 4.7
show that compared to isocitrate alone, the additional presence
of NADP , stimulated the conversion of Ccholesterol
-J-
to labelled steroids, whereas NAD had no appreciable effect,
indicating the presence of an active NADP+ dependent isocitrate
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FIGURE 4.7 INFLUENCE OF DIFFERENT FACTORS ON CHOLESTEROL
SIDE-CHAIN CLEAVAGE ACTIVITY SUPPORTED BY
ISOCITRATE
Washed heavy mitochondria (0.45 mg) were incubated
in medium A with ,/4- c/ cholesterol, isocitrate
(5 mM) and different additional factors as indicated
NADP+ (5 mM); NAD+ (5 mM), NADH (5 mM), KCN (2.0
mM), Ca2+ (2.0 mM), ATP (5.0 mM), ADP (5.0 mM)
and BSA 1% (w/v). In each case controls were run
which were identical to the experimental except
that isocitrate was omitted. The control values
obtained were subtracted from the experimental
value•
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factor in isocitrate supported side-chain cleavage activity
in the washed heavy mitochondria. Cyanide - a respiratory
inhibitor, slightly stimulated the cholesterol side-chain
cleavage activity probably by conserving the intramitochondriaHy
generated NADPH. When incubations were carried out in the
"I" ~4~ |
presence of NADP plus NAD or NADP plus NADH support for
the cleavage activity was reduced by up to 50%. This
inhibition could be explained as due to the activation of
transhydrogenase by NAD+.
"f* +
In contrast to the stimulatory affect of Ca on the
extramitochondrial NADPH supported system, with the isocitrate
"4" "4"
supported system the presence of Ca resulted in a pronounced
inhibition of cholesterol side-chain cleavage activity. This
inhibition- could be attributed to the 'loss of intramitocnuhcriai
NADP(H) which could occur as a consequence of the -Ca inducedJfeWV'- TSUW Ai* aHmtsugm :■ •.
t -rt • v* p-g.«'—■/'ti'Mgy* *>■*?%•.■ *1 .»>v,. - *..
swelling and disruption of the" ■ structural integrity of the
mitochondria. This vieJiv was supporbednby the observation that
+
when exogenous NADP was added to this system consisting of
++
isocitrate, Ca and cyanide, the reaction was now greatly
enhanced. The rate of cholesterol side-chain cleavage was
much higher than that obtained with isocitrate plus NADP+.
A similar marked stimulation of the cholesterol side-chain
cleavage reaction was also observed when ADP was included in
++
the incubations, together with Ca and cyanide. When ATP or
ADP alone were added to the isocitrate supported cholesterol
side-chain cleavage system they were found to be slightly
inhibitory. Although the magnitude of the stimulation of
++
NADP and ADP in the presence of Ca were similar, the important
difference was in the products formed (see Figure 4.8 and
section 4.7).
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An explanation for these results is possible if it is
assumed that NADH:NADPH transhydrogenation is occurring in
these mitochondrial preparations. Kaplan et al. (1952, 1953)
and Kaufman and Kaplan (1961) have described such a
mitochondrial pyridine nucleotide transhydrogenase which,
when isolated from various mammalian tissues, had an equilibrium
constant for the reaction close to unity (Kaplan et al., 1953).
If such a reaction were occurring in the testis mitochondrial
preparations, then the addition of inhibitors of NADH
oxidation might be expected to displace the NADH:NADPH
equilibrium in favour of NADPH. Furthermore, if one assumes
that under normal conditions in steroidogenic mitochondria,
most of the electron flux from NADPH is to the NADPH-cytochrome
P450 reductase system, rather than to the transhydrogenase
reaction, and that the greater part of the electron flux from
NADH is to the NADH-cytochrome oxidase system, then some of
the results shown in Figure 4.7 and also in Figure 4.5 can
be explained:
(i) exogenous NADPH would be expected to be a better electron
donor for cholesterol side-chain cleavage than exogenous NADH.
(ii) Inhibitors of NADH-cytochrome oxidase electron transport
(e.g. CN~) would cause diversion of electrons from NADH to
NADPH, so stimulating cholesterol side-chain cleavage.
(iii) Agents which stimulate NADH-cytochrome oxidase electron
flux (e.g. ADP and uncoupling agents) would displace the
equilibrium of the transhydrogenase in favour of NADH and so
tend to inhibit cholesterol side-chain cleavage.
- 89 -
The effect of bovine serum albumin on the isocitrate
supported cholesterol side-chain cleavage reaction is shown
in Figure 4.7. BSA (fatty acid free) had a marked stimulatory
effect (approximately a 2-fold increase). The percentage
conversions at the different BSA concentrations (0.5 to 2.5%)
were the same. This stimulatory effect was probably due to
the "protective effect" of BSA on the mitochondria; free
fatty acids have been reported to effect the permeability of
the mitochondrial membrane (Van den Bergh, 1967). BSA protects
against this effect by binding the free fatty acids and thus
prevents the leakage of endogenous cofactors essential for
+
cholesterol side-chain cleavage. The failure of NADP to
exert any significant stimulatory influence on the isocitrate
supported side-chain cleavage system in the presence of BSA
(see Figure 4.7) is consistent with this view. In rat
adrenal mitochondria, Peron and McCarthy (1968) also observed
a stimulatory effect of BSA on 11|3-hydroxylation of deoxy¬
corticosterone supported by Krebs cj'cle intermediates.
Robinson (1971) showed that the fatty acids in undefatted
albumin could support cholesterol side-chain cleavage in
porcine corpus luteum mitochondria.
4.7 INFLUENCE OF SUBSTRATES AND COFACTORS UPON THE PRODUCTS
OF CHOLESTEROL METABOLISM BY RAT TESTICULAR HEAVY
MITOCHONDRIA
It is evident from studies presented in this section
that the total yield, the nature and ratio of products of
cholesterol metabolism could be greatly influenced, depending
10r
















FIGURE 4.8 INFLUENCE OF DIFFERENT ELECTRON DONORS AND
COFACTORS ON THE NATURE OF STEROIDS FORMED
FROM CHOLESTEROL
Washed heavy mitochondria were incubated with
r~ 14 "7
£4- C/ cholesterol and e? ther extramitochond-
rial NADPH-generating system or DL isocitrate.
In addition the following factors were added as
indicated NADP+ (5 mM), ADP (5 mM), Ca2+ (2 mM),
KCN (2 mM) and BSA 1% (w/v).
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on whether the electron source employed during incubations,
was the extra mitochondrial NADPH generating system or iso-
citrate. The nature of steroid products could be further
altered by the addition of certain factors such as NADP ,
"f" "I"
Ca , BSA, ADP, and cyanide to the incubation. These
variations in steroid products formed are summarized in
Figure 4.8.
When the extramitochondrial NADPH was used as an electron
source for cholesterol side-chain cleavage, testosterone,
androstenedione and 17a-hydroxyprogesterone (i.e. 3-oxo-4-ene
steroids) were the main products together with small amounts
of progesterone and pregnenolone. The accumulation of
pregnenolone was generally smaller than the other steroids
formed. Under the experimental conditions used the amounts
of pregnenolone and progesterone together did not exceed 70%
of the total 3-oxo-4-enesteroids present at the end of the
reaction. The ratio of the three3-oxo-4-ene steroid products
often varied with different mitochondrial preparations and
age of the rats. In immature rats (7-8 weeks old) the
predominant steroids found were androstenedione and 17a-
hydroxyprogesterone and in older rats (9 weeks plus) testost¬
erone and androstenedione. It would appear therefore that
rat testes heavy mitochondria contain all the enzymes
necessary for androgen biosynthesis from cholesterol, namely
cholesterol side-chain cleavage system, 3P~hydroxysteroid
dehydrogenase, 17a-hydroxylase ,C-17y 20 lyase and 17j3-hydroxy-
steroid dehydrogenase. These findings are consistent with
the earlier reports of Menon et al. (1965) and Tamaoki and
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Shikita (1966) who observed that rat testis mitochondrial
preparations possessed significant quantities of enzyme
activities involved in the bio-transformation of pregnenolone
to testosterone (but believed them to be of microsomal origin).
In other steroid producing tissues, namely adrenals (Simpson &
Boyd, 1967a), ovaries (Sulimovici & Boyd, 1968), corpus luteum
(Robinson & Stevenson, 1971; Hall & Koritz, 1964) and placenta
(Morrison, 1965; Mason, 1970), pregnenolone and/or progesterone




In the presence of Ca plus extramitochondrial NADPH
generating system, relatively more progesterone and pregnenolone
accumulated in the testicular incubations than the 3-oxo-4-ene-
androgens.
When isocitrate was used as the electron donor, the
pattern of steroid products formed was different to that
obtained with extramitochondrial NADPH. Pregnenolone was the
major product with a smaller quantity of progesterone. (Ratio
of progesterone/pregnenolone = 0.6.) The 3-oxo-4<-ene-steroids
j—1 14
formed rarely exceeded 0.5% of the total /4- C/ cholesterol
incubated. NADP in addition to stimulating the isocitrate
supported cholesterol side-chain cleavage reaction altered
the pattern of steroids formed - mimicing that obtained with
extramitochondrial NADPH. Testosterone was the main product
together with progesterone (Ratio 2:1). The pregnenolone
accumulation was very small and accounted for less than 5% of
the total steroid products. These observations lend support
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to the earlier suggestion that intramitochondrially generated
NADPHf (in the presence of isocitrate) although readily
available to the cholesterol side-chain cleavage enzyme
complex, is not available to the enzymes responsible for the
further metabolism of progesterone to testosterone.
When either BSA or ADP or ATP were added to the isocitrate
supported cholesterol side-chain cleavage system, the end
products isolated were essentially the same as with isocitrate
alone, but the amount of pregnenolone accumulated was greater.
The ratio of progesterone:pregnenolone was approximately 0.37.
++
When Ca plus cyanide were present in addition to isocitrate
and ADP, pregnenolone was the major product formed. Of the
total labelled products formed pregnenolone accounted for
81%, progesterone 16% and the 3-oxo-4ene- steroids only 4%.
When ADP was replaced by NADP in the above experiment, the
steroid pattern was again altered - testosterone was noxv the
major product with little pregnenolone and progesterone
+
(similar to NADP plus isocitrate).
In the presence of BSA the stimulatory influence of
NADP on the isocitrate supported cleavage activity was prevented
The main products accumulating were progesterone and pregnenolone
Of significance was the observation that only a small amount
of testosterone (1%) accumulated compared to 5.6% in the absence
of BSA.
ISOC ITRATE CONCENTRATION (mM)
FIGURE 4.9 THE EFFECT OF VARYING CONCENTRATIONS OF ISO-
CITRATE ON CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY
Washed heavy mitochondria (0.45 mg protein)
were incubated in medium A with Q?
cholesterol and different amounts of DL
isocitrate for 90 minutes at 37°C. Cholesterol
side-chain cleavage activity was estimated as
described in Chapter 2.
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FIGURE 4.10 TIME COURSE OF THE REACTION
Washed heavy mitochondria were incubated in
yT—■ 4 mmymedium H with £4- C/ cholesterol and isocitrate
(5 mM) for varying periods up to 2 hours.
1 1 1 1 1 1
0 0.2 0.4 0.6 0.8 l.o
[ MITOCHONDRIAL PROTEIN] mg/tube
FIGURE 4.11 RELATIONSHIP BETWEEN CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY AND CONCENTRATION OF
MITOCHONDRIAL PROTEIN
Incubation system consisted of
cholesterol in medium A; DL isocitrate (5 mM)
and varying amounts of washed heavy mitochondria.
Incubations were carried out at 37°C for
90 minutes.
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4.8 OPTIMAL CONDITIONS FOR ISOCITRATE SUPPORTED CHOLESTEROL
SIDE-CHAIN CLEAVAGE REACTION
4.8.1 Effect of Varying Isocitrate Concentrations
Washed heavy mitochondria were incubated in medium A
— 14 —
with </4- C/ cholesterol and in the presence of different
amounts of isocitrate for 90 minutes at 37°C, and cholesterol
side-chain cleavage activity was estimated as described in
Chapter 2, section 2. The results of a typical experiment
are shown in Figure 4.9. The optimal concentration of
isocitrate was 5 mM. A further increase up to 10 mM had
little additional effect on the cleavage activity.
4.8.2 Time Course of the Reaction
This is shown in Figure 4.10. The rate of side-chain
cleavage of cholesterol increased linearly for about 90 minutes.
Similar results were obtained with extramitochondrial NADPH
generating system.
4.8.3 Relationship Between Rate of Cholesterol Side-Chain
Cleavage and Concentration of the Enzyme
Figure 4.11 shows the effect of varying amounts of
mitochondrial enzyme on the rate of side-chain cleavage.
Different amounts of washed heavy mitochondria were incubated
with isocitrate (5 mM) and Z4-14c7 cholesterol for 90 minutes.
The rate of cleavage was linear up to 0.5 mg mitochondrial
protein per tube.
4.8.4 Influence of Different Buffer Systems
For this experiment mitochondria were isolated in 0.25 M
"f"+



























FIGURE 4.12 INFLUENCE OF DIFFERENT BUFFER MEDIA ON
CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
Washed heavy mitochondria isolated in 0.25 M
sucrose were incubated at 37°C for 90 minutes
with cholesterol and DL isocitrate
(5 mM) in different media at pH 7.5 with and
without BSA (1% w/v). The final buffer
2+
concentrations were 60 mM. Mg (10 mM) was
present except in buffer medium B.
Rats were 11 weeks old.
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except in medium B) and £4- c/ cholesterol. Different
buffer media (pH 7.5) with or without BSA - 1% (w/v) were
used. The results are illustrated in Figure 4.12. It can
be seen that phosphate buffer, with or without BSA, was a
poor medium. Compared to other buffer media, phosphate buffer
appeared to inhibit the cholesterol side-chain cleavage
reaction. When Tris buffer was substituted for phosphate
buffer the conversion of cholesterol to steroids doubled.
The addition of BSA (1%) to the Tris buffer resulted in a
further marked two-fold stimulation of the cleavage reaction.
Medium B was more effective than phosphate buffer (with or
without BSA) in supporting cholesterol oxygenase activity.
This rate of cleavage was hoivever comparable to that obtained
with Tris buffer (in the absence of BSA) but very much less
(40%) than that with Tris buffer plus BSA. Medium B contained
-f-
BSA (0.15/2) but no Mg . However, with the addition of
++
lO mM Mg to incubations containing medium B, a 50% stimulation
of cholesterol side-chain cleavage was observed (Figure 4.12).
As discussed earlier in Chapter 3, mitochondria exhibited
respiratory coupling only in the presence of medium B. The
++
presence of Mg completely uncoupled the mitochondria.
From the above observations it appears that uncoupling
conditions favour cholesterol side-chain cleavage.
The steroid products formed in each case were mainly
pregnenolone and progesterone. The amount of 3-oxo-4-ene-
steroids formed was very small - less than 0.5%. The ratio
of progesterone:pregnenolone formed in both Tris and phosphate





























FIGURE 4.13 EFFECT OF VARYING pH ON ISOCITRATE SUPPORTED
CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
The pH of Tris buffer (60 mM) used varied between
6.5 and 8.5 (measured at room temperature 23°C).
1% BSA was included in the incubation medium.
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when BSA was present there was a marked accumulation of
pregnenolone with comparatively little or no increase in
progesterone or 3-oxo-4-ene-steroids. In the case of medium B,
pregnenolone accounted for 63% of the total steroid formed
and progesterone 23%.
4.8.5 Effect of Varying pH
Cholesterol side-chain cleavage estimations were carried
out in medium A as described previously. The pH of the Tris
buffer in the incubation medium was varied between 6.5 and
8.5 (measured at room temperature 23°C). In addition,
incubation media contained 1% BSA. The activity profile
over this range, is presented in Figure 4.13 and shows that
the optimal pH was gradually reached near pH 7.5. The rate
of cholesterol side-chain cleavage fell off very rapidly
as the pH increased stepwise to pH 8.5. The data also show
that the ratio of the products formed (progesterone and
pregnenolone) were not significantly altered at different pHs.
For the same reaction sequence in rat adrenal mitochondria
Koritz (1962) found the pH optimum to be 6.2.
From the studies presented in this section the optimal
conditions for the isocitrate-supported cholesterol side-chain
cleavage reaction could be summarized as isocitrate 5 mM,
Tris buffer pH 7.5 incubation time 90 minutes, and mitochondrial
protein 0.5 mg/tube. These conditions were therefore used
for most of the studies on cholesterol side-chain cleavage.
10
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FIGURE 4.14 CORRELATION BETWEEN THE NADPH AND ISOCITRATE IN
SUPPORTING CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY IN RAT TESTES OF DIFFERENT AGES
Washed heavy mitochondria (0.45 mg) from rats of
different age groups were incubated for 90 mins.
/— 2.4 —>
in medium A with [4- C/ cholesterol and the
following electron donor systems:extramitochond-
rial NADPH-generating system (see Table 2.3);
DL isocitrate (5 mM) and isocitrate (5 mM) plus
NADP (1.5 mM). Each group consisted of 12
animals•
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4.9 CORRELATION BETWEEN ISOCITRATE AND EXTRAMITOCHONDRIAL
NADPH IN SUPPORTING CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY IN RAT TESTES MITOCHONDRIA AT DIFFERENT AGES
Washed heavy mitochondria from rats of different age
groups were incubated for 1.5 hours in medium A with /4-^c/
cholesterol. The electron sources were extramitochondrial
+
NADPH generating system or isocitrate or isocitrate plus NADP „
The results in Figure 4e14 confirm that with isocitrate there
is a greater conversion of cholesterol to steroids than with
extramitochondrial NADPH generating system. This difference
was more pronounced in mitochondrial preparations from younger
rats (8 to lO weeks). With both electron sources an increase
in cholesterol side-chain cleavage activity with increasing age
of the animals was observed but the correlation ivas much
clearer with the isocitrate system. With isocitrate plus NADP
the rate of conversion, although higher, paralleled those with
isocitrate alone at the different ages. From such studies it
appears that the isocitrate system is more reliable than the
NADPH generating system for t he study of cholesterol side-chain
cleavage in rat testicular mitochondria.
4.10 EFFICACY OF EXTRAMITOCHONDRIAL NADPH AND ISOCITRATE AS
ELECTRON SOURCE FOR THE MEASUREMENT OF CHOLESTEROL
SIDE-CHAIN CLEAVAGE ACTIVITY
4.10.1 In Different Subcellular Fraction
Testicular homogenate (350 x g supernatant), heavy mito¬
chondria and heavy mitochondria ficoll fraction 5 (HMF^_) were
assayed for cholesterol side-chain cleavage activity, using
r oo
o
FIGURE 4.15 EFFICACY OF DIFFERENT ELECTRON DONORS IN
SUPPORTING CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY IN COUPLED MITOCHONDRIA
Washed heavy mitochondria ficoll fraction 5
(0.5 mg) were incubated in medium B for
90 minutes with cholesterol and an
electron source:extramitochondrial NADPH-
generating system or isocitrate (5 mM) or malate
(5 mM). Results are mean ± SD of 5 different
determinations run in duplicate. Rats were of
the same age. Mitochondria were prepared in
0.25 M sucrose-lO mM Tris-0.1 mM EDTA (pH 7.5)
and fractionated through a ficoll gradient.
Respiratory control ratios = 1.8 (with succinate).
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the two electron donor systems. The results in Table 4.2
show that with crude testicular preparations the exogenous
NADPH supported activity was very low, probably due to the
presence of hydrolytic enzymes. With purer preparations
(HMFj.) the values approached those obtained with isocitrate.
Compared xvith homogenate, heavy mitochondria ficoll subfraction
5 in the presence of isocitrate showed a four-fold increase
in activity and with extramitochondrial NADPH generating
system, a ten-fold increase.
4.10.2 With Coupled Mitochondria
Since most of the investigations presented were carried
out under conditions in which the mitochondria were observed
to be in the uncoupled state it was of interest to study
cholesterol side-chain cleavage activity under coupled
conditions. For this study heavy mitochondria ficoll sub-
fraction 5 was prepared as previously described using 0.25 M
sucrose - 10 mM Tris, O.l mM EDTA as the homogenizing medium
These mitochondria were coupled and showed good respiratory
control (RCR = 1.8 with succinate). Cholesterol side-chain
cleavage activity was measured in these heavy mitochondria
incubated in medium B with either isocitrate (5 mM) malate
or NADPH generating system. The results presented in
Figure 4.15 show that extrami.tochondrial NADPH was less than
half as effective as isocitrate confirming the relative
impermeability of the pyridine nucleotide. Compared to iso¬
citrate malate too was a comparatively inefficient donor (only
50% of isocitrate supported activity). However, the overall
pattern was essentially similar to that previously described.
TABLE 4.2
ASSAY OF CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY IN THE DIFFERENT SUBCELLULAR FRACTIONS
SUBCELLULAR
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Subcellular fractions were prepared as described
in Chapter 2.
Each subcellular fraction (0.46 ma) was incubated
for 90 minutes in medium A with Z4-1^C/ cholesterol
and an electron source - either isocitrate (5 mM)
or extramitochondrial NADPH-generating system.
Cholesterol side-chain cleavage activity was




H Mg + + (10 mM)
SYSTEM
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FIGURE 4.16 INFLUENCE OF METAL IONS ON CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY SUPPORTED BY ISOClTRATE
Washed heavy mitochondria ficoll fraction 5 were
incubated in medium B at 37°C for 90 minutes.
++
The final concentration of metal ions were Mg
(10 mM), Mn++ (10 mM) and Ca++ (1.5 mM). Results
are mean ± SD of 4 experiments of duplicate
determinations•
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4.H INFLUENCE OF METAL IONS ON CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY
The requirement for Mg for cholesterol side-chaxn
cleavage activity could only be clearly demonstrated in
intact mitochondria, prepared and incubated as described
+-r
above. The results in Figure 4.16 show that Mg stimulates
cholesterol oxygenase activity (also see Figure 4.12). The
failure to demonstrate such an effect with earlier preparations
could be attributed to the presence of adequate amounts of the
++
endogenous metallic ion. Mn was observed to have an
inhibitory effect. This difference may be linked to the
specific requirement of NADP dependent isocitrate dehydro-
-r *r +-}■
genase for Mg . Ca , as previously observed, was a potent
inhibitor of the isocitrate supported cleavage activity.
4.12 EFFECT OF REDUCING AGENTS ON CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY
It has previously been reported that in ovarian tissue
(Goldzieher, 1953; Lazaroiv, 1954) and adrenal gland (Harding,
1961), there is a relationship between glutathione and
ascorbic acid. Sulimovici (1968) demonstrated that cholesterol
side-chain cleavage activities in immature rat ovaries were
influenced by reducing agents - glutathione, ascorbic acid,
cyteine and cysteamine. Since ascorbic acid - a normal
cytoplasmic constituent is also found in high concentrations
in the interstitium of the testis, the effect of glutathione,
ascorbic acid and cysteine on cholesterol side-chain cleavage
FIGURE 4.17 EFFECT OF REDUCING AGENTS ON CHOLESTEROL SIDE-
CHAIN CLEAVAGE ACTIVITY IN INTACT MITOCHONDRIA
Washed heavy mitochondria ficoll fraction 5
were incubated in medium B for 90 minutes at
37°C. Isocitrate 5 mM was the electron donor.
Reducing agents tested were glutathione (1 mM) ,
ascorbic acid (1.5 mM) and cysteine (1.5 mM).
Results are mean ± SD of three experiments each
of quadruplet determinations. Rats were
13 weeks old.
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in intact mitochondria from rat testis, was studied.
Figure 4.17 shows that all three reducing agents tested had
no significant effect on cleavage activity supported by
isocitrate. The concentrations of glutathione and cysteine
used in this study were shown to produce a maximal effect in
immature rat ovaries (Sulimovici, 1968).
4.13 EFFECT OF CYANOKETONE ON CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY IN TESTIS MITOCHONDRIA
In the course of the above studies it became evident that
the rat testicular mitochondria possess the enzymes involved
in testosterone synthesis. Since the main interest of this
study was on the cholesterol side-chain cleavage reaction
it was felt that, if the further metabolism of pregnenolone
could be prevented, it would be an advantage in routine
analysis. In this case pregnenolone would be the only
product formed from cholesterol. This in turn would reflect,
in the main, Leydig cell mitochondrial activity, since it is
likely that a significant portion of the enzymes involved in
pregnenolone metabolism to testosterone may be of tubular
origin (Christensen & Mason, 1965). To this end the effect
of cyanoketone - a synthetic steroid and an inhibitor of
5-ene-3|3-hydroxysteroid dehydrogenase, was tested.
Cyanoketone causes a marked inhibition of 5-ene-3p-hydroxy-
steroid dehydrogenase in extracts of Pseudomonas testosteroni
(Ferrari & Arnold, 1963; Goldman et al., 1965; Neville &
Engel, 1968) and in the ovary and adrenals of rats in vitro
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FIGURE 4.18 EFFECT OF VARYING CONCENTRATIONS OF CYANOKETONE
ON CHOLESTEROL SIDE-CHAIN CLEAVAGE ACTIVITY
Incubations consisted of (/4-^4c7 cholesterol,
isocitrate (5 mM), medium B, heavy mitochondria
ficoll fraction 5 (0.4 mg) and varying amounts
of cyanoketone (in ethanol). The amount of
ethanol in the final incubation did not exceed
2% (v/v). Incubation time 90 minutes. Incubated
controls containing equivalent amounts of ethanol
were also run. Results are corrected for zero
time control values. Results of the ethanolic
controls were identical to those not containing
the alcohol. Results in figure are typical of
those observed repeatedly.
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The effect of cyanoketone on the rate of rat testicular
cholesterol side-chain cleavage and the nature of steroids
formed from cholesterol was investigated.
Figure 4.IS shows the effect of different concentrations
of cyanoketone on the rate of cholesterol side-chain cleavage
activity. It can be seen that at concentration of 6-12 [iM,
cyanoketone did not inhibit the cleavage reaction but was
in fact stimulatory. 6 cyanoketone resulted in a 13-20%
increase in pregnenolone formed. This stimulatory effect was
consistently observed as shown in Table 4.3. At higher
concentrations, cyanoketone appeared to inhibit the cholesterol
side-chain cleavage reaction. At 60 |iM inhibition was
approximately 27%. Farese (1970) found that cyanoketone at
high concentrations (1 mM) inhibited rat adrenal cholesterol
side-chain cleavage activity. This inhibition was suggested
to be a direct effect of cyanoketone on the cleavage enzyme
complex.
In the absence of cyanoketone but with isocitrate as the
electron donor, pregnenolone and progesterone were the products
formed from labelled cholesterol. In the presence of cyanoketone
pregnenolone xvas the' only labelled steroid formed, indicating
that 3|3-hydroxysteroid dehydrogenase was inhibited. This was
confirmed by the results shown in Figure 4.19. As demonstrated
earlier when testicular mitochondria were incubated with
isocitrate, the presence of NADP stimulated overall, the
cholesterol side-chain cleavage reaction and the 3j3-hydroxy
steroid dehydrogenase activity, resulting in the formation of
TABLE4.3
EFFECTOFCYANOKETONENCHOLES EROLSID -CHAINCL AV GEA IV TY
EXPT. No.
%^4-14C7CHOLESTEROLC NVERSION ADDITIONSTISOCITRATEYSTEM




































CYANOKETONE NADP + NADP+ +
CYANOKETONE
FIGURE 4.19 EFFECT OF CYANOKETONE ON CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY IN INTACT TESTICULAR MITO¬
CHONDRIA AND NATURE OF STEROID PRODUCTS FORMED
Ficoll fractionated heavy mitochondria (HMF^
0.4-0.5 rng protein) were incubated in medium A
at 37°C for 90 minutes with /4-^C/7 cholesterol
and either isocitrate (5 mM) or isocitrate and
NADP (1.5 mM) . Cyanoketone (6 |iM in ethanol)
was added where indicated. Incubated controls
containing an equivalent amount of ethanol were
also included. Results were corrected for zero
time control values. The amount of ethanol added
was always less than 2% of the final incubation
volume j
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testosterone as the major product. However, xvhen cyanoketone
•J"
(6 (iM) ivas included in the incubations with NADP and iso-
citrate, the 3(3-hydroxysteroid dehydrogenase was completely
inhibited, since now pregnenolone was the only product formed.
The total percentage conversion of cholesterol was however
reduced by 25%.
The reasons for the stimulatory effect of cyanoketone
on the isocitrate supported side-chain cleavage system and
its inhibitory .influence on the NADP -isocitrate system is
not clear, but it does not appear to be related to the
pregnenolone feed-back inhibition of the desmolase complex
as reported by Koritz and Hall (1964a).
The data with testis show that the presence of cyanoketone
produces a large rise of pregnenolone concentration in the
mitochondria, yet the rate of cholesterol side-chain cleavage was
not inhibited but was similar to that obtained in the absence
of cyanoketone, when pregnenolone levels were lower due to
further metabolism.
In bovine adrenal cortex and corpus luteum mitochondria
pregnenolone has been reported to inhibit cholesterol side-
chain cleavage activity (Koritz & Hall, 1964a; Ic'nii et al. ,
1963)o On the basis of such observations it was postulated
that the rate limiting step in steroidogenesis was the efflux
of pregnenolone for the mitochondria. The action of ACTH was
considered to result in the increased efflux of pregnenolone
from the mitochondria thus releasing the inhibition. From the
results obtained with testicular mitochondria, such a control
of steroidogenesis may not exist in testes.
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SUMMARY
1. The requirement of NADpH for cholesterol side-chain
cleavage activity in rat testis was confirmed. NADH could
not be substituted for NADPH. NAD and NADP were completely
ineffective, whereas NADPH-generating system and NADH together
were inhibitory. The results also indicate the absence of
glucose-6-p'nosphate dehydrogenase in these mitochondrial
preparations.
2. The effect of varying Ccholesterol and NADPH
concentrations on the cleavage reaction were investigated.
With purified mitochondrial preparations, the concentrations
of NADP(H) required for maximal activity was about 1.8 mM.
Higher concentrations were inhibitory. With crude preparations
higher concentrations of the nucleotide (2.5-5 mM) were required.
"H"
3. Studies on the influence of various factors (KCN, Ca \
ATP and BSA) on cholesterol side-chain cleavage activity
supported by extrainitochondrial NADPH-generating system
indicated that, in general, compounds such as Ca which induce
mitochondrial swelling enhanced the activity, whereas those
that decrease swelling (like ATP) and protect the mitochondrial
integrity (e.g. BSA), inhibited the conversion.
4. Of the Krebs cycle intermediates examined as alternative
electron sources, isocitrate was more effective than malate,
and both were better than NADPH in supporting cholesterol
side-chain cleavage activity. Succinate was least efficient.
5. The optimum conditions for cholesterol side-chain cleavage
activity supported by isocitrate were investigated. These
included the effect of substrate concentrations, increasing
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amounts of mitochondrial protein and varying pH. The optimum
pH in Tris buffer was pH 7.5. Studies with different buffered
media showed that Tris buffer was the most efficient medium
whereas phosphate buffer was inhibitory. Medium B, although
better than phosphate buffer, was not as favourable as Tris.
However, the inclusion of Mg in medium B greatly enhanced
cleavage activity - implying that uncoupling conditions favour
the reaction.
6. The presence of various cations and anions, nucleotides and
BSA in the incubation medium with isocitrate greatly influenced
the rate of the cholesterol side-chain cleavage reaction and
the nature of steroid products accumulating. Reducing agents
such as glutathione and ascorbate had no effect on the reaction.
+
Evidence suggest that testis mitochondria contain an NADP
dependent isocitrate dehydrogenase.
7. From a consideration of the nature of steroid products, the
studies show that the total yield, ratio and type of products
formed from cholesterol could be greatly influenced by
the electron donor used, (whether extramitochondrial NADPH
generating system or isocitrate) and the picture further altered
by the presence of cations, anions, nucleotides and BSA. These
testes mitochondria appear to contain the enzymes involved in
testosterone biosynthesis.
8. Cholesterol side-chain cleavage activity was found to be
slightly stimulated by cyanoketone at low concentrations (6 jiM)
and inhibited a very high concentration (50 [iM) • Pregnenolone
was the only product formed indicating that the 3|3 hydroxysteroid
dehydrogenase activity in these mitochondria was inhibited.
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EVIDENCE FOR THE PRESENCE OF CYTOCHROME P450 AND
CYTOCHROMES OF THE NORMAL RESPIRATORY CHAIN IN RAT
TESTES MITOCHONDRIA
5.1 INTRODUCTION
In the course of steroid biosynthesis from cholesterol
a number of hydroxylation reactions occur. Of these the
cholesterol side-chain cleavage enzyme system of all steroido¬
genic tissues has been located in the mitochondria (see
Sulimovici and Boyd, 1969) as has the ll|3-and 18-hydroxylases
of the adrenal cortex (Halkerston et al., 1961). By contrast
the mixed-function oxidases involved in 17a- (Plager & Samuels,
1954) and 21-hydroxylations (Ryan & Engel, 1957) have been
found to be associated with the endoplasmic reticulum
(microsomes).
It is fairly well established for most steroid producing
tissues that cytochrome P450 is involved as the terminal
oxidase in these hydroxylase reactions (Harding et al., 1964,
1965; Kinoshita et al., 1966; Horie et al., 1966; Simpson
& Boyd, 1967; Yohro & Horie, 1967; Meigs & Ryan, 1968;
Mason & Boyd, 1971; Ryan & Engel, 1957; Estabrook et al.,
1963; Greengard et al., 1967; Omura et al., 1965, 1966;
Kimura & Suzuki, 1967; Wilson & Harding, 1970; Jefcoate
et al., 1970) and is responsible for oxygen activation in both
mitochondrial and microsomal mixed function oxidases.
To date there has been no evidence for the presence of
cytochrome P450 in testicular mitochondria from normal rats.
Employing the conventional carbon monoxide difference spectra
technique of Omura and Sato (1964a,b), significant amounts of
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cytochrome P450 were detected only in the microsomal fraction
from rat testis but none in the mitochondrial fractions, even
of x-irradiated (Machino et al., 1969) and gonadotrophin
treated rats (Machino et al.t 1969; Mason et al. , 1973).
Hence studies were undertaken to assess the presence or
absence of cytochrome P450 in the mitochondria of rat testis.
In addition, the present study examines for comparison the
presence and distribution of the normal respiratory chain
cytochromes.
5.2 PRESENCE AND SUBCELLULAR DISTRIBUTION OF THE CYTOCHROMES
OP THE NORMAL RESPIRATORY CHAIN
For these investigations "heavy mitochondria", "light
mitochondria" and microsomal fractions were prepared from
homogenates of rat testes by differential centrifugation and
the heavy mitochondria further fractionated on 3-10% ficoll
as previously described in Chapter 2, section 2.2 and 2.3.
(Heavy mitochondria ficoll fraction 5 was used.) These
particulate fractions were suspended in medium A and the
difference spectrum measured at room temperature (approximately
22°C) in an Aminco-Chance dual wavelength/split beam recording
spectrophotometer set to scan wavelengths. Two silica
cuvettes of 3.0 ml. capacity and 1 cm light path were used and
are referred to as reference and experimental cuvettes. The
spectral data presented are replots made by substracting the




FIG. 5.1 SUBCELLULAR DISTRIBUTION OF THE NORMAL RESPIRATORY
CHAIN CYTOCHROMES OF RAT TESTES
Reduced minus oxidized difference spectra of testi¬
cular heavy mitochondria (ficoll fraction 5), light
mitochondria and microsomal fractions. Each sub¬
cellular fraction was divided equally into two
cuvettes and a base-line of equal light absorption
established. A few crystals of solid sodium
dithionite were added to the contents of the
experimental cuvette with a stirring rod and the
difference spectrum of reduced minus oxidized
cytochrome recorded. The final protein concentrations
were: heavy mitochondria 1.6 mg/ml, light mitochondria
2.6 mg/ml and microsomes 3.3 mg/rol,
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5.2.1 Dithionite reduced minus oxidized difference spectra
of testicular heavy mitochondria, light mitochondria and
microsomal fractions
To obtain this spectrum, each subcellular fraction was
divided equally (3 ml. each) into the two cuvettes. After a
base-line of equal light absorbance was established between
the oxidized suspensions in the reference and experimental
cuvettes, a few grains of solid sodium dithionite were added
to the contents of the experimental cuvette with a stirring
rod and the difference spectrum of reduced minus oxidized
cytochromes recorded. The results are presented in Figure 5.1.
The heavy mitochondria exhibited the typical absorption bands
of the classical respiratory chain cytochromes characteristic
of mitochondria isolated from other tissues (Harding & Nelson,
1966, Yohro & Horie, 1967). The a absorption band of cyto¬
chrome a( + a„) was at 606 nm and that of cytochrome C + C-3 1
at 553 nm with a shoulder at about 560 nm produced by the a
band of cytochrome b. The combined p bands of the cytochromes
appeared at approximately 520 nm and the oxidized flavo-protein
trough at 470 nm. In the Soret region the prominent £ bands
of cytochromes a (+ a) and b were seen at 445 nm and 434 nm
respectively with a slight shoulder at about 420 nm representing
probably the band of cytochrome C + .
The reduced versus oxidized difference spectrum of light
mitochondrial fraction was essentially the same as that of
the heavy mitochondria except that the levels of the cytochromes
were lower. This presence of respiratory chain cytochromes
confirmed the mitochondrial nature of this fraction.
TABLE5.1
CONCENTRATIONOFMIT CHONDRIALRESPIRATO YCHAIN CYTOCHROMESANDMICROSOMALCYTOCHROMP450IRATTESTES
COMPONENT
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The difference spectrum produced with the microsomal
fraction showed the presence of a absorption band at 560 nm
and a Soret band with maxima at 429 nm, similar to that of
cytochrome b. No other absorption peaks characteristic of
cytochromes a + a„ or C + CE were detectable.
j 1
From spectral studies of this type the concentrations of
the normal respiratory chain cytochromes in testes mitochondria
were determined using the molar extinction coefficients
indicated by Estabrook and Holowinsky (1961). The results are
summarized in Table 5.1. These values compare well with those
of other steroidogenic tissue like the adrenal cortex (Cammer
& Estabrook, 1967; Harding & Nelson, 1966) and corpus luteum
(Mcintosh et al., 1971). However, compared with testes
mitochondria of other species (Mason et al«, , 1973) rat testes
contains an unusually high concentration of cytochrome
oxidase (a + a„).
5.3 PRESENCE AND SUBCELLULAR DISTRIBUTION OF CYTOCHROME P450
5.3.1 Reduced-carbon monoxide difference spectra of the
subcellular particulate fractions from rat testis homoaenates
To obtain such a reduced-carbon monoxide versus reduced
difference spectrum, sodium dithionite was added to both
cuvettes containing the oxidized cytochromes. After the base¬
line was established, carbon monoxide was bubbled into the
experimental cuvette for a few seconds and the difference
spectrum recorded. Figure 5.2 shows the typical carbon
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FIG. 5.2 PRESENCE AND SUBCELLULAR DISTRIBUTION OF CYTOCHROME
P450
Both cuvettes containing equal amounts of a sub¬
cellular suspension were treated with sodium
dithionite and the base-line recorded. The
experimental cuvette was then saturated by bubbling
carbon monoxide through the suspension for 30 sees,
and the difference spectrum recorded. The final
protein concentrations of the particulate suspensions
were: heavy mitochondria (ficoll fraction 5)
1.6 mg/ml, light mitochondria 2.6 mg/ml and micro¬
somal fraction 3.3 mg/ml
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subcellular fraction. The addition of CO to the reduced
microsomal preparation produced an intense absorption band at
450 nm which completely dominated the spectrum and thus
confirmed the presence of cytochrome P450 in this fraction.
However, the heavy mitochondrial fraction did not show the
450 nm peak of cytochrome P450:CO complex but instead gave
rise to a large broad trough with a minimum at 446 nm and a
prominent absorption peak at 430 nm associated with the
formation of the CO complex of reduced cytochrome oxidase
(cytochrome a^ ++:CO). No discernible cytochrome P450 peak
was detectable even at high mitochondrial protein concentrations
of 5 mg/ml. The 450 nm minus 490 nm absorbance difference was
negative. Kowal et al. (1970) reported that cytochrome P450
could be determined by the 460 nm minus 490 nm absorbance
difference contribution since the difference spectrum of the
reduced CO complex of cytochrome oxidase had only a small
spectral contribution in this region.
The CO- difference spectrum of the light mitochondria
appeared to be of a mixed type as indicated by the absorption
bands at about 430 nm and 453 nm and thus could be attributable
to the presence of both mitochondrial (cytochrome a + a^) and
microsomal (cytochrome P450) pigments respectively, in this
fraction. The slight shift of the absorbance maximum of
cytochrome P450:CO complex could be due to pertubation by
cytochrome oxidase present in this fraction (also see Figure 5.3
curve of microsome and heavy mitochondria).
It has been reported that upon aging of the particulate
preparations (Harding & Nelson, 1966) or exposure to various
agents (Omura & Sato, 1964a,b) cytochrome P450 is converted
390 410 430 450 470 490 510 530
WAVELENGTH (nm)
FIG. 5.3 EFFECT OF TESTICULAR MITOCHONDRIAL CYTOCHROMES ON
MICROSOMAL CYTOCHROME P450:C0 COMPLEX
The curves represent the carbon monoxide-reduced
minus reduced difference spectrum produced by
saturating the experimental cuvette which contained
the reduced cytochromes with carbon-monoxide
Microsomes 3.3 mg/ml
i ii. Mixture of microsomes 3.3 mg/ml plus heavy
mitochondria (ficoll fraction 5) 0.9 mg/ml
(equivalent to 0.15 nmoles a + a^)
Ratio: cytochrome oxidase/microsomal
cytochrome P450 = 0.57.
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to a complex absorbing at 42O nm. This cytochrome P420 was
shown to be the enzymatically inactive form of cytochrome
P450 (Ichikawa & Yamano, 1967b; Mason et al., 1965). In this
study, with all three testicular subcellular fractions, the
CO:reduced minus reduced difference spectra did not show the
presence of such a P420 cytochrome.
The cholesterol side-chain cleavage enzyme complex of
other steroidogenic tissues such as the adrenals (Simpson &
Boyd, 1967), corpora luteum (Yohro & Horie, 1967; Mcintosh
et al., 1971) and placenta (Mason & Boyd, 1971) all contain
readily detectable levels of cytochrome P450 localized to the
mitochondria. Therefore, by analogy, the corresponding
hydroxylating system of rat testes heavy mitochondria might
be expected to involve cytochrome P450 and to function in a
similar manner.
Since Leydig cells, which are the principal source of
androgens, constitute only 3-6% of the total mass of the adult
testis (Christensen & Mason, 1965) it is likely that small
amounts of cytochrome P450, if present in the mitochondria
could be masked by the relatively large content of other
cytochromes such as cytochrome oxidase or haemoglobin and thus
escape detection as the carbon monoxide reduced complex.
Experiments were therefore performed to determine the effects
of cytochrome oxidase and haemoglobin on the detection of
cytochrome P450.
5.3.2 Effect of cytochrome oxidase on the determination of
cytochrome P45Q:CO complex
To determine this effect, the experiments were carried
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FIG. 5.4 HAEMOGLOBIN DIFFERENCE SPECTRA
A haemoglobin solution prepared from heparinized rat
blood was divided equally into two cuvettes and a
base-line of equal light was recorded. Carbon
monoxide was bubbled into the experimental cuvette
and the oxidized carbonmonoxide minus oxidized
difference spectrum recorded - curve A .
Curve B is the dithionite reduced minus
oxyhaemoglobin difference spectrum.
Curve C ..... is the reduced carbonmonoxide minus
reduced haemoglobin difference spectrum.
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testicular heavy mitochondria as a rich source of cytochrome
oxidase and testicular microsomes a source of cytochrome
P450. Different ratios of the two subcellular preparations
were mixed in medium A ana the CO-reduced minus reduced
difference spectrum determined as described above (section
"5.2.2). The results presented in Figure 5.3 show that the
CO-complex of cytochrome oxidase interfered with cytochrome
P450 absorption by decreasing not only the amount of cyto¬
chrome P450 measurable by about 40%, but also by causing an
apparent shift in the absorption maximum of the CO-complex
of cytochrome P450 to 455 nm.
5.3.3 Effect of haemoglobin on the absorption spectra of
cytochrome P45Q
Because the 'absorption bands of haemoglobin and the
respiratory chain cytochromes tend to overlap, haemoglobin
contamination of the mitochondrial fraction, if present, would
distort the appearance of the absorption spectra and make
quantitation of the cytochromes difficult. The absorption
spectra of haemoglobin depicted in Figure 5.4 shows the
difference spectrum of (a) carbonmonoxy-haemoglobin versus
oxyhaemoglobin (curve A), (b) the dithionite reduced versus
oxidized difference spectrum of haemoglobin (curve B) and (c)
reduced carbon monoxide minus reduced difference spectrum of
haemoglobin (curve C). In the latter a peak absorption band
at 420 nm and a trough with a minimum at 436 nm was obtained.
This negative absorbance could contribute to the masking of
the cytochrome P450 absorption band.
To determine the effect of haemoglobin on cytocnrome P45G:CO
reduced spectrum, the reduced carbon monoxide minus reduced
I | A = 0 01
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FIG. 5.5 EFFECT OF HAEMOGLOBIN ON CYTOCHROME P450:CO COMPLEX
The difference spectra were obtained by reducing the
sample in both cuvettes with sodium dithionite and
after recording the base-line the experimental
cuvette was saturated with carbon monoxide and the
reduced carbonmonoxide minus reduced difference
spectrum recorded.
——— Microsomes 1.1 mg/ml
..... Microsomes 1.1 mg/ml plus haemoglobin 10 p. 1
(= 0.07 nmoles Hb)
*«<a<id Microsomes 1.1 mg/ml plus haemoglobin 50 |il
(= 0.33 nmoles Hb).
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difference spectrum of the microsomal fraction (used as
source of cytochrome P450) was first determined, as described
above. Aliquots of haemoglobin solution were added into the
experimental cuvette and CO bubbled again. Into the reference
cuvette an equivalent amount of water was added. The difference
spectra obtained are shown in Figure 5.5. It can be seen that
increasing concentrations of haemoglobin perturbed and markedly
reduced the 450 nm-490 nm optical difference of the cytochrome
P450:CO complex similar to the effect of cytochrome oxidase.
From these studies it can be inferred that haemoglobin
also could interfere with the detection of cytochrome P450
in the testis mitochondria by contributing to the negative
absorption at 446 nm. However, the absence of the haemoglobin
peak at 420 nm and the symmetry of the absorption band at 430
in the reduced carbon monoxide difference spectrum of heavy
mitochondria suggest that haemoglobin contamination, if present
in these preparations, was not significant.
5.3.4 Presence of haemoglobin contamination in the heavy
mitochondrial fraction
In order to detect the presence of haemoglobin contamination
the aerobic carbon monoxide minus aerobic difference spectrum
of the heavy mitochondrial fraction was examined as described
above for carbon monoxy haemoglobin versus oxyhaemoglobin
difference spectrum. As shown in Figure 5.6 curve A, a small
absorption band at 420 nm was produced indicating that the
degree of haemoglobin contamination in the heavy mitochondrial
fraction was slight.
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FIG. 5.6 DETECTION OF HAEMOGLOBIN CONTAMINATION OF HEAVY
MITOCHONDRIA
A suspension of rat testis heavy mitochondria
ficoll fraction 5 was divided equally into two
cuvettes and a base-line of equal light absorption
was recorded. The contents of the experimental
cuvette was then saturated with carbonmonoxide and
the carbonmonoxide oxidized minus oxidized difference
spectrum recorded.
Curve A .......... is the difference spectra of heavy
mitochondria (HMF^) 2.0 mg/ml prepared from
unperfused rat testis.
Curve B difference spectra of heavy mito¬
chondria (HMF^) 3.9 mg/ml prepared from perfused
animals.
Curve C haemoglobin difference spectra (for
comparison).
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5.3.5 Attempt to detect cytochrome P45Q in mitochondria
from perfused rat testes
5.3.5.1 Perfusion of rat testes
In order to eliminate all possible interference of
haemoglobin with the absorption spectrum of the P450:C0
complex, attempts were made to remove the haemoglobin con¬
tamination in the heavy mitochondria rat testis. A perfusion
technique was developed for washing out the blood from the
testes in situ. Since the spermatic arteries in the rat were
small, direct perfusion was not feasible. Furthermore, since
the spermatic arteries originate directly from the aorta in the
region of the kidneys, successful perfusion was achieved via the
aorta just above the diaphragm (i.e. through the thoracic cavity).
The ether-anaesthetized rats were perfused with Lock's perfusion
medium (consisting of 0.92% NaCl, 0.042% Kcl, 0.02% CaCl^, O.Ol5%
NaHCO^ and 0.2% glucose and 50,000 IU heparin/litre) until both
testis were visually free of blood (i.e. about 10-15 minutes).
From such perfused testes heavy mitochondria were prepared
as previously described. Perfusion usually decreased the
haemoglobin contamination in the isolated heavy mitochondrial
fractions to a spectrophotometrically undetectable level (see
curve B in Figure 5.6).
5.3.5.2 Spectral studies
With these mitochondria the following spectral studies
were conducted in a further attempt to detect cytochrome P450.
a. The reduced CO versus reduced difference spectrum was
prepared and as shown in Figure 5.7 was identical with that
produced with heavy mitochondria from unperfused testes. No
cytochrome P450 was detectable.
445
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FIG. 5.7 DIFFERENCE SPECTRA OF HEAVY MITOCHONDRIA FROM
PERFUSED RAT TESTES
Both experimental and reference cuvettes contained
equal amounts of heavy mitochondria ficoll fraction 5
(1.6 mg/ml) prepared from perfused rats. After
establishing a base-line a few crystals of solid
sodium dithionite was added to the contents of the
experimental cuvette and the reduced minus oxidized
difference spectrum recorded - Curve A . The
reference cuvette was then also reduced with
dithionite and after determining the reduced minus
reduced base-line, the experimental cuvette was
saturated with carbonmonoxide and the carbonmonoxide
reduced minus reduced difference spectrum recorded
(curve B ) .,
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b. Reduction of cytochrome by succinate.
Cammer and Estabrook (1967), using bovine adrenal mitochondria,
demonstrated that the addition of succinate caused a reduction
not only of the respiratory cytochromes but also of those
cytochromes concerned with steroid hydroxylation in these
mitochondria. Furthermore, when succinate was used as an
electron donor, the presence of inhibitors of mitochondrial
respiration such as cyanide prevented the reduction of
cytochrome P450 (i.e. only cytochromes of the normal
respiratory chain were reduced).
In an attempt to obtain such a difference spectra a
suspension of heavy mitochondria (from perfused testes) were
divided equally into two cuvettes and the base-line established.
After the addition of cyanide (1 mM final concentration) and
succinate (5 mM) to the experimental cuvette curve A (Figure
5.8) was recorded and shows the characteristic absorption bands
of reduced cytochromes of the classical mitochondrial respiratory
chain similar to that observed with dithionite (see section 5.2).
Curve B was obtained when succinate was added to the other
(reference) cuvette. The spectrum shows the splitting of
the broad Soret absorption band into two with peak maxima at
428 nm and 44-6 nm representing the bands of cytochromes b
and (a + a^) respectively. The optical increment at 446 nm
was slightly decreased. No new absorption bands were detected
at 432 or 557 nm as expected if cytochrome P450 were present
(Cammer & Estabrook, 1967; Robinson, 1971). This spectrum
would have represented the difference spectrum of reduced
cytochrome P4-50 minus oxidized cytochrome P450.
446
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FIG. 5.8 SUCCINATE REDUCTION OF CYTOCHROMES
A suspension of heavy mitochondria (1.8 mg/ml)
from perfused rat testes were divided equally
into two cuvettes and the base-line established.
Curve A was recorded after the addition of
potassium cyanide (1-mM final concentration) and
succinate (5 mM) to the experimental cuvette
(reduced minus oxidized cytochromes).
Curve B was obtained when succinate was
added to the reference cuvette (reduced cytochrome
P450 minus oxidized cytochrome P450).
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The results obtained so far show that rat testis
mitochondria contain a compliment of cytochromes b, C +
and a large amount of a + a„. These mitochondria unlike
those of other steroidogenic tissues do not appear to
contain the second chain involving cytochrome P450. From the
above investigations it was apparent that the ability to
detect mitochondrial cytochrome P450 was dependent upon at
least three factors (a) the absolute level of the pigment in
the Leydig cell mitochondria, (b) the relative amount of
interstitial cells and (c) the concentration of the mitochondrial
respiratory chain cytochromes. Since it was likely that the
spectral changes associated with cytochrome oxidase could
obscure cytochrome P450 present in low concentrations, an
alternative method was soughtto detect and measure this pigment
in the heavy mitochondria without the interference from
absorption bands of the normal respiratory chain cytochromes.
5.4 DETECTION OF CYTOCHROME P45Q IN RAT TESTIS MITOCHONDRIA
It has been demonstrated with adrenal preparations and
liver microsomes that various substrates (Cheng & Hardy, 1971;
Schenkman et al., 1967) and inhibitors (Remmer et al., 1966;
Imai & Sato, 1966; Wilson et al., 1969; Jefcoate et al.,
1969) combine with the oxidized forms of cytochrome P450 so
as to produce characteristic changes in the absorption spectrum.
In general three types of difference spectra have been observed.
(1) A type I spectral change with X max 390 nm and \min 420 nm.
This spectra characterizes the change from oxidized free
enzyme to the enzyme-substrate complex observed in the presence
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of certain substrates such as cholesterol (Cheng & Harding,
1973) and deoxy corticosterone (Cooper et al., 1965).
Whysner et al. (1970) demonstrated using E.P.R. spectroscopy,
that such changes were due to the steroid converting low spin
cytochrome P450 to a high spin form.
(2) An inverted type I spectral change with X max at 420 nm
andXmin at 390 nm (Mitani & Horie, 1969 ; Jefcoate & Boyd,
1971). E.P.R. spectroscopy has shown that this change is
probably due to a high to low spin transition of the cytochrome
P450 in the presence of certain steroids such as pregnenolone
(Whysner et al., 1970). Inverted type I changes have also
been termed type II spectral changes (see Jefcoate et al., 1974).
(3) The term type II spectral change has usually been applied
to the binding of lipophilic amines such as aniline, pyridine,
amphenone metyrapone octylamine or aminoglutethimide to
cytochrome P450. These amines bind both high and low spin
P450 to give a low spin amine-cytochrome P450 complex having
a difference spectra with Xmax 425 nm,Xmin 390 nm and Xmax
432 nm,Xmin 410 nm respectively in the soret region of the
spectrum (Jefcoate & Gaylor, 1970; Jefcoate & Boyd, 1971;
Jefcoate et al., 1974). Studies with such spectrally identi¬
fiable species have indicated that the mitochondria of steroid
producing organs possess a type of cytochrome P450 apparently
different from that present in the microsomal fractions of the
adrenal cortex (Sweat et al., 1970) and liver (Harding &
Nelson, 1966).
Of the nitrogenous base inhibitors, it has been observed
that metyrapone is a general ligand for cytochrome P450 (both
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oxidized and reduced) of various sources such as adrenal
mitochondria and microsomes (Sweat et al., 1970) liver
microsomes (Hildebrandt et al., 1969) and Pseudomonas putida
(Peterson et al., 1971) whereas aminoglutethimide has been
reported to interact with all mitochondrial cytochrome P450
in the adrenal cortex (Jefcoate et al., 1973). Metyrapone and
aminoglutethimide have been widely used in clinical practice,
the former as a diagnostic and therapeutic tool in hypothalamic-
pituitary-adrenal cortical function (Chart & Sheppard, 1959;
Gaunt et al,, 1968) and the latter in the treatment of adrenal
hyperplasia (Cash et al. , 1967; Smilo et al., 1967). These
drugs block certain steps in adrenal steroid biosynthesis.
Metyrapone competively inhibits the lip-hydroxylase reaction
(Liddle et al. , 1958; Sanzari & Peron, 1966; Harding et al.,
1969) while aminoglutethimide inhibits the cholesterol side-chain
cleavage reaction in adrenal mitochondria (Kahnt & Neher, 1966;
Dexter et al., 1967; Cash et al., 1967; Kowal, 1969). This
apparent selective binding property of these lipophilic amines
was investigated and employed to detect, characterize and
estimate the cytochrome P450 in rat testis mitochondria.
5.4.1 Methodology
For these studies subcellular fractions of rat testes
were prepared by differential centrifugation and the heavy
mitochondrial preparation further fractionated on a ficoll
gradient as previously described (Chapter 2, section 2.2 and 2.3).
Spectral changes in these testicular preparations were measured
using an Aminco-Chance dual wavelength/split beam recording
spectrophotometer in the dual wavelength mode and at 1% trans¬
mission. The wavelength pairs (390-410)nm; (410-425)nm or
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(406-448) nm were used for measuring the type II amine induced
spectral changes and the (390-420)nm for the steroid inverted
type I or substrate (sterol) type I difference spectra.
These changes in percentage of transmittance were converted to
absorbance. In most cases the spectral change AA (448-406)nm
was used to estimate cytochrome P450 since the absorbance change
between these wavelengths is not dependent on the initial spin
state of the cytochrome P450, but solely on the concentrations
of the haemoprotein. The subcellular fractions were suspended
in medium B in a final volume of 3.0 ml per cuvette (1 cm
light path). After establishing a base-line sufficient amine
(approx. 35 |xM aminoglutethimide ox metyrapone in 5 |xl aqueous
solution), steroid or sterol (lO jxM in 5 p. 1 ethanol) was
added to give a maximal spectral change. Controls with the
same amount of solvent (water or ethanol) did not produce any
spectral change. Aminoglutethimide (Ellipten) and metyrapone
(SU4885) were purchased from CIBA. Because the amount of
testicular preparation available was limited, the spectral
changes with aminoglutethimide and metyrapone were often
measured on the same sample. First the optical change induced
with aminoglutethimide was recorded (since metyrapone binds
to both mitochondrial and microsomal species of cytochrome
P450). Metyrapone was then added to the same sample and a
further spectral change, if any, measured. All determinations
were made in duplicate. Figure 5.10 shows an example of
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5.4.2 Aminoqlutethimide and metyrapone induced binding
spectra with heavy mitochondria and microsomal fractions from
rat testes.
The induced difference spectra obtained are shown in
Figure 5.11 A,B,C. Because of the low cytochrome P450 content
and thedifficulty in attenuating samples of high protein concentra¬
tion, the spectra shown were constructed from the wavelength
pairs taken at intervals of approximately 10 nm in the spectral
range of 360 to 520 nm, in the dual wavelength mode as described
above. Aminoglutethimide and metyrapone were added to separate
samples of the same preparation.
It was observed that aminoglutethimide preferentially
interacted with the heavy mitochondrial fraction (curve A) and
not with the microsomes producing a difference spectrum with
\ max 425 nm and Xmin 400 nm whereas metyrapone produced similar
spectra with both the heavy mitochordrial (curve B) and micro¬
somal fractions (curve C). These induced difference spectra
are characteristic of the modified low spin type II cytochrome
P450 complex produced with a number of other nitrogenous base
compounds such as amphenone, RS3504, 1-o-nitro-p-tolyl imidazole
(Wilson et al., 1969) and octylamine (Jefcoate et al., 1969;
Jefcoate & Gaylor, 1970). The difference spectra induced by
aminoglutethimide and metyrapone with heavy mitochondria
(HMFj.) were quantitatively similar. These spectra provide
strong evidence for the presence of cytochrome P450 in the
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FIG. 5.11(c) METYRAPONE INDUCED DIFFERENCE SPECTRUM IN
MICROSOMAL FRACTION
Microsomal protein used 3.0 lag/ral and
metyrapone 30 (iM.
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5.4.3.1 Specificity and distribution of arainoqlutethimide
and metyrapone detectable cytochrome P45Q
The amines were added to a suspension of subcellular
fractions of rat testes and the induced spectral change measured
using the wavelength pair (406-425)nm as described above under
"methodology". The results are presented in Table 5.2. In
Experiment 1,aminoglutethimide was added first. After recording
the resulting optical change metyrapone was then added to the
same sample and any further optical change recorded. In
Experiment 2 the order of the addition of amines was reversed -
metyrapone was added first.
The results of Experiment 1 confirm that aminoglutethimide
specifically complexes with the cytochrome P450 of the heavy
mitochondrial fraction of the testis (rich in cholesterol side-
chain cleavage activity) but not with the cytochrome P450 of
the microsomes. When metyrapone was subsequently added to the
sample containing aminoglutethimide, an additional spectral
response was obtained. This was small with the heavy mitochondria
and large with the microsomal fractions. This observation
clearly demonstrates that the cytochrome P450 of the heavy
mitochondrial and microsomal fractions of the testes are two
distinct species. No optical change was observed with the
supernatant (105,000 x g), indicating the absence of cytochrome
P450 in this fraction. The small spectral change in the light
mitochondrial fraction produced with aminoglutethimide and the
contrasting large absorbance obtained with iretyrapone are
consistent with this particulate fraction, being a mixture mainly
of microsomes with a small amount of mitochondria.
TABLE5.2
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The data in Experiment 2 demonstrates the non-specific
nature of metyrapone binding. When added first, metyrapone
interacted with the heavy mitochondrial (HMF,.) cytochrome P450
producing a spectral response of similar magnitude to that
obtained when aminoglutethimide was added first (Experiment 1).
In Experiment 2 the subsequent addition of aminoglutethimide
to the heavy mitochondrial fraction already containing metyrapone
did not produce any further optical change thus indicating that
all the cytochrome P450 was bound up with metyrapone. Similarly
with the light mitochondria and microsomal fractions only the
metyrapone-cytochrome P450 complex was formed. In each of
these cases the magnitude of the spectral change observed (in
Experiment 2) wa£ the same as in ^Experiment 1.
These experiments show that both amines produce quanti¬
tatively similar spectral changes in the same species of
cytochrome P450 and further demonstrate that aminoglutethimide
was bound to all the mitochondrial cytochrome P4-50. These
observations indicate that by virtue of its specificity,
aminoglutethimide could be used for detecting and quantitating
the mitochondrial type cytochrome P450 even in the presence of
the microsomal cytochrome species.
5.4.3.2 Distribution of aminoqlutethimide detectable
cytochrome P45Q during ficoll gradient fractionation of heavy
mitochondria
When heavy mitochondria obtained by differential centri-
fugation was subjected to 3-10% ficoll gradient fractionation four
particulate subfractions were obtained as described in Chapter 2.
These fractions were examined for the distribution of
I 1 1 1 1 1
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% OF TOTAL PROTEIN
FIG. 5.16 DISTRIBUTION OF CYTOCHROME P450 DURING FICOLL
GRADIENT CENTRIFUGATION OF TESTICULAR HEAVY
MITOCHONDRIA
Heavy mitochondria prepared by differential
centrifugation of testicular homogenate was
subjected to gradient fractionation on 3-10%
ficoll as described in section 2.3. Mitochondrial
type and microsomal cytochrome P450 were detected
using aminoglutethimide and metyrapone respectively
as described in text (section 5.3.1).
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cytochrome P450, with aminoglutethimicle and metyrapone added to
the same sample as described above. Figure 5.16 shows the
results obtained with a typical preparation.
In the homogenate (350 x g supernatant) the amount of
aminoglutethimide detectable cytochrome P450 was relatively
small compared to that by metyrapone. In the washed heavy
mitochondrial fraction (5,000 x g particulate fraction), the
mitochondrial species present was contaminated with the micro¬
somal type cytochrome P450. The amount present varied,
depending on the number of washings of the particulate fractions.
After ficoll fractionation, subfractions 1, 2 and 3 appeared
to be mainly microsomal as indicated by the large metyrapone
induced absorbance change compared to aminoglutethimide which
was insignificant. Subfraction 4 was found to contain amino¬
glutethimide detectable cytochrome P450 as well as an appreciable
amount of microsomal contamination r-s indicated by the additional
metyrapone spectral change. The heavy sedimenting subfraction 5
(HMF^_) however, contained only the aminoglutethimide detectable
cytochrome P450. It is interesting to note that the cholesterol
side-chain cleavage activity followed a similar distribution
pattern to the aminoglutethimide detectable cytochrome P450.
Both cholesterol side-chain cleavage activity and mitochondrial
cytochrome P450 are therefore localized mainly in ficoll
subfraction 5 and to a lesser extent in subfraction_4. The
spectral response by subfraction 5 to aminoglutethimide was
two to three times greater than the crude heavy mitochondrial
fraction (5,000 x g) (Table 5.3). Cholesterol side-chain
cleavage activity in ficoll subfraction 5 also exhibited a
TABLE5.3
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a similar higher value (see Chapter 3).
5.4.4 Specificity of steroid binding to testicular
cytochrome P450
The cytochrome P450 of adrenal cortex mitochondria react
specifically with a limited number of steroids producing
distinct complexes. The 5-ene-3(3-ol steroids such as pregnenolone
and 17a~methyl androst-5-ene-3|3 , 17|3-diol (MAD) interact with
the cholesterol side-chain cleavage cytochrome P450 in
mitochondria to give a difference spectrum with a trough at
390 nm and peak at 420 nm. This inverted type I difference
spectrum, which is believed to result from a displacement of
substrate cholesterol from cytochrome P450 by the added steroid
(Harding et al., 1972) is directly related to the proportion
of high spin cytochrome P450 associated with cholesterol side-
chain cleavage (Jefcoate & Boyd, 1971; Brownie et al., 1972).
On the other hand, potential substrates such as DOC (of 11|3-
hydroxylase), 25-hydroxycholesterol and 20a,22R-dihydroxy
cholesterol (substrates of cholesterol side-chain cleavage
system) combine with cytochrome P450 in adrenal cortex
mitochondria resulting in an enzyme substrate complex which is
identifiable by difference spectroscopy as a type I spectral
response (X max 390 nm and Xmin 420 nm). The DOC type I and
5-ene-3|3-ol steroid inverted type I binding was suggested to
involve two distinct P450 cytochromes (Whysner et al., 1969;
Jefcoate & Gaylor, 1970 ). This was subsequently confirmed by
the partial separation of the two P450 cytochromes and their
corresponding hydroxylases (Jefcoate et al., 1970).
TABLE5.4
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The ability of certain steroids to complex with testicular
mitochondrial or microsomal cytochrome P450 was compared. The
results are shown in Table 5.4.
Deoxycorticosterone, which produces a type I spectral
change with cytochrome P450 in adrenal mitochondria, was without
effect on testis mitochondria reflecting the absence in testis
of a cytochrome P450 species associated with 11(3- or 18-
hydroxylation. The soluble cholesterol analogue, 25-hydroxy-
cholesterol produced a small but significant type I absorbance
change when added to testicular mitochondria, presumably due
to the formation of a typical substrate complex with a cytochrome
P450 which is associated with cholesterol side-chain cleavage
activity. Such a spectral response to 25-hydroxycholesterol
was reported to occur only with intact mitochondria (Jefcoate
et al., 1973). 20a,22R-Dihydroxycholesterol, a possible
intermediate in the metabolism of cholesterol to pregnenolone
(Burstein & Gut, 1971) interacted only with the heavy mitochondria
cytochrome P450 of testes producing a type I response. When
these type I sterols were added to the testicular microsomal
preparations no detectable spectral changes were observed. In
bovine and rat adrenal mitochondria such a type I difference
spectrum was reported to be specifically due to cytochrome P450
which is associated with cholesterol side-chain cleavage
(Jefcoate et al., 1973).
The interaction of methylandrostenediol or pregnenolone
with testes mitochondrial cytochrome P450 resulted in the
production of an inverted type I spectral change. The magnitude
FIG. 5.12 CHANGES IN SPIN STATE OF MITOCHONDRIAL CYTOCHROME
P450 INDUCED BY DIFFERENT pH s AND DETECTED BY
AMINOGLUTETHIMIDE
Tris buffer was used. HMF^ protein 2.2 mg/ml.
Percentage low spin or high was calculated as
described by Jefcoate et al. (1973).
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of pregnenolone binding was approximately 30% of that observed
with methylandrostenediol, even at pH 6.0. However, when
pregnenolone was added to testicular microsomal preparations
a type I spectrum characteristic of a substrate induced change
was produced. These spectral differences strongly indicate that
the mitochondrial and microsomal P450 cytochromes of testes are
distinct species. The mitochondrial cytochrome P450 is therefore
not a contaminant from the microsomes.
5.4.5 Effect of pH changes on mitochondrial cytochrome P45Q
Mitani and Horie (1969) first suggested that changes in
spin state of the adrenal mitochondrial cytochrome P450 may
be affected by alterations to the pH of the environment.
Jefcoate et al. (1973, 1974) demonstrated that the pH dependent
change in spin state was a property unique to the cholesterol
side-chain cleavage cytochrome P450. It was not displayed by
cytochrome P450 involved in other reactions. In the amino-
glutethimide induced spectrum the absorbance change at 390 nm
was reported to be largely derived from the binding to the high
spin component and that at 410 nm from the binding to the low
spin form. By using the ratio of these absorbances at 390 nm
and 410 nm, the proportion of high and low spin cytochrome P450
in adrenal mitochondria was estimated (Jefcoate et al., 1973,
1974). Such a method was used for rat testicular cytochrome
P450.
The effect of varying the pH of the medium on the amino-
glutethimide induced difference spectra of rat testicular
mitochondria was examined. The results of a typical experiment
are present in Table 5.5 and Figure 5.12. Table 5.5 shows that
with a decrease in pH there was an increase in the AA (390-410)nm
TABLE5.5
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TheA A (406-448)nm remained almost constant. The calculated
percentage low spin increased as the pH of the medium was raised
from pH 6 to 8 (see Fig. 5.12) suggesting a shift from high to
low spin state. At pH 7.5 70-75% of the cytochrome P450 in the
heavy mitochondrial ficoll subfraction 5 was found to occur in
the low spin state. These pH sensitive changes in spin state
of testes mitochondria cytochrome P450 appear to be similar to
those observed with a partially solubilized cholesterol side-
chain cleavage cytochrome P450 from adrenal mitochondria
(Jefcoate & Boyd, 1971).
Since an inverted type I difference spectrum indicates a
high to low spin transition of the cytochrome P450 (Jefcoate
& Boyd, 1971), the effect of varying pl-l on the formation of the
methylandrostenediol induced inverted type I difference spectrum
with testes mitochondrial cytochrome P450 was also examined.
A sigmoid curve was obtained. Figure 5.13 demonstrates that
as the pH of the medium increased from pH 6 to 8, the magnitude
of the inverted type I absorbance change decreased. The
spectral change at pH 7.5 was approximately 25% of that at
pH 6.0, This pH dependent change in the methylandrostenediol
induced spectrum was analogous to that obtained with amino-
glutethimide.
In the adrenals a measure of the amount of cholesterol
bound to mitochondrial cytochrome P450 was determined from the
magnitude of the inverted type I difference spectrum produced
by pregnenolone. The magnitude of the spectrum was shown to be
dependent on the amount of high spin cytochrome P450 initially




















FIGURE 5.13 EFFECT OF pH ON FORMATION OF METHYLANDROSTENEDIOL
INDUCED INVERTED TYPE I DIFFERENCE SPECTRA WITH
MITOCHONDRIAL CYTOCHROME P45G
Ficoll fractionated heavy mitochondria (I-IMF^)
at protein concentrations of 3.3 mg/ml was
used. Buffer was Tris at pH 6.0, 6.4, 7.0,
7.5 and 8.0.
Methylandrostenediol = 10 fiM.
TABLE5.6
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(Jefcoate et al. . 1973, 1974). Such a method of estimating
the amount of high spin complex of cytochrome P450 seemed to
be applicable to testicular mitochondria using the methyl-
androstenediol induced inverted type I spectral changes.
Table 5.6 shows that there is a very good correlation between
the percentage high spin calculated from the inverted type I
spectral difference produced with methylandrostenediol and the
percentage low spin value obtained by the aminoglutethimide
spectral ratio method.
5.4.6 Solubilization of mitochondrial cytochrome P45Q from
rat testis
A preliminary attempt was made to solubilize cytochrome
P450 from rat testes heavy mitochondria using the iso-octane
extraction procedure described by Jefcoate et al« (1970) with
slight modifications. The procedure was carried out in the
presence of 0.1 mM dithiothreitol to protect cytochrome P450.
Ficoll fractionated heavy mitochondria (HMF^_) was obtained
as previously described in Chapter 2 (section 2.2 and 2.3)
from 12 rats (17 weeks old). The mitochondrial fraction was
suspended in 0.1 M phosphate buffer pH 7.4 containing O.lmM
dithiothreitol, sonicated under nitrogen, and then extracted
with iso-octane by stirring for 30 minutes. After centrifugation
at 105,000 x g for 30 minutes three layers were obtained - a
yellow iso-octane supernatant (containing mainly lipid and
cholesterol), a brown solid interlayer and a reddish yellow
lower phase. The supernatant was aspirated and the remaining
layers homogenized and re-extracted with iso-octane, twice,
as above. The resulting interlayer was washed with distilled
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FIG. 5.14 SOLUBILIZATION OF MITOCHONDRIAL CYTOCHROME P450
Ammonium sulfate fractionation of iso-octane
extracts of HMF,.
A 0-15% Ammonium sulfate saturation
B 15J-25% " " "
— Dithionite reduced versus oxidized
difference spectra
mm-mm Reduced CO minus reduced difference
spectra
















FIG. 5.14 SOLUBILIZATION OF MITOCHONDRIAL CYTOCHROME P450
Ammonium sulfate fractionation of iso-octane
extracts of HMF..
C 25-35% Ammonium sulfate saturation
D 35-50% " » «»
Dithionite reduced versus oxidized
difference spectra
----- Reduced CO minus reduced difference
spectra
These recordings were made on a Shimadzu
spectrophotometer.
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FIG. 5.14 SOLUBILIZATION OF MITOCHONDRIAL CYTOCHROME P450
Ammonium sulfate fractionation of iso-octane
extracts of HMF
J
E 50% Ammonium sulfate supernatant fraction
i Dithionite reduced versus oxidized
difference spectra
—_Reduced CO minus reduced difference
spectra
These recordings were made on a Shimadzu
spectrophotometer.
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in O.l M Tris buffer 7.4 containing 0.5 mg sodium cholate/mg
protein and then subjected to ammonium sulfate fractionation.
All fractions were examined for the presence of cytochrome
P450 as the reduced CO complex as described earlier.
Figure 5.14 shows that the protein fraction sedimenting
between 0-15%, 15-25% and 25-35% ammonium sulfate saturation
(Figs. A, B, C) contained mainly cytochromes of the normal
respiratory chain and no cytochrome P450. The soluble 35-50%
ammonium sulfate fraction (Fig. D) showed the presence of a
reduced CO:complex of cytochrome P450 as depicted by the small
but definite peak at 452 nm. The absorption peak at 420 nm
could be due to cytochrome P420 or hemoglobin. The 50%
ammonium sulfate supernatant fraction appeared to be devoid
of a CO binding pigment (Fig. E).
In adrenals, it was observed that the fraction precipitating
between 15-25% ammonium sulfate saturation yielded mainly
cytochrome P450 associated with 11(3-hydroxylase activity,
whereas the 35-50% ammonium sulfate cut contained the cholesterol
side-chain cleavage cytochrome P4-50 (Jefcoate et al. , 1970) .
This fractionation thus provides conclusive evidence for the
presence of cytochrome P450 in normal testes mitochondria and
for a similarity of this cytochrome P4-50 to the adrenal
cytochrome P450 which is involved in cholesterol side-chain
cleavage.
5.4,7 Cytochrome P45Q content in rat testis
The specific cytochrome P450 content in the ficoll
fractionated mitochondria of rat testis calculated from the
aminoglutethimide difference spectrum (AA (406-448)nm and
Ae 28cm"~ mM*""'') was 0.014 ± 0.003 nmoles/mg protein (mean ± 2 SD
of 13 different experiments, each of 8 rats, average age
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18 weeks). The corresponding value for microsomal cytochrome
P450 using metyrapone was 0.058 ± 0.019 nmoles/mg protein.
A similar value of 0.058 ± 0.021 nmoles/mg protein was obtained
for the microsomes by the reduced carbonmonoxide method
(i.e. AA (450-490)nm and AE 95cm~\iM~"''") . Thus the two methods
are comparable. This demonstrates that metyrapone measures
all cytochrome P450 in the testis microsomes.
The microsomes contain approximately four times as much
cytochrome P450/mg protein as the mitochondria. The specific
content of cytochrome P450 in rat testis is very much lower
than that reported in other steroid producing tissues (Cammer
& Estabrook, 1967; Mcintosh et al., 1971; Jefcoate et al.,
1973).
The total endogenous cholesterol content (free and
esterified cholesterol) in the heavy mitochondrial fraction was
found to be 76.5 nmoles/mg protein (70 ± 0.5 nmoles free and
6.5 ± 0.2 nmoles esterified cholesterol). On this basis it
appears that there are approximately 7,000 nmoles of cholesterol/
nmole of mitochondrial cytochrome P450. However, unlike
cytochrome P450, which is localized entirely in the interstitium
(see Chapter 7 section 7.4) a sizeable proportion of the cholesterol
measured could be of tubular origin.
An approximate estimate of the total mitochondrial and
microsomal cytochrome P450 per testis was O.l nmoles and 0.9
nmoles respectively.
5.4.8 Involvement of testis mitochondrial cytochrome P45Q in
cholesterol side-chain cleavage activity.
The spectral properties of cytochrome P450 in rat testis














AMINOGLUTETHIMIDE CONCENTRATION (yuM )
FIG. 5.15 EFFECT OF VARYING CONCENTRATIONS OF AMINO¬
GLUTETHIMIDE ON CHOLESTEROL SIDE-CHAIN CLEAVAGE
ACTIVITY
Incubations consisted of medium B,
cholesterol (Ca 200,000 c/m), DL isocitrate
(5 mM) , cyanoketone (6 piM) , heavy mitochondria
(HMFj.) C.4 mg and varying concentrations
(0-800 |iM) of aminoglutethimide. Incubations
were carried out at 37°C for 60 minutes. In
addition to zero minute controls, incubated
controls containing boiled enzyme were also
included.
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cytochrome associated with the cholesterol side-chain cleavage
enzyme. Furthermore, the close association of the cholesterol
oxygenase activity and the aminoglutethimide detectable cyto¬
chrome P450 during subcellular fractionation and their
localization entirely in the Leydig cells of the testis
(demonstrated in Chapter 7) provide circumstantial evidence
for the involvement of cytochrome P450 in steroidogenesis in
testis. Direct evidence supporting this view was obtained by
the following experiment demonstrating the inhibitory effect
of aminoglutethimide on the conversion of cholesterol to
pregnenolone in the ficoll fractionated heavy mitochondria from
rat testis.
Figure 5.15 shows the effect of different concentrations
of aminoglutethimide (0-800 |iM) on the cholesterol side-chain
cleavage activity in the ficoll fractionated heavy mitochondria
of rat testes. For this study cholesterol side-chain cleavage
activity was assayed as previously described . Expressed as
the percentage of /4-^c/ cholesterol converted to labelled
steroids the results of Figure 5.15 curve 1 shows that at
approximately 80 fiM aminoglutethimide inhibited cholesterol
metabolism by 50% and at 400 |iM by 80%. With higher concentra¬
tions up to 800 fiM, complete inhibition did not occur. When
longer incubation periods of 90 to 150 minutes were used the
inhibition observed was much lower (55-66% at 400 fxM amino¬
glutethimide). However, from the nature of products obtained
it was observed (curve 2 Fig. 5.15) that the conversion of
cholesterol to pregnenolone was completely inhibited, but a
- 130 -
new product was obtained resembling DHA on TLC. The nature
and formation of this new product is discussed in Chapter 8.
It was therefore concluded that aminoglutethimide appears to
bind the mitochondrial cytochrome P450 and thus inhibit the
conversion of cholesterol to pregnenolone in rat testis.
In other steroidogenic organs, the cholesterol side-chain
cleavage enzyme system has been shown to involve cytochrome
P450, an iron-sulfur protein (adrenodoxin) and a FAD-containing
flavoprotein (NADPH-adrenodoxin reductase) (Simpson & Boyd,
1967b) .
Although in vivo and in vitro studies have demonstrated
the inhibitory effect of aminoglutethimide on the conversion
of cholesterol to pregnenolone in adrenals of humans (Cash
et al., 1967), monolayer of adrenal tumour cells (Kowal, 1969)
and ovaries (Behrman et al., 1970), similar effects on testes
have not been previously observed.
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SUMMARY
1. By difference spectroscopy it was demonstrated that rat
testis heavy mitochondria contained a complement of cytochromes
b, c + c^ and a(+ a^) similar in quantity to other steroidogenic
tissue. In contrast the presence of the carbon monoxide
binding pigment (cytochrome P450) could not be demonstrated
even in mitochondria from perfused testes. Attempts to
preferentially reduce and form a CO:complex with cytochrome
P450 were unsuccessful. The presence of cytochrome oxidase
or hemoglobin was observed to have a masking effect on the
cytochrome P450:C0 binding spectrum. The molar ratio of
cytochrome a(+ a^) to mitochondrial cytochrome P450 appeared
to be unusually high. Cytochrome P450 was present in the
microsomal fraction. The fraction called "light mitochondria"
was found to be a mixture of mitochondria and microsomes -
based on the presence of cytochrome oxidase and cytochrome
P450 respectively.
2. The presence of cytochrome P450 in rat testis mitochondria
was demonstrated by specific amine binding. Aminoglutethimide
produced a type II difference spectra only with mitochondrial
cytochrome P450 whereas metyrapone interacted with both
mitochondrial and microsomal cytochrome P450 . This specificity
was utilized for the detection, quantification and distribution
of the mitochondrial cytochrome P450.
3. The effect of steroid binding to testicular cytochrome P450
was investigated. DOC did not interact with either mitochondrial
or microsomal cytochrome P450 reflecting the absence of the
adrenal type cytochrome P450 associated with ll|3-or 18-hydroxy-
lation. 25-Hydroxycholesterol and 20a,22R-dihydroxycholesterol
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produced a type I spectral change only with the mitochondrial
hemoprotein. Methylandrostenediol and pregnenolone both
produced an inverted type I spectra with mitochondrial
cytochrome P450 and a type I with corresponding cytochrome in
the microsomal fraction. These spectral differences clearly
indicate that the testes contain at least two very distinct
cytochrome P450s, one localized in the mitochondria and the
other in the microsomes.
4. Using aminoglutethimide to measure low spin cytochrome
P4-50 and MAD the high spin complex, the effect of pH on the
spin state was studied. High pH favours the low spin form and
low pH the high spin state.
5. The conversion of cholesterol to pregnenolone by rat
testis mitochondria was inhibited by aminoglutethimide
(50% at 100 fiM).
6. A preliminary attempt to solubilize mitochondrial cytochrome
P450 involving sonication, iso-octane extraction and ammonium
sulfate fractionation resulted in a partially soluble preparation
(35-50% ammonium sulfate fraction) which formed the CO:complex
of reduced cytochrome P450.
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EFFECT OF DIFFERENT IN VIVO TREATMENTS ON
TESTICULAR STEROIDOGENESIS IN VITRO
In this chapter the results of the effect of different
in vivo pretreatments on steroidogenesis in rat testis are
presented. The methods used in these investigations and the
parameters studied were similar to those developed and
described in previous chapters. Mitochondria were prepared
from testes of rats subjected to one of the following
pretreatments:- a) thyroidectomy, b) stress, c) cyclo-
heximide injections.
6.1. EFFECT OF THYROIDECTOMY ON SOME ASPECTS OF STEROIDO¬
GENESIS IN RAT TESTIS
There have been numerous clinical observations indicating
that the adrenals and gonads are affected by thyroid activity.
However, in respect to the gonads, there is very little direct
experimental evidence to support these observations.
The thyroid gland has long been known to affect the
metabolism of adrenal cortical hormones. It has been generally
acknowledged, from in vivo experiments, that thyroxine brings
about an increase of adrenal cortical secretions (D'A.ngelo &
Grodin, 1964; Burstein & Fajer, 1965), while hypothyroidism
(surgical or chemical thyroidectomy) is associated with a
diminished function of the adrenal cortex (Eik-Nes & Brizzee,
1956; Drucker & Christy, 1963; Gaunt et al. , 1970).
However, in vitro studies by Jao and Koritz (1962) indicated
that when thyroxine was added in pharmacological doses to
adrenal homogenates, the production of corticosteroids was
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inhibited. Strashirairov et al. (1968) observed that
thyroidectomy significantly diminished the adrenal 3|3-hyaroxy
steroid dehydrogenase activity.
Ovarian structure and function have also been reported
to be affected by thyroid activity (Thorsoe, 1961; Gaunt
et al., 1970; Armstrong, 1968b).
In rats, hyperthyroidism appears to alter spermatogenesis,
xvhile in hypothyroidism there was disorganization within the
tubules with a high incidence of ruptured basement membranes
(Johnson, 1969). It has also been reported that the total
testis lipid was decreased in hyperthyroid animals whereas
hypothyroidism resulted in a marked increase which was
associated with the impaired spermatogenesis. Brown et al.
(1966) examined certain lipogenic related enzymes in testis
of hypophysectomized rats and suggested from their results
that thyroxine may not have a direct control over the
metabolism of the testis. There has, however, been no report
on the effect of thyroid function on steroidogenesis.
The present preliminary study deals with the effect of
thyroidectomy on cholesterol side-chain cleavage and 3(3 —
hydroxysteroid dehydrogenase activities, cytochrome P45G and
free cholesterol content of the rat testicular mitochondria.
In this experiment adult rats of the Sprague Dawley
strain were used. The animals were divided into three groups:
one group of 13 rats consisted of thyroidectomized animals;
the second "control" group of 11 rats were sham operated, i.e.
animals were subjected to the same treatment as the thyroid¬
ectomized rats but the thyroids were not removed; the third
TAhi Lii0,1
EFFECTOFTHYROIDECTOMYNSTEROID GEN SISINRATTESTISMITOC NDRIA
Sourcef Heavy Mitochondria Ficolln5)
RAT
BodyWt gm/rat Mean±SD
Testis Wett gm/testis Mean±SD
STEROIDOGENICACTIVITY
MITOCHONDRIALCYTOCHROMEp450
Free Chol¬ esterol content nmoles/mg protein Mean±SD























































Significantlydifferentfromthyro dectomizedandshaoper teanim ls(P<0.001) Steroidogenicactivity:Resultsa em an±st ndardeviationof4determin tions.Thmitochondrialprote n contentperincubationtuwere:-thyroide t my0.46mg,shamope ted0.5mgandnor l0.41mg. Cholesterolside-chaincleavage(CSCC)a ti itywasdetermin dapreviou lydescribediChapt r2.H vy mitochondria(fic llfra ti n5)wereincubatedMed uBwithcholester l,isocitrateacya o- ketone,at37°Cfor90minutes.Pregn nolonew stho ymajorp oductfor ed.3|3-Hydroxysteroiddehydrogenase activitywasmeasuredbyincub tingpregnenolonewithheavmitochondriaiMediumBfo60minutes. Progesteronecon tituted75%fthp duc sformed,thremainderwertest st nandandro tened o e. Spectralstudies:Opticalchangeswermea ureapr vio slydescribedinCha t r5.Valuesriabsorb nce andreverag sofduplic tdeterminations.LS=ows ,Highspin. Freechol sterolcontentofthmito hondrialfractiwasdeterminedbyGLC(s eChapt r2). RespiratoryControlRatioswerem a uredpol rographicallyusi gs ccin teasubstr t(seeChapt3).
- 135 -
group consisted of 8 normal, untreated animals. The
surgical operations were performed under ether anaesthesia
by Dr. G. S. Boyd. All animals were fed on the normal pellet
diet and allowed water ad libitum. The rats were sacrificed
6 weeks after the operation. Success of the thyroidectomy
was confirmed by the typica.1 bradycardia trace.
Heavy mitochondria were prepared from each group of
testes by differential centrifugation and then further
fractionated by ficoll gradient centrifugation as described
in section 2.2.and 2.3. The resulting subfraction 5 contain¬
ing intact heavy mitochondria was used. The results are
summarized in Table 6.1. No statistically significant
difference was observed in the cholesterol side-chain cleavage
and 3|3-hydroxysteroid dehydrogenase activities between the
testis mitochondria from thyroidectomized animals and the
sham operated controls; but compared with the normal
untreated rats, these activites were significantly reduced
(P<O.G01). The aminoglutethimide detectable cytochrome P450
content (AA 406-448 nm) of testes from "thyroidectomized"
rats were found to be similar to those from sham operated
animals (0.CO72 n moles cytochrome P450/mg mitochondrial
protein). Furthermore, no significant difference was observed
in the spin state of these two groups of mitochondrial
cytochrome P450, whether measured by the aminoglutethimide
method (determining % low spin) or by MAD (determining %
high spin; see Chapter 5 section 4). The values obtained by
these two methods showed good correlation. The free cholesterol
content of the heavy mitochondria from all three groups of
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animals were not significantly different from each other.
The data obtained are preliminary. It appears that
thyroidectomy has no influence on testes mitochondrial
steroidogenesis when compared with the sham operated controls.
Such a conclusion would be in accord with the observations of
Menon et al. (1967) that pretreatment of hypophysectomized
immature rats with TSH did not affect the cholesterol side-
chain cleavage activity of the testis (also see Forchielli
etal,, 1969). However, when compared with the results of
normal untreated rats, thyroidectomy appears to significantly
diminish the cholesterol side-chain cleavage and 3(3-hydroxy-
steroia dehydrogenase activities in the rat testis mitochondria.
On the basis of such a comparison it has been reported that
thyroidectomy inhibits the adrenal 3P-hydroxysteroid dehydro¬
genase (Strashimirov et al., 1968). Such reports should be
treated with some caution in view pf the above observations.
6.2 EFFECT OF STRESS
Adult Wistar rats (16-18 weeks old) were used in this
study. In each experiment animals of the same age were
divided into two groups, each of 8 rats. One group of rats
was subjected to a 15-20 minute ether stress prior to death.
Such a treatment has been reported to cause an acute increase
in the blood level of ACTH (Matsuyama et al. , 1971-)-. Rats of
the "control" group were killed quickly with a minimum of
stress.
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Ficoll fractionated heavy mitochondria (fraction 5)
were prepared from testis of both stress and normal animals
as previously described (Chapter 2, sections 2 and 3) and
the different parameters examined and compared. No significant
difference was observed in cholesterol side-chain cleavage
and 3(3-hydroxystcroid dehydrogenase activities, mitochondrial
cytochrome P450 and its spin state and free cholesterol
content of the two groups. The results obtained were similar
to those presented in Table 6.1. The mode of death, whether
by ether, decapitation or cervical dislocation, also did not
result in any significant difference in the testicular
mitochondrial activities studied.
These results suggest that ACTH and/or adrenal corticoids
do not have a direct influence on testicular steroidogenesis,
at least in the mitochondria. Forchielli et al. (1969)
observed that ACTH treatment of hypophysectomized immature
rats failed to stimulate the cholesterol side-chain cleavage
reaction in the testes.
It has been reported that ether anaesthesis results in
a reduction of testosterone secretion in rats (Bardin &
Peterson, 1967). This was associated with the reduction of
testicular testosterone content, which was demonstrated to
occur within 2 minutes and persist for at least 24 hours
after ether anaesthesia (Fariss et al. , 1969). Eik-Nes
(1962) also reported a fall of testosterone in testicular
venous blood in pentobarbital anaesthetized dogs. These
effects of anaesthesia have been attributed to the inhibition
of pituitary release of gonadotrophins rather than a block in
in the metabolic pathways for the formation of testosterone
(Fariss et al., 1969).
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6.3 EFFECT OF IN VIVO CYCLOHEXIMIDE TREATMENT ON RAT
TESTIS CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME ACTIVITY
The isolated mitochondria from rat testes, as indicated
earlier, are rich in free cholesterol. Most of the cholesterol
found might be present in the outer membrane of the mito¬
chondria as observed in liver mitochondria (Graham & Green,
1970). In mitochondria from Leydig tumour cells very little
of the cholesterol in mitochondria was found in the inner'
mitochondrial membrane (Moyle et al., 1973). Cytochrome P450,
a component of cholesterol side-chain cleavage enzyme system
has been reported to be located in the inner mitochondrial
membrane of adrenal cortex and corpus luteum mitochondria
(Satre et al., 1969; Yago & Ichii, 1969; Sottocasa & Sandri
1970). Thus it has been suggested that the rate limiting
step in steroidogenesis in bovine adrenal cortex might be the
penetration of cholesterol into the mitochondria (Kahnt
et al., 1974) or transport of cholesterol from other
mitochondrial sites to the cholesterol side-chain cleavage
cytochrome P450 (Simpson et al., 1971). A "rapid turning
over" protein was postulated to be involved in cholesterol
transport (Davis & Garren, 1966). Whether a similar situation
may occur in the rat testes mitochondria was investigated
using cycloheximide - an inhibitor of protein synthesis.
Cycloheximide has been shown to prevent the stimulation of
steroidogenesis induced by LH or cyclic AMP in ovarian and
luteal tissue (Gorski & Padnos, 1966; Hermier et al., 1971,
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Normal adult rats (17-19 weeks old) of the VJistar strain
were used in this study. Each experiment consisted of two
groups of rats (of at least 8 animals per group) all of the
same age. One group of rats .W&s' treated with cyclohexiraide
(10 mg/rat; Koch-Light Labs Ltd.) by intraperitoneal
injection, while the other control group was either untreated
or injected with saline. Animals were killed 40 minutes
after the injection. Intact ficoll fractionated testis
heavy mitochondria (HMF^) were prepared from both groups and
a comparison made of the ability of each preparation to
cleave the side-chain of cholesterol. The total cytochrome
P450 content and the spin change due to the cycloheximide
treatment were also measured. These results are presented
in Tables 6.2 and 6.3 respectively. The data in Table 6.2
show that the cholesterol side-chain cleavage activity in
cycloheximide treated animals was significantly reduced
compared to controls (P<0.001). The spectral data presented
in Table 6.3 also shows a corresponding marked decrease
(50-60%) in the methylandrost-5-ene-33 ,17-diol (MAD) inverted
type I absorbance change in the cycloheximide treated group
indicating a fall in the amount of cholesterol bound to
P450. However, there was no significant difference in the
content of free cholesterol and cytochrome P450 of the two
groups of mitochondria. (Average cytochrome P450 content =
O.OH8 ± 0.00074 n moles/mg protein.) As indicated earlier
(in Chapter 5), cytochrome P450 in the high spin state is
thought to be a complex with cholesterol (Harding et al.,
1972; Jefcoate & Boyd, 1971). In testis, only about 25%
FIGURE6.1RoleOfLabilPr teinctorInSteroidog n sisMit cho dr aatTes i . CHOL=holesterol Pr=LabileC rr errotein—=inhibition +=stimulation
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of the mitochondrial cytochrome P450 was found to occur in
the high spin state. Since rat testis mitochondria contain
a large amount of free cholesterol (72 ± 6 n moles/mg
protein), it is obvious that only a fraction of the available
cholesterol is associated with the cytochrome P450. The
inverted type I spectral change produced by the interaction
of methylandrostenediol with cholesterol side-chain cleavage
cytochrome P450 is thought to provide a measure of the
proportion of cholesterol bound to the enzyme (Jefcoate &
Boyd, 1971). Methylandrostenediol was postulated to alter
the interaction of cholesterol with the cytochrome P450
possibly causing the displacement of cholesterol from its
binding site (Harding et al., 1972). From the results
obtained it can be inferred that cycloheximide, which is a
specific protein synthesis inhibitor, reduces pregnenolone
biosynthesis by probably affecting the redistribution of
cholesterol within the mitochondrion and thereby decreases
the amount of precursor cholesterol bound to cytochrome
P450. This means that less cholesterol is available for
side-chain cleavage (see Fig. 6.1). Since the cytochrome
P450 and free cholesterol content of the mitochondria were
not significantly altered by in vivo cycloheximide treatment,
this inhibitor may exert its rapid influence on steroid
biosynthesis by limiting the synthesis of a labile protein
factor which possibly transports cholesterol (Ritter &
Dempsey, 1973). Evidence for such a protein has been
reported in the corpus luteum (Hermier, 1971) and adrenals
(Davis & Garren, 1966; Simpson et al., 1972). It is
synthesized in response to trophic hormones (Davis & Garren,
1966).
TABLE 6.4
EFFECT OF IN VIVO CYCLOHEXIMIDE TREATMENT ON
















1 CYCLQHEXIMIDE (a) 3.0 5.3 4.7
CONTROL (b) 3.0 3.8 8.4
Ratio a/b 1.0 1.4 0.6
2 CYCLOHEXIMIDE (c) 3.8 5.3 5.0
CONTROL (d) 3.6 3.1 13.5
Ratio c/d 1.1 1.7 0.4
Mitochondria from rat adrenals xvere prepared as described
by Simpson et a.1. , (1972). Spectral measurements were
made in an Aminco-Chance spectrophotometer in the dual
wavelength mode. The final concentrations of substrate
added were DOC 20 jiM, 25-HOC ) 25 [iM, and MAD 20 fiM.
Values presented are averages of duplicate determinations.
Inv = inverted
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6.3.1 Effect of in vivo cycloheximide treatment on rat
adrenal mitochondrial cytochrome P450
In order to verify the response of the animal to
in vivo cycloheximide treatment, the adrenals were removed
from the same group of rats used in the above experiments,
and the mitochondria prepared as described by Simpson et al.,
(1972). With these intact adrenal mitochondria some spectral
properties of cytochrome P450 were examined. The results
obtained were similar to those previously reported (Brownie
et al.. 1972; Simpson et al. . 1972; Jefcoate et al.. 1973)
and are summarized in Table 6.4. No difference was observed
between adrenal mitochondria from cycloheximide treated and
control rats in the magnitude of the type I binding by
deoxycorticosterone (DOC) - the substrate of 11(3-hydroxylase.
The 25-hydroxy cholesterol (25-KOC) type I spectral change,
was increased by cycloheximide treatment. This type I spectral
change has been attributed to an interaction of 25-HOC with a
low-spin cholesterol side-chain cleavage cytochrome P450,
which Is depleted of cholesterol (Jefcoate et al M 1973).
25-HOC readily undergoes side-chain cleavage in adrenal mito¬
chondria (Burstein & Gut, 1971). Compared to controls,
cycloheximide caused a decrease (40-60%) in the MAD inverted
type I difference spectrum similar to that observed in the
testis. It thus appears that the basic mechanism for control
of cholesterol side-chain cleavage activity in testis may be
similar to that of the adrenal cortex.
In adrenals the inhibitory effect of cycloheximide on











immediately (t \ - 5 mins.; Garren et al. , 1965; Kovval ,
1970). Simpson et al, (1972) observed changes in adrenal
activity within 10 minutes of treatment. However, in rat
testis there was no significant effect of cycloheximide
within this time period. A longer period of in vivo treatment
(40 minutes) was required to produce in vitro measurable
changes in the rat testicular steroidogenic activities and
spectral properties. It thus appears that cycloheximide
acts more slowly on the testis.
6.3.2 Effect of cycloheximide added in vitro to testis
mitochondria from control rats
The possibility that cycloheximide could interact
directly with cytochrome P450 was considered. When cyclo¬
heximide was added to 2 mM concentrations to normal incubations
containing ficoll fractionated heavy mitochondria from testes
of control rats, no effect on cholesterol side-chain
cleavage was observed (Table 6.2, expt. 3). Similarly, at
0.3 mM concentrations, cycloheximide did not induce a spectral
change in the mitochondria from controls suggesting an
absence of a cycloheximide:cytochrome P450 complex comparable
to that induced by aminoglutethimide and metyrapone. As
illustrated in Figure 6.2, these three inhibitors are all
nitrogenous bases. Cycloheximide resembles aminoglutethimide
in that both possess a glutarimide structure but differs from
the latter in the absence of a nitrogen on the second ring
structure. Glutethimide, which also lacks the amine group,
has been reported to be without effect on adrenal function
when administered in clinical doses (Gaunt et al., 1968).
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SUMMARY
In this chapter the effect of different types of in vivo
treatments on testicular steroidogenesis was investigated.
1. The results of thyroidectomy were inconclusive. When
compared with sham operated animals no significant difference
was found in the ability of the mitochondria to convert
cholesterol to pregnenolone and to further metabolize pregnen¬
olone. Also no differences were observed in spectral properties
of cytochrome P450. However, when compared with normal untreated
rats, thyroidectomy appeared to significantly inhibit cholesterol
side-chain cleavage and the 3(3 -hydroxysteroid dehydrogenase
activities. No significant differences were found in the free
cholesterol content of all three groups.
2. No differences were observed in the various parameters
studied with respect to ether stress or mode of sacrifice of
the animals.
3. Treatment of intact rats with cycloheximide resulted in a
decrease in the conversion of cholesterol to pregnenolone as a
result of the reduction in the amount of cholesterol bound to
mitochondrial cytochrome P450. The cytochrome P450 content and
free cholesterol content were not significantly different from
controls. Cycloheximide added in vitro to normalmitochondria
did not produce any significant effect in enzyme activity or
spectral properties. From these observations it was concluded
that cycloheximide did not have a direct effect on the cholesterol
side-chain cleavage enzyme or cytochrome P450 but exerted its
effect via a labile protein which is probably involved in
cholesterol binding and transport.
CHAPTER 7
CELLULAR LOCALIZATION OF CHOLESTEROL SIDE-CHAIN
CLEAVAGE ENZYME ACTIVITY AND CYTOCHROME P45Q
OF RAT TESTES
CONTENTS
CELLULAR LOCALIZATION OF CHOLESTEROL
SIDE-CHAIN CLEAVAGE ENZYME ACTIVITY AND











Dissection of the testis
Washing of separated testicular tissues
Subcellular fractionation of washed
testicular tissues
HISTOLOGY OF DISSECTED TESTICULAR TISSUE
COMPONENTS
LOCALIZATION OF CHOLESTEROL SIDE-CHAIN
CLEAVAGE ENZYME ACTIVITY













CELLULAR LOCALIZATION OF CHOLESTEROL SIDE-CHAIN
CLEAVAGE ENZYME ACTIVITY AND CYTOCHROME P45Q
OF RAT TESTES
Although it is generally accepted that interstitial or
Leydig cells of the testis are the principal source of
testicular steroids (see Chapter 1), there are suggestions
based on some histochemical (Baillie & Mack, 1966) and biochemical
studies (Lacy, 1967; Ellis, 1969; Lacy & Pettit, 1970;
Dufau et al., 1971) that the Sertoli cells and the germinal
epithelial cells of the seminiferous tubules may also be
capable of de novo steroid production.
Employing the technique previously used by Christensen
and Mason (1965) for separating seminiferous tubules from
interstitial elements of rat testis, Hall et al. (1969),
Bell et al. (1968a,b; 1971), as well as Christensen and
Mason, demonstrated that the seminiferous tubules converted
added labelled pregnenolone and progesterone to testosterone.
On the basis of such studies Ellis (1969), and Lacy and Pettit
(1970) suggested that the Sertoli cells might convert
cholesterol to steroids which are required for maintenance
of SDermatogenesis. However, Hall et al. (1969) could not
demonstrate any significant conversion of radioactive
cholesterol to steroids by the isolated intact seminiferous
tubules.
All the above mentioned biochemical studies were performed
with intact tissues. The failure of seminiferous tubules to
convert exogenous cholesterol to androgens may reflect the
restricted penetration of cholesterol into the tubules
- 145 -
(Parvinen et al., 1970) as well as dilution effects rather
than the absence of enzyme activity. Furthermore, in the
experiments with separated, histologically intact components
of the testis, less than 50% of the added radioactivity was
recovered (Hall et al., 1969; Christensen & Mason, 1965).
In order to circumvent such difficulties, studies were
performed employing subcellular fractions from the separated
testicular components instead of the isolated whole intact
tissue. Since steroids are normally synthesized from
cholesterol (Menon et al., 1965) and since the heavy mito¬
chondrial fraction from testis has been shown (see Chapters
3 and 4) to convert cholesterol to androgens in vitro and to
contain cytochrome P450 (Chapter 5), it was of interest too}
to discover the cellular origin of the heavy mitochondrial
fraction responsible for the cholesterol side-chain cleavage
reactions in the testes. Such experiments could prove whether
the seminiferous tubules (Sertoli cells) are capable of
de novo steroid synthesis from cholesterol.
7.1.1 Preparation of tissue
Testis from two adult rats 12-15 weeks old were used for
each experiment. Rats were killed and the testis removed as
described in Chapter 2. After removal of the tunica albuginea
and spermatic artery, the testis tissue was placed in a Petri
dish with ice cold medium H (see Chapter 2) containing
glucose (2 mg/ml) and kept on ice (or at 0°C).
7.1.2 Dissection of the testis
Rat testis interstitial tissue and seminiferous tubules
were separated by the wet dissection technique similar to
that previously described by Christensen and Mason (1965)
FIGURE 7.1
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and modified by Hall et al. (1969). All dissection procedures
were performed in ice (or at 0°C).
Small pieces of testis were very gently teased apart and
the reddish web of interstitial tissue removed with the aid
of jeweller's forceps, retained and then examined under a
dissecting microscope in order to remove the remaining small
fragment of tubules. The tubules were removed from the rest
of the tissue mass, transferred to another container with ice
cold medium H plus glucose and also examined under the micro¬
scope for adhering interstitial tissue. When all the tubules
were removed, the small tissue fragments remaining on the
dissection petri dishes were collected by rinsing with the
above medium. This was referred to as the "Residual Fraction".
Complete dissection of one testis by one person required
approximately 2 hours. However, with the technical assistance
of colleagues, the dissection of four testes was usually
completed in 4-5 hours.
7.1.3 Washing of separated testicular tissues
The tubules were centrifuged at 200 x g for 2 minutes and
the supernatant aspirated and pooled with the residual fraction.
The tubular mass was then suspended in 10 ml of medium H and
layered onto 30 ml of 5% ficoll containing medium H and
centrifuged at 200 x g for 3 minutes. Three layers were
obtained (a) the upper turbid (whitish) sucrose layer was
aspirated and pooled with the residual fraction, (b) the
middle clear ficoll layer was discarded and (c) the loosely
packed tubular layer at the bottom of the tube was suspended
in medium H (see Fig. 7.1). All three testicular fractions
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FIG. 7.2 Microscopic appearance of dissected fractions
from testes of adult rats (stained with hema¬
toxylin and eosin).
1. Photomicrograph of the seminiferous tubules
after separation from intertubular tissue.
I
Figures l.a (x lOO) showing tubules free of
interstitial tissue. In Figure l.b (x 400) shows
that the lamina propria forming the boundary of the
tubules are free of adhering interstitial tissue.







11 -r«n~ J? '^4
2. Photomicrograph of the interstitial tissue
fraction from the same testes containing Leydig
cells, fibroblastic cells, blood vessels and
occasional contaminating spermatozoa, spermatids
and germ cells from broken tubules. No tubules
present. Figures 2.a (x 250) and 2.b (x 400).
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(interstitial, pooled residual and tubular suspensions) were
centrifuged at 10,000 x g for 15 minutes. Each fraction was
then washed again by resuspending in medium H and re-centri-
fuging as above.
7.1.4 Subcellular fractionation of washed testicular tissues
Each washed testicular fraction was separately homogenized
in medium H. Using the differential centrifugation procedure
developed, each isolated testicular component was fractionated
into heavy mitochondria, light mitochondria, microsome and
supernatant fractions, as described in Chapter 2.
7.2 HISTOLOGY OF DISSECTED TESTICULAR TISSUE COMPONENTS
Aliquots from the three washed testis fractions obtained
after dissection were fixed in Bouin's solution for 18 hours
and subsequently dehydrated in graded concentrations of
alcohol. The tissues were then embedded in paraffin, sectioned,
stained with hematoxylin and eosin or Giemsa's stain and
examined under the light microscope.
Figure 7.2.1 shows a typical photomicrograph view of
the tubules and indicates that the tubules are free of
contamination by interstitial tissue, i.e. the walls (lamina
propria) of the tubules show no adhering cells or connective
tissue. The cells within the tubules appear normal. Figure
7.2.2 shows a photomicrograph of the intertubular fraction
(interstitial tissue) containing Leydig cells and fibroblastic
cells. Occasional spermatozoa, spermatids and germ cells
from broken seminiferous tubules are present but no tubules.
FIG. 7.2 3. Photomicrograph of the residual fraction
cont'd
(x 400) comprising mainly of components of the
seminiferous tubules such as spermatozoa, spermatids,
other germ cells and some contaminating interstitial
tissue constituents.
(The histology processing was kindly performed by
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FIG. 7.3 SUBCELLULAR DISTRIBUTION OF CHOLESTEROL SIDE-CHAIN
CLEAVAGE ENZYME SYSTEM ISOLATED FROM DISSECTED RAT
TESTIS COMPONENTS
Graph shows the relative specific activity of cholesterol side-
chain cleavage enzyme in the subellular fractions obtained from
the isolated interstitial tissue, residual fraction and semini¬
ferous tubules. Aliquots of each subcellular fraction (0.3-0.5
mq protein) were incubated for 90 mins. at 37°C in medium B with
^--^C/cholesterol (2 x 10^ cpm) , DL i socitrate (5 mM) and
cyanoketone (5.5 |iM - an inhibitor of 3(3 hydroxvsteroid
dehydrogenase). Labelled pregnenolone was the .only product
formed. Activity is expressed as per cent of i/4--'-^C/cholesterol
converted. Determinations were carried out in duplicate. Zero
time values from unincubated samples were subtracted from the
values of incubated samples. Ordinate: shows the mean relative
specific activity of subcellular fractions. Abscissa: sub¬
cellular fractions are represented by their relative protein
content in the order in which they were isolated. Rats were
15 weeks old. With different groups of rats the results were
essentially similar.
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Figure 7.2.3 shows a photomicrograph of the residual fraction.
This fraction was found to comprise mainly of components of
seminiferous tubules such as sperms, spermatids, spermatogonia
and other germ cells (compare with the intact tubular section
Fig. 7.2.1) and tubular fragments as well as some dislodged
interstitial tissue constituents (Leydig cells). Most of
the components of the residual fraction are quite distinct
from those of the interstitial fraction.
7.3 LOCALIZATION OF CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME
ACTIVITY
The relative cholesterol side-chain cleavage activity was
measured as described in Chapter 2.4. The results obtained
are presented in Figure 7.3 and Table 7.1. Illustrated in
Figure 7.3 is the subcellular distribution pattern of
cholesterol side-chain cleavage activity in each of the
three fractionated testicular tissue components. The
comparative ability of the mitochondria isolated from the
three testicular tissue components to convert /4- C/
cholesterol to labelled pregnenolone is demonstrated in
Table 7.1. These data show that the cholesterol side-chain
cleavage enzyme activity is localized only in the heavy
mitochondrial fraction obtained from interstitial tissue and
residual fraction. The heavy mitochondria from the semini¬
ferous tubules failed to convert the exogenous labelled
cholesterol to pregnenolone even when NADPH was used as an
alternative electron source. This failure suggests that the
enzymes involved in the conversion are not present in the cells
TABLE7.1
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of the tubules. The other subcellular fractions, namely
light mitochondria, microsome and supernatant, showed no
cholesterol side-chain cleavage activity.
7.4 TISSUE DISTRIBUTION OF TESTICULAR CYTOCHROME P45Q
Using the procedure developed for detecting and
measuring cytochrome P450 (described in Chapter 5.3), the
subcellular fractions prepared from the three dissected
testicular constituents were examined in order to establish
the nature and type of cells from which cytochrome P450 was
derived. For these studies light mitochondrial and micro¬
somal fractions were pooled ("microsomal fraction"). The
content ofmitochondrial and microsomal cytochrome P450's were
measured from the amine-difference spectra induced by
aminoglutethimide and metyrapone respectively, using the
wavelength pair (406-448)nm and the reported extinction
co-efficient of AE = 28 mM-"*" cm""*" (Jefcoate et al. , 1973).
The inverted type I spectral change produced by methyl-
androstenediol and the type I binding spectrum induced by
20a,22R-dihydroxy-cholesterol were measured using the wave¬
length pair (390-4-20)nm. The results are presented in
Table 7.2 and 7.3.
The data in Table 7.2 show that only the heavy mitochondrial
fraction from the interstitial cells of testis possess cyto¬
chrome P450 of the species which specifically binds amino¬
glutethimide producing a type II difference spectrum
(Xmin. 390 nm,Xmax. 425 nm). No spectral changes were
detectable in the mitochondrial fractions of seminiferous
TABLE7.2
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ND = Not Detectable
The amine induced spectral changes produced with the micro¬
somes were made on an Ann nco-Chance spectrophotometer in
{ the dual wavelength mode and at 1% transmittance using the
wavelength pair (406-448)nm. 0.2-0.5 ml aliquots of
microsomal fraction (2-5 mg protein) was suspended in
medium B (pH 7.4) in a final volume of 2.5 ml. After
establishing a base-line, 25 |ig of aminoglutethimide or
metyrapone in aqueous solution (5 p. 1) was added to give a
maximal spectral change. All determinations were carried
out in duplicates. In this study light mitochondrial and
microsomal fractions were pooled. These subcellular fractions
were isolated from each separated testicular tissue compart¬
ment as described in Chapter 2.2.
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tubules, with either aminoglutethimide and/or metyrapone.
The spectral changes shown in Table 7.3 were obtained only
with the microsomal fraction from interstitial tissue.
Unlike the mitochondrial cytochrome P4-50 the type II difference
spectrum produced in this case was induced only by metyrapone.
Aminoglutethimide did not react with the microsomal cytochrome
P450. These results suggest that the cytochrome P450 rich
organelles appear to be derived exclusively from the inter¬
stitial tissue of the testis. The observations also clearly
demonstrate the relative differential selectivity and
specificity of the amines (aminoglutethimide and metyrapone)
and provide confirmation for the earlier observations (see
Chapter 5) with subcellular fractions from whole testis of rat
that there are two distinct species of cytochrome P450 - one
mitochondrial and the other microsomal.
Further supporting evidence for the interstitium being
the sole source of the cholesterol side-chain cleavage enzyme
in testis was provided by the additional spectral results shown
in Table 7.2. Methylandrostenediol and 20a,22R-dihydroxy-
cholesterol each reacted only with the heavy mitochondrial
cytochrome P450 from the interstitium. No spectral changes
were induced with the corresponding subcellular fraction from
the seminiferous tubules. As discussed in Chapter 5 these
spectral changes have been attributed to the cytochrome P450
associated with cholesterol side-chain cleavage activity (Whysner
et al,, 1969; Jefcoate et al.. 1973; Burstein et al., 1972;
Harding et al., 1970; Simpson et al., 1971).
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The small spectral changes observed with the heavy
mitochondrial and microsomal fractions obtained from the
residual fraction could, in view of the above histological
observations, be ascribed to Leydig cell contamination.
Conclusion
The metabolic data based on cholesterol side-chain
cleavage activity and the spectralevidence obtained with the
amines aminoglutethimide and metyrapone and further supported
by methylandrostenediol and 20a,22R-dihydroxycholesterol
clearly indicate that the interstitial cells possess the
cholesterol side-chain cleavage enzyme complex and hence are
the major source of testicular steroids. The failure to
detect cytochrome P450 in both the mitochondrial and micro¬
somal fractions of the seminiferous tubules, coupled with its
inability to convert cholesterol to pregnenolone,strongly
suggests that the key steroid hydroxylating enzyme systems,
namely cholesterol side-chain cleavage enzyme and 17a—
hydroxylase, may not be present in the cells of the seminiferous
tubules.
The evidence obtained in this chapter also establish and
confirm that the observations made in previous chapters with
subcellular fractions from whole testes relate solely to the
steroidogenic capacity of the Leydig cells.
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SUMMARY
1. Seminiferous tubules and interstitial tissue were dissected
out from rat testis by a wet dissection method,, In addition to
these two components a third "Residual Fraction" consisting
mainly of tubular components and some Leydig cells was obtained.
The tubules were "cleaned" by layering on a ficoll gradient.
Each isolated tissue component was separately homogenized and
subcellular fractions prepared by differential centrifugation.
2. Cholesterol side-chain cleavage activity was localized only
in the heavy mitochondrial fraction from interstitial tissue.
Tubular mitochondria failed to convert ,/4-^c/cholesterol to
labelled steroids.
3. The presence of two distinct species of cytochrome P450 in
rat testis was confirmed by selective amine binding spectral
evidence. The aminoglutethimide specific mitochondrial cyto¬
chrome P450 and metyrapone detected microsomal cytochrome P45G
were both located exclusively in the interstitial tissue. No
cytochrome P450 was detectable in the seminiferous tubular
fractions.
These results, supported by spectral changes produced by
methylandrostenediol and 20a,22R-dihyaroxy-cholesteroi, establish
that the interstitium is the only testicular tissue capable of
de novo steroid synthesis from cholesterol. Seminiferous tubules
appear to lack the enzyme systems involved in the side-chain
cleavage of cholesterol and 17a-hydroxylation of progesterone —
two key rate limiting steps in the steroid biosynthetic pathway
and the possible sites of control by trophic hormones.
CHAPTER 8
A POSSIBLE ALTERNATIVE PATHWAY FOR CHOLESTEROL
METABOLISM IN RAT TESTIS MITOCHONDRIA
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A POSSIBLE ALTERNATIVE PATHWAY TOR CHOLESTEROL
METABOLISM IN RAT TESTIS MITOCHONDRIA
8.1 INTRODUCTION
Stimulated by the suggestions of Dorfman and colleagues
(Burstein & Dorfman, 1962; Gual et al., 1962; Dorfman 1960),
Jungman (1968a,b, 1969) reported the existence of a new pathway
for the biosynthesis of androgens from cholesterol. Unlike
the traditional route, by which cholesterol is transformed
into pregnenolone by cleavage of a six carbon side-chain
fragment, this alternative route involved the cleavage of all
eight carbon atoms of the side-chain of cholesterol, splitting
off 6-methyl-heptan-2-one with the direct formation of a
steroid product - dehydro-epiandrostenedione (DHAj see
Fig. 1.3, Chapter 1). Evidence for the existence of this
pathway was adduced from the accumulation of radioactivity in
the eight carbon fragment 6-methyl-heptan-2-one, which was
_ 14
supposedly formed by incubating /26- <2/ cholesterol with
homogenates of testes and other steroid producing glands from
several species. However, Hochberg et al. (1971) and Burstein
et al. (1971) were unable to prove unequivocally that 2-methyl-
heptan-6-one was formed from cholesterol and thus failed to
support the existence of the alternative pathway in which
cholesterol is converted to androgens by way of a side-chain
cleavage between C-17 and C-20.
Another pathway of steroid hormone biosynthesis which
bypasses pregnenolone (or pregnenolone sulfate) has been
reported to proceed as follows:
cholesterol—>20a-hydroxycholesterol—>17,20a-dihydroxy- cholesterol















FIG. 8.1 Typical radiochromatography scan traces obtained
after TLC of extracts from incubations of testi¬
cular heavy mitochondria (0.4 mg ficoll fraction 5)
r- 14 -7 5 .
with i/4- C/ cholesterol (approximately 3 x 10 cpm)
in the presence of:
1. Isocitrate (5 mM) plus cyanoketone (5.5 (iM) .
2. Isocitrate (5 mM) plus cyanoketone (5.5 (iM)
plus aminoglutethimide (400 fiM).
The thin layer plates were developed four times in
solvent IV as described in Chapters 2 and 3.
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metabolism of 20a-hydroxycholesterol and 17,20a-dihydroxy-
cholesterol to steroids by human fetal adrenal tissue
(Shimizu et al., 1965). However, the proposed pathway of
formation of Cjg steroids directly from 17,20a-dihydroxy-
cholesterol has yet to be demonstrated.
8.2 PRELIMINARY EVIDENCE FOR AN ALTERNATIVE PATHWAY IN RAT
TESTIS
In the course of studies presented earlier (section
5.3) it was observed that when testicular mitochondria were
r- 14 ~7
incubated with /4- C/ cholesterol and isocitrate in the
presence of 5.5 fiM cyanoketone to inhibit 3[3 -hydroxysteroid
dehydrogenase and 400 |iM aminoglutethimide to inhibit the
conversion of cholesterol to pregnenolone, there was no
accumulation of pregnenolone, but another radioactive
labelled product (compound X) having an identical mobility to
authentic DHA on TLC was formed as (-shown in Figure 8.1.2.
(Also see Fig. 5.14.) Figure 8.1.1 shows a typical radio-
chromatographic scan trace obtained after TLC of the extract
from testicular heavy mitochondria (HMF^) incubated in the
presence of isocitrate and cyanoketone (5.5 |iM) . It can be
seen that only pregnenolone was formed. No DHA or any other
steroids were obtained. From these observations amino¬
glutethimide (400-800 |iM) appeared to fully inhibit the
orthodox cholesterol side-chain cleavage reaction but not
-14-7
the conversion of /4- C/ cholesterol to radioactive product
'X1 thus suggesting the existence of another pathway for
cholesterol metabolism. Preliminary studies were therefore

































FIG. 8.2 The effect of cofactors on the rate of pregnenolone
metabolism and nature of products formed by rat
testis mitochondria.
Incubations were carried cut for 60 minutes of 37°C
/— 14-7in medium B with /4- C/ pregnenolone and 0.4 mg
protein of heavy mitochondria ficoll fraction 5.
The following cofactors were added where indicated:
DL isocitrate (5 mM); NADP (1.5 mM) or NADPH-
generating system (see Table 2.2 Chapter 2).
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the existence of an alternative pathway(s) for steroid bio¬
synthesis from cholesterol. On the basis of its mobility
on TLC in different solvent systems (III, IV, V, VI),
compound X was tentatively regarded as DHA.
8.2.1 Effect of different cofactors on the rate of
pregnenolone metabolism and steroid products formed
In the course of previous studies (see chapters 3 & 4)
circumstantial evidence was obtained for the presence in
rat testes mitochondria of significant amounts of enzymes
involved in the metabolism of pregnenolone to androgens.
With a view to determining whether pregnenolone could be
converted to DHA by the rat testes mitochondrial preparations,
the 5-ene-3|3 - hydroxysteroid dehydrogenase activity was
/— 14 ~7
measured using /4- C/ pregnenolone as substrate as described
in Chapter 2.6. Activity is expressed as the percentage
conversion of pregnenolone to steroid products. The steroids
formed being presented in 3 groups based on TLC separation:
1. progesterone and androstenediol
2. DHA
3. testosterone, androstenedione and 17a-hydroxyprogesterone
The results in Figure 8.2 and Table 8.1 illustrate the
effect of different cofactors (DL isocitrate 5 mM; NADP+
1.5 mM; extra-mitochondrial NADPH generating system) on the
rate and products of pregnenolone metabolism in intact rat
testicular heavy mitochondrial fraction. In the absence of
added cofactor the rate of pregnenolone conversion was linear
up to 2 hours. The presence of isocitrate had no effect on
— 14-7
the rate of conversion. In both cases 44-47% of /4- C/
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pregnenolone was transformed to progesterone and about 1%
to labelled testosterone in 1 hour. These results confirm
the presence of an active 33-hydroxysteroid dehydrogenase in
rat testicular heavy mitochondria. In the presence of NADP
the rate of 33-hydroxysteroid dehydrogenase activity was
greatly enhanced. In 1 hour 97% of the added pregnenolone
was consumed. Of this 95% was transformed to progesterone
+
and a further 2% metabolized to testosterone. NADP thus
appears to be the cofactor in the conversion of pregnenolone
to progesterone. The 33-hydroxysteroid dehydrogenase from
bovine adrenal microsomes (Beyer & Samuels, 1956), rat
ovarian mitochondria and microsomes (Sulimovici & Boyd, 1969)
+
were reported to use NAD as the preferred cofactor.
When an extra mitochondrialNADPH-generating system was
used as cofactor, a similar stimulation to that of NADP was
observed, but in this case the major product was testosterone
(63%). The amount of progesterone accumulated was 31%.
This observation indicates that NADPH is a cofactor in the
metabolism of progesterone to testosterone in rat testis.
In these studies no DHA was detected. However, these
studies no not prove the absence of the pregnenolone }
17a-hydroxypregnenolone—>DHA pathway, since DHA if formed,
could be rapidly converted to androgens. In an attempt to
verify whether pregnenolone could be metabolized via DHA, an
inhibitor of 33-hydroxysteroid dehydrogenases — cyanoketone
was employed. Cyanoketone would therefore inhibit progesterone
formation and hence the progesterone to testosterone pathway.
TABLE8.1
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The only products expected from pregnenolone in the presence
of cyanoketone would be 17a-hydroxypregnenolone, DHA and
androstenediol (see Figure 8.4).
8.2.2 Effect of inhibitors on pregnenolone metabolism
Incubations were carried out for 60 minutes, as described
above except that the following inhibitor(s) were included
in the incubation: cyanoketone (5.5 jiM) and/or aminoglutethimide
(400 fiM) , The results in Table 8.1 show that in the absence
(experiment 1) or presence (experiment 2 and 3) of cofactors
+
(isocitrate or NADP ), cyanoketone completely inhibited 3|3-
hydroxysteroid dehydrogenase activity and no radioactive
pregnenolone was consumed. No labelled products were detected.
A-minoglutethimide did not have any significant inhibitory
effect on the metabolism of pregnenolone indicating that the
site of inhibition of aminoglutethimide is at a point prior
to the synthesis of pregnenolone. When cyanoketone and
aminoglutethimide were both added to the incubations, the
effect was the same as that observed in the presence of
cyanoketone alone. No labelled peak corresponding to DHA
or any other steroid was produced. These results establish
that pregnenolone conversion to DHA via 17a-hydroxypregnenolone
does not occur in testicular mitochondria from mature animals,
at least, under the conditions of these studies.
Except for the labelled substrate used the incubation
conditions employed in the studies presented above (Table 8.1,
experiment 2.d), were identical to those under which compound X
('DHA') was formed. These results in conjunction with













FIG. 8.3 EFFECT OF TIME ON THE RATE OF FORMATION OF COMPOUND X
Ficoll fractionated heavy mitochondria (HMF^ 0.4 mg)
were incubated at 37°C for O, 60 and 120 minutes in
— 14 —
medium B with l_'4- C/ cholesterol, isocitrate (5mM),
cyanoketone (5.5 ^M) and aminoglutethimide (400 jiM).
In addition to the zero minute control incubations,
two other controls were included, each incubated
for 120 minutes. One consisted of the complete
system but with a boiled mitochondrial fraction,
while in the other, isocitrate was omitted from the
complete system. Each data point in the figure
represents the mean and range of duplicate deter¬
minations from two different groups of rats of the
same age (8-10 animals/group). Results shown are
typical of those observed repeatedly.
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compound X ('DHA') could only be derived from cholesterol
and not from pregnenolone.
8.3 EFFECT OF TIME ON THE RATE OF FORMATION OF COMPOUND X
('DHA')
Ficoll fractionated mitochondria (0.4 mg) were incubated
at 37°C for O, 60 and 120 minutes in medium B with £7
cholesterol, isocitrate (5 mM) , cyanoketone (5.5 |_tM) and in
the presence of aminoglutethimide (400 (iM) . The results
are shown in Figure 8.3. Compound X was the main product
formed and its rate of formation was linear with time.
Compared with controls the small increase in pregnenolone
formation at 120 minutes incubations may be due to partial
reversal of the inhibition (due to metabolism of the
inhibitor - Kowal, 1970). The amount of compound X formed in
60 minutes (0.81%) was approximately one fifth of that of
pregnenolone (4.3%) obtained under similar conditions but in
the absence of aminoglutethimide. These observations indicate
that the relative rates of the two pathways viz pregnenolone:
DHA is of the order of 5:1.
8.4 SUBCELLULAR DISTRIBUTION OF THE ENZYME SYSTEM INVOLVED
IN THE BIOSYNTHESIS OF COMPOUND X
The subcellular distribution of the enzyme involved in
the synthesis of compound X is shown in Table 8.2. The sub¬
cellular fractions were obtained by differential centrifugation
and ficoll gradient fractionation as described previously
(section 2.2). Experiment 1 shows that the enzyme system
TABLE 8.2
SUBCELLULAR DISTRIBUTION OF THE ENZYME
INVOLVED IN THE BIOSYNTHESIS OF COMPOUND X
% /J-14C/ CHOLESTEROL
EXPT. SUBCELLULAR FRACTION









Crude HM (0.5 mg) 2.4 COm•o
1
.24
Light mito (0.5 mg) O 0 -
1
Microsomes (0.7 mg) 0 o -













(Middle layer 0.29 mg) 6.9 1.6 .23
Sub Fraction 3
(pellet 0.24 mg) 5.6 1.0 .17
The different subcellular fractions were incubated for 90 minutes
at 37°C in medium B with /4- "C/ cholesterol, 5 mM isocitrate,
5.5 |iM cyanoketone and/or the presence of 400 [iM aminoglutethiraide.
In Expt. 1 the testis subcellular fractions were obtained by
differential centrifugation as described in Chapter 2. Heavy
mitochondrial fraction 5 was obtained after discontinuous ficoll
gradient.(3-6-10% ficoll) fractionation of the crude heavy mito¬
chondria.
In Expt. 2 subfractions 1, 2 and 3 represent the different layers
obtained after subjecting HMF^ to a second (10-15-20%) ficoll
gradient centrifugation as described in Chapter 3.
These results are typical of those obtained repeatedly.
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concerned with the production of compound X is localized
exclusively in the heavy mitochondrial fraction and is
closely associated with the cholesterol side-chain cleavage
activity. The other fractions viz light mitochondria,
microsomal and supernatant fractions were completely devoid
of activity.
In an attempt to separate the cholesterol side-chain
cleavage activity from the enzyme system producing compound X,
the mitochondria (fraction 5) obtained from the 3-10% ficoll
gradient was further subjected to a second fractionation on
a discontinuous 10-20% ficoll gradient as described in
Chapter 2. The three subfractions obtained were washed and
assayed as above for the two activities. The results are
shown in Table 8.2 experiment 2. The ratios indicate that
the two activities are not readily dissociable by the
ficoll gradient procedure.
8.5 ENZYMATIC NATURE OF COMPOUND X FORMATION
The results in Figure 8.3 also show that the reaction
involved in the production of compound X is enzymatic since
no product was synthesized in the complete incubation system
terminated at zero time or after incubation for 120 minutes
with the boiled heavy mitochondrial fraction. Furthermore,
in the absence of isocitrate, compound X was not produced
indicating a requirement for reducing equivalents. The
subcellular distribution and ficoll gradient fractionation
studies (section 8.4) lend further support for the enzymatic















FIG. 8.4 Sites of inhibition of cyanoketone and amino¬
glutethimide in the biosynthesis of testosterone
from cholesterol.
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in the presence of inhibitors cyanoketone and aminoglutethimide.
Since cyanoketone inhibited pregnenolone conversion to
*
androgen via progesterone and 17a-hydroxyprogesterone pathway
and aminoglutethimide prevented the formation of pregnenolone
from cholesterol, ' DHA' (X) could only have been derived
directly from cholesterol (see Figure 8.4).
The data presented in this chapter establish that a
compound which behaves like DHA on TLC appears to be
enzymatically synthesized from cholesterol in the presence
of reducing equivalents by an enzyme localized in the heavy
mitochondrial fraction from rat testis.
The studies presented in this chapter are far from
complete and hence do not allow any firm conclusions to be
drawn. Further investigations need to be carried out to
establish the identity and nature of X. Since the mechanism
of removal of the side-chain of cholesterol is not clear and
since the present studies have not proved the identity of
compound X as DHA, it is possible that compound X may be an
intermediate in the formation of pregnenolone or DHA from
cholesterol such as 20oc 22R-dihydroxy-cholesterol or a hydro¬
peroxide intermediate. If X was DHA, its formation would
have to occur by a different mechanism - probably involving
hydroperoxide formation, e.g. cholesterol 20cc-hydroperoxide,
since the postulated enzymic removal of the entire Cg side-
chain of cholesterol could not be confirmed (Hochberg et al.,
1971; Burstein e_t_al. , 1971). Thermal decomposition of
cholesterol 20a-hydroperoxide has been reported (Van Lier &
Smith, 1970c)to result in the formation of androst-5-ene-
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3(3,17(3-diol and other similar products. Furthermore, the
isolation of DHA from air aged cholesterol (Van Lier et al.,
1972) suggests a prior formation of a cholesterol 17a-hydro¬
peroxide from which DHA could be derived by (3 scission of the
C^-C20 bond. It is possible therefore that similar direct
enzymatic pathways could exist and is elaborated (or induced)
under certain conditions.
The investigations on the nature and identity of X could
present a considerable problem.
An approach to the problem of the identity of X would
be to accumulate X and (1) make derivatives by subjecting X
to chemical treatments such as acetylation, oxidation,
reduction etc. and (a) determine molecular weight (b) identify
X and its derivatives by TLC in different solvent systems,
radio-GLC and mass spectrometry. (2) Enzymatic oxidation
using a-or (3-hydroxysteroid dehydrogenase from Pseudomonas
testosteroni. If X were DHA only the free steroid would be
oxidized whereas the acetate would not react.(Stempfel &
Sidbury, 1964).
As regards the source of X: by using cholesterol
/26-^c/ instead of or double labelled cholesterol,
it should be possible to demonstrate whether X is still a
derivative of cholesterol with the side-chain lost - i.e. would
14 -f
X accumulate when / C/ cholesterol labelled at is used
as substrate.
Since aminoglutethimide and metyrapone both bind mito¬
chondrial cytochrome P450 it would be of interest to determine




1. Data presented in this chapter established that in the
presence of aminoglutethimide and cyanoketone, no pregneno¬
lone was formed from cholesterol indicating that amino¬
glutethimide fully inhibits the orthodox side-chain cleavage
reaction. However, the formation of a new radioactive
product - compound X which behaves like DHA on TLC - suggested
the existence of another pathway for cholesterol metabolism
not involving pregnenolone as an intermediate. The relative
rates of the two pathways (Pregnenolone/DHA) is 5:1. Since
compound X was detected only in the presence of aminoglutethi¬
mide the alternative pathway may not occur under normal conditior
2. Formation of compound X was enzymatic; was linear with time
and required an electron source.
3. The enzymatic system involved was localized in the heavy
mitochondrial fraction from rat testis and was closely assoc¬
iated with the cholesterol side-chain cleavage enzyme complex.
4. Studies on pregnenolone metabolism confirmed that the rat
testis heavy mitochondrial fraction contains an active 5-ene-3j3-
hydroxy steroid dehydrogenase as well as other enzymes involved
in the further conversion of progesterone to androgens. These
latter enzymes were activated by NADPH while the former was
stimulated by NADP .
5. Pregnenolone metabolism was completely inhibited by cyano¬
ketone (a known potent inhibitor of 3(3-hydroxysteroid
dehydrogenase) but not affected by aminoglutethimide.
6. Under the in vitro conditions used, the inhibitor studies
indicated that in these testes mitochondria the transformation o
pregnenolone to DHA via 17a-hydroxypregnenolone or pregnenolone to
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The investigation of steroidogenesis in testes proved to
be difficult in comparison to similar studies in the adrenals
and ovaries. The major handicap was that in the testes the
androgen synthesizing cells constituted only a small fraction
of the organ. In adult rats the seminiferous tubules make up
90% of the whole testis and the interstitium only about 10% by
volume (or 6% by weight). Of this the Leydig cells were
estimated to constitute about 3% (Roosen-Runge, 1955, 1956;
Christensen & Mason, 1965). Therefore, for a proper evaluation
of the results of steroidogenesis in testes it was desirable to
work with a homogeneous population of cells. Reported attempts
at preferentially isolating or increasing the concentration of
Leydig cells employing techniques such as radiation (Oakberg,
1959; Rugh & Grupp, I960), induction of spontaneous interstitial
cell tumours (Inano et al., 1968) and cell culturing (Kodani &
Kodani, 1966; Steinberger et al., 1966, 1970) were unsatisfactor
as they resulted either in the loss of some specific enzyme
activities or in the production of abnormal steroids. Micro¬
dissection (Christensen & Mason, 1965), although apparently the
best available method, was found to be time consuming and
laborious, requiring a dissecting time of about 4 h per testis.
This procedure was not practical for routine use. In this
present study, these difficulties were circumvented by preparing
heavy mitochondria from whole testes and then attempting to
isolate the mitochondria of steroidogenic cells before any
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investigations were carried out on the mechanism of control of
steroidogenesis or on how steroid biosynthetic activity was
affected. Some of the findings were then confirmed by using
the subcellular preparations obtained from dissected out
interstitial tissue and seminiferous tubules.
The rat was chosen as the source of testicular tissue
because in comparison to other animal species it offered several
advantages - some of these being (a) the age of the rats of
each experimental group could be strictly controlled. This was
important in view of the variation of the steroid biosynthetic
capacity of the testes with the age of the animal. (b) Steroido¬
genesis in rat testes did not appear to be influenced by
seasonal changes. (c) Compared to other species such as cats,
dogs, rabbits etc., the separation of interstitial tissue from
seminiferous tubules by microdissection was most easily
accomplished with rat testes (Christensen & Mason, 1965).
9.2 THE ASSAY SYSTEM
In earlier studies on the cholesterol side-chain cleavage
in testes and other steroid producing organs, the assay methods
used were based on either the estimation of the side-chain
fragment, isocaproic acid (Ichii et al., 1963) or measurement
of pregnenolone, the first steroid product of the cleavage
reaction by means of the Pettenkofer colour reaction (Hall &
|.
Koritz, 1964; Koritz, 1962). The first method had the
disadvantage that it yielded no information on the nature of
the steroids produced in the reaction and thus could not provide
any indication of the presence of the alternative pathway of
androgen synthesis as proposed by Jungman (1968a,b). The second
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method assumed that pregnenolone was the sole product of the
reaction accumulating. This however was not always the case.
These problems were largely overcome by the use of a radiometric
— 2.4 —}
assay method based on the conversion of the substrate [4- C/
cholesterol to labelled steroid products which were separated
by thin-layer chromatography as described in Chapters 2 and 3.
In view of the low cholesterol side-chain cleavage activity
in testes in vitro and the formation of a number of steroid
products compared to other tissues, it was necessary to reduce
procedural losses of compounds during routine analysis and yet
achieve good separation of the steroid products formed. For
this purpose a quantitative extraction procedure (described in
Chapter 2) and a reproducible one plate thin layer separation
of steroids (described in Chapter 3.5) was developed. Radio-
chromatogram scanning and liquid scintillation spectrometry were
used to detect and cuantitate the products. The assay procedure
was quantitative, reproducible and sensitive allowing the
detection of metabolites which might occur in small amounts.
However, since it is not known to what extent the exogenous
cholesterol added as substrate mixes with the endogenous
cholesterol nor how large the endogenous cholesterol pool is,
this assay method did not permit the determination of the
absolute rates of cholesterol side-chain cleavage.
9.3 SUBCELLULAR LOCALIZATION OF CHOLESTEROL SIDE-CHAIN
CLEAVAGE ACTIVITY
It has generally been observed that cholesterol side-chain
cleavage activity occurs in the mitochondrial fraction of most
steroid synthesizing tissues (Sulimovici & Boyd, 1969a). Howev
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Flint and Armstrong (1971a,b) reported that the microsomal
fraction obtained from rat lutealized ovaries was also capable
of catalyzing the cleavage of the cholesterol side-chain. In the
majority of published investigations the particulate fraction
which sedimented between 800-10,000 x g on differential centri-
fugation was employed as the mitochondrial fraction. However,
such a subcellular preparation from rat testes was found to be
contaminated with sperms, spermatids and other cell fragments.
In view of the fact that sperms and spermatids are rich in
mitochondria and constitute the bulk of the cells in the mature
testis (Roosen-Runge, 1956), their removal was important. This
was achieved by the differential centrifugation technique
described in Chapter 2. This procedure also achieved an initial
fractionation of the mitochondria into "heavy" and "light"
fractions. The cholesterol side-chain cleavage activity was
found to be localized only in the "heavy" mitochondrial fraction
(470-6,000 x g) whereas the "light" mitochondrial (6,000-11,000 x c
and microsomal fractions were completely devoid of the enzyme
activity.
With the view of further separating out the mitochondria
not involved in cholesterol side-chain cleavage from those
containing the enzyme, the heavy mitochondrial fraction was
subjected to a ficoll gradient centrifugation as proposed in
Chapters 2 and 3. This fractionation procedure not only achieved
the removal of subcellular organelles equivalent to about 40%
of the total protein present in the original heavy mitochondrial
fraction but also resulted in a mitochondrial pellet (HMF )
which contained most of the cholesterol oxygenase activity and
which was free of microsomal contamination as indicated by
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spectral studies (see Chapter 5). Furthermore, this ficoll
gradient purification of the heavy mitochondria made possible
the detection of cytochrome P450 involved in cholesterol
hydroxylation as demonstrated in Chapter 5.
Evidence that the mitochondria catalyzing cholesterol
side-chain cleavage reaction were intact was provided by
measurement of respiratory control and ADP/O ratios, inability
of NADI-I and NADPH to stimulate oxygen utilization, demonstration
of the presence of normal respiratory chain cytochromes and of
a specific mitochondrial type cytochrome P450, and by electron
microscopy.
9,4 RAT TESTES MITOCHONDRIAL CYTOCHROME P45Q
The cholesterol side-chain cleavage enzyme system of most
steroid producing organs have been resolved by partial purificati
into three separable components, namely a flavoprotein, an iron
sulfur protein and cytochrome P450. However, with testes, such
attempts were not successful. The failure to demonstrate the
presence of cytochrome P450 in the rat testicular mitochondria
(Machino et al♦, 1969; Inano et al., 1970; Mason et al.,
1973) cast some doubt on the nature and mechanism of the
cholesterol side-chain cleavage reaction. The studies presented
in Chapter 5 demonstrated that normal rat testes mitochondria
contained a relatively small amount of cytochrome P450 and that
it was not possible to detect this cytochrome P450 by the
conventional reduced-carbonmonoxy difference spectra. There
appeared to be some spectral interference from the relatively
high cytochrome oxidase content. This problem was overcome by
using the ficoll fractionated mitochondria and employing the
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difference spectra changes selectively induced by amines which
interact with the cytochrome P450 and not with the respiratory
chain cytochromes. Aminoglutethimide was observed to form a
typical cytochrome P450-amine complex with all the cytochrome
P450 in the testes mitochondria. It did not bind to the
microsomal cytochrome P450. Metyrapone, on the other hand,
was a general ligandand bound to both the mitochondrial and
microsomal cytochrome P450 species. This specificity formed
the basis of the method developed for the detection and
estimation of the two species of testicular cytochrome P450.
The specific cytochrome P450 content in the ficoll fraction¬
ated mitochondria of rat testes calculated from the amino¬
glutethimide difference spectrum (&A 406-448 nm and AE 28 cm-"*"
nM ■*") was 0.0137 ± 0.003 nmoles/mg protein (mean ± SD of 13
different experiments, each of 8 rats, average age 18 weeks).
The corresponding value for microsomal cytochrome P450 using
metyrapone was found to be 0.058 ± 0.019 nmo'les/mg protein.
The microsomes thus contained approximately four times as much
cytochrome P4-50/mg protein as the mitochondria. A similar
value of 0.058 ± 0.021 nmoles/mg protein was obtained for the
microsomal P450 content by the reduced carbonmonoxide method
(i.e. AA 450-490 nm and AE 95cm~^"nM . The amine methods of
measuring cytochrome P450 was thus comparable to the reduced-
carbon monoxide method. With mitochondria prepared from
isolated interstial tissue, a higher and much truer value
(0.026 ± .003 nmoles cytochrome P450 per mg of mitochondrial
protein) was obtained (data from 5 experiments). This value
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however was approximately only two-fold higher than that found
with ficoll fractionated mitochondria from whole testes.
These observations imply that the ficoll gradient fractionation
does achieve a good degree of purification of the crude mito¬
chondria from whole testes - separating out the bulk of the
tubular mitochondria from the interstitial ones.
The content of cytochrome P450 in rat testis mitochondria
is considerably lower ("^/lO-^/lOOth) than that reported in
other steroid producing tissues (Cammer & Estabrook, 1967;
Mcintosh et al., 1971; Jefcoate et al. , 1973). This relatively
low cytochrome P450 content of the testis could therefore account
■for the very low cholesterol side chain cleavage activity observed in vitro»
That virtually 'all the aminoglutethimide-dectectable
cytochrome P4-50 in testes mitochondria is involved in the mixed
function oxidation of cholesterol was indicated by several lines
of evidence:-
The aminoglutethimide induced spectral change exhibited pH
dependence. As pH was lowered there was an increase in the high
spin cytochrome P450. So also the magnitude of the methyl-
androstenediol induced inverse Type I difference spectral change,
which is attributed to the conversion of high spin cytochrome
P450 to the low spin state (Whysner et al., 1969; Jefcoate et al♦,
1973), increased with a decrease in pH. In contrast the Type I
difference spectrum induced by 20,22R-dihydroxycholesterol was
observed to be independent of pH. Since the rate of cholesterol
side-chain cleavage appears to depend on the amount of high spin
cytochrome P450 in the mitochondria (Simpson et al., 1972) and
also since the high spin form of cytochrome P450 is thought to be
due to the cytochrome complexing with substrate cholesterol,
- 170 -
changes in the amount of cholesterol bound to cytochrome P450
as a high spin complex would change the rate of cholesterol
side-chain cleavage. The pH changes induced around the mito¬
chondria would cause an increase or decrease in the amount of
high spin cytochrome P450 and hence activate or inhibit
pregnenolone synthesis. These pH dependent changes in spin state
appear to be a property unique to the cholesterol side-chain
cleavage cytochrome P450. It is not displayed by the cytochrome
P450s involved in other reactions.
The sum of the cholesterol-bound and cholesterol-free
cytochrome P450 at pH 6.0 as determined by the spectral responses
to methylandrostenediol and 20,22R-dihydroxycholesterol respective]
agreed closely with the total testes mitochondrial cytochrome
P450 which was detected with aminoglutethimide. The magnitude
of the methylandrostenediol binding spectrum is thought to depend
on the amount of cholesterol bound to cytochrome P450. 20,22R-
dihydroxycholesterol has been suggested to occupy a specific
site on cytochrome P450 and thus reflect the proportion of mito¬
chondrial cytochrome P450 which is not bound by cholesterol
(Jefcoate et al., 1973).
Deoxycorticosterone, the substrate in llp-or 18-hydroxy-
lations in the adrenal cortex failed to produce a Type I spectral
response with testicular mitochondria implying the absence of
the cytochrome P450 species associated with such hydroxylation
reactions.
During subcellular fractionation procedures the cholesterol
side-chain cleavage activity and the aminoglutethimide detectable
cytochrome P450 showed a similar distribution pattern. There
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were also similarities in the fractionation behaviour of
cytochrome P450 of testes mitochondria during the partial
solubilization procedure,with those of adrenal cholesterol side-
chain cleavage cytochrome P450. Therefore, there appeared to be
a very close correlation between the mitochondrial cytochrome
P450 based on spectral studies and cholesterol side-chain
cleavage activity. Further spectral studies (presented in
Chapter 6) demonstrated that the pretreatment of rats with
cycloheximide, reduced by half the proportion of cholesterol,
which is bound by the mitochondrial cytochrome P450. Correspond¬
ingly, the rate of cholesterol side-chain cleavage activity was
also reduced in these testes mitochondria from animals previously
treated with cycloheximide. These observations in conjunction
with the in vitro studies which demonstrated that aminoglutethi-
mide fully inhibited the conversion of cholesterol to pregnenolone
in vitro (see Chapter 4) provided the evidence for the involvemenl
of mitochondrial cytochrome P450 in cholesterol side-chain
cleavage reaction.
9,5 USE OF INHIBITORS
In the present study on steroidogenesis in testes, the
inhibitors - cyanoketone, cycloheximide, metyrapone and amino-
glutethimide proved to be very useful chemical tools. Cyanoketonc
an inhibitor of the 3P-hydroxysteroid dehydrogenase (Goldman
et al., 1967) was used to overcome the difficulties encountered
in the measurement of the rate and pathway of cholesterol side-
chain cleavage when three or more steroid products were formed.
Pregnenolone was the only product of side-chain cleavage under
normal conditions (see Chapters 4 and 8). Cycloheximide, a known
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inhibitor of protein synthesis, aided in elucidating the possibl<
mechanism of control of steroidogenesis in testes as discussed
in Chapter 6. The two amine inhibitors, aminoglutethimide and
metyrapone in particular, helped to highlight differences betweer
the individual cytochrome P450s, thereby revealing two distinct
cytochrome P450 species in the testes - one mitochondrial and
the other of microsomal origin.
The precise action of aminoglutethimide in the inhibition
of cholesterol side-chain cleavage activity is poorly understood.
It is probable that the inhibitory effect could be the result
of the intervention of the compound at several sites
(a) Alteration of the mitochondrial structure, particularly
the internal membrane of the cristae as observed in the adrenal
cortex (Kadioglu & Harrison, 1971; Racela et al., 1969). The
20a-, 11(3-and 18-hydroxylases, which are all of mitochondrial
origin, are affected by aminoglutethimide.
(b) Competitive inhibitory effect with the substrate as has
been shown to occur with 11(3-hydroxylase (Kowal, 1969a).
(c) Inhibition of hydroxylation by the action on cytochrome
P450; the reduction of the oxidized form of cytochrome P450-
substrate complex is considered to be the rate limiting step of
the reaction. Aminoglutethimide, which forms a complex with
the oxidized form of cytochrome P450, considerably slows the
speed of the reduction and blocks the hydroxylation (Whysner &
Harding, 1968; Mcintosh & Salhanick, 1969).
Metyrapone and aminoglutethimide both induce a similar
Type II spectral change but unlike aminoglutethimide metyrapone
interacts with oxidized and reduced cytochrome P450 (Cooper
- 173 -
et al., 1968; Sweat et al♦, 1969; Peterson et al., 1971) and
interferes with the interaction of CO and with the cytochrome.
9.6 CELLULAR LOCALIZATION OP THE CHOLESTEROL SIDE-CHAIN
CLEAVAGE ENZYME COMPLEX
Having established that the cholesterol side-chain cleavage
enzyme and its associated cytochrome P450 are localized
exclusively in the mitochondria of testes, it was of interest
to determine the type of cells from which these mitochondria
were derived. Since cholesterol is regarded as an obligatory
precursor of steroids, the presence or absence of cholesterol
side-chain cleavage activity in a particular tissue could be
regarded as reflecting the steroid biosynthetic ability of that
tissue. Although the Leydig cells have generally been considered
as the source of testicular steroids, it was reported that the
Sertoli cells in the seminiferous tubules were also capable of
synthesizing steroids de novo.(Lacy & Pettit, 1970). Most of
the evidence for this was based on the metabolism pregnenolone
and progesterone (Bell et al., 1968; Christensen & Mason, 1965).
Other studies based on the conversion of labelled cholesterol to
androgens were inconclusive because of the very low rates of
conversion (<0.6%) (Hall et al., 1969). This apparent steroid
biosynthetic activity attributed to the seminiferous tubules
could easily have resulted from contamination by a small amount
of highly active interstitial cell enzymes. To overcome such a
problem in the present studies the testes were dissected out into
the two main components - the interstitium and seminiferous
tubules, and a third miner residual fraction of mixed cells from
tubules and interstitium. The seminiferous tubules were thorough
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washed using ficoll. Unlike previous investigations which were
performed with whole tissues in this present study, subcellular
fractions were prepared from these washed isolated tissues.
This approach also had the advantage of avoiding the problems
of differential penetration of exogenously added substrates.
Studies were carried out with these subcellular fractions from
isolated testicular tissue, applying the techniques developed
with whole testes.
The data presented in Chapter 7 demonstrates that the
mitochondria containing the enzyme system, which catalyzes the
first step in steroid biosynthesis from cholesterol, v;as derived
exclusively from the interstitial tissue. The evidence for this
was based on measurement of the cholesterol side-chain cleavage
activity as well as spectral studies on cytochrome P450. The
mitochondria obtained from the seminiferous tubules did not
exhibit any such detectable enzyme activity, and did not possess
cytochrome P450. The spectral studies also revealed that the
microsomal fractions isolated from the interstitial tissue were
rich in cytochrome P450, whereas those from seminiferous tubules
lacked the cytochrome. In view of the reported involvement of
microsomal cytochrome P450 in the hydroxylation of progesterone
(Menard & Purvis, 1972) this finding implies that the semini¬
ferous tubules may also lack the steroid 17a-hydroxylase enzyme
system. In view of the relatively larger proportion of tubular
tissue to interstitial tissue, the number of Sertoli cells in
the tubules may, at the very least, be similar to the number of
Leydig cells present (Heller et al., 1971). Thus, if Sertoli
cells were capable of de novo steroid synthesis from cholesterol
FIGURE 9.1 Postulated mechanism for the inhibitory effect of
aminoglutethimide and the formation of dehydro-
epiandrosterone. ( postulated pathway)
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it should have been possible to detect both cholesterol
side-chain cleavage activity and cytochrome P450 if present
in the seminiferous tubular fractions. Menard and Purvis
(1972) also observed that rat testis microsomal cytochrome
P450 measured as the CO complex and the associated steroid
17a-hydroxylase were located in the interstitial cells. Dufau
et al. (1971) demonstrated that cell cultures derived from the
seminiferous tubules were deficient in 17a-hydroxylase. The
reported observations that aminoglutethimide injected into
rats produce hyperplasia of the interstitial cells without
appreciable changes in the spermatogenic elements of the testes
(Limanowski & Miskowiak, 1972) are, in view of the present
studies, of particular significance. The cells of the semini¬
ferous tubules, although lacking the biosynthetic capability
may, however, utilize the steroids synthesized by the Leydig
cells and thereby maintain spermatogenesis.
9.7 POSSIBLE MECHANISM FOR THE FORMATION OP DEHYDROEPIANDKQ-
STENEDIONE
A mechanism is proposed involving cytochrome P450 as
depicted in Figure 9.1 assuming that product X is dehydro-
epiandrostenedione (see Chapter 8), and taking into account
(a) the formation of DHA only in the presence of aminoglutethi¬
mide, and (b) the necessity of an electron source. Although
aminoglutethimide is postulated to inhibit the reduction of
oxy-cytochrome P450 by the iron sulfur protein testodoxin
(reduced), steroid formation could however occur via a hydro¬
peroxide intermediate. Van Lier and Smith (1970b) have
demonstrated that in adrenal cortex mitochondria, cytochrome P450
is involved in certain hydroperoxide reactions of cholesterol
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20a-hydroperoxide. Hrycay and O'Brien (1971) have suggested
that cytochrome P450 acts as a peroxidase in adrenal cortex
microsomal metabolism of sterol hydroperoxides.
Recently Dufau et al. (1971) found that cell cultures
derived from seminiferous tubules could form testosterone from
certain steroid precursors. The cell cultures showed minor
conversions of pregnenolone to progesterone and 17a-hydroxy-
progesterone to testosterone but in contrast substantial
conversions of DHA to testosterone and androstenedione, and of
androstenediol to testosterone were observed. This generation
of high local concentrations of testosterone from precursor DMA
may be an important function of the tubules and significant in
the maintenance of spermatogenesis. These authors also observed
the absence of 17a-hydroxylation of pregnenolone and progesterone
Further, it was reported that no significant conversion of
labelled pregnenolone to 17a-hydroxypregnenolone occurred in rat
testis microsomes (Shikita et al., 1964) or in rat testis
interstitial tissue freed from tubules (Bell et al., 1968).
In view of these findings, the existence in the testis of an
alternative pathway for androgen biosynthesis from cholesterol
via DHA which bypasses pregnenolone, could be physiologically
highly significant.
9.8 SUPPLY OF SUBSTRATES FOR CHOLESTEROL SIDE-CHAIN CLEAVAGE
During the course of the present study it was decided to
investigate some of the potential sources of the reactants -
cholesterol + + NADPH —> pregnenolone + isocaproic acid.
It was conceivable that control of the rate of cholesterol
side-chain cleavage (and the overall steroidogenic activity)
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could be exerted (presumably via LH in vivo) by some initial
effect on the supply of the reactants involved.
(A) CHOLESTEROL
It has long been held that the profuse lipid droplets
present in adrenal cortex, corpus luteum and immature testes are
stored precursors for steroidogenesis (Deane et al. , 1948; see
Christensen & Gillim, 1969) and their presence and abundance
thought to reflect the secretory activity of the cells. These
droplets are known to be rich in cholesterol, present mainly in
an esterified form with long chain (and often poly-unsaturated)
fatty acids (Claesson, 1954; Garren et al.. 1971; Johnson, 1969
Boyd & Trzeciak, 1973). Cholesteryl ester depletion and steroid
production in adrenal (Garren et al♦, 1971) and luteal tissues
(Armstrong, 1968a) induced by ACTH and LH respectively suggest
that synthesis of cholesteryl esters may be an important
regulatory site in steroid biosynthesis - providing a source of
cholesterol for cholesterol side-chain cleavage. The possibility
that a comparable effect of gonadotrophin on testicular cholester
or cholesteryl ester might be of importance in the action of
gonadotrophins on steroid production in testis was investigated
by Van der Molen et al. (1973). Their results did not indicate
a specific effect of HCG on any cholesterol pool in testis
although testosterone levels in peripheral blood of the rats
reflected the effect of hypophysectomy and HCG administration.
Moyle and Armstrong (1970) also reported that LH had no effect
on the content of free and esterified cholesterol in Leydig-cell
tumours of mouse although stimulation of steroidogenesis was
observed.
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The adult rat testicular heavy mitochondria used in this
present study contained very little cholesteryl esters
(6.5 ± 0.2 nmoles/mg protein) compared to free cholesterol
(70 ± 0.5 nmoles/mg protein). In addition these washed mito¬
chondria were found to possess an active sterol ester hydrolase
but less than 0.8% of the cholesterol so released was oxidized
to steroids. These findings, in conjunction with the reported
electron microscopic observations that the interstitial cells from
mature rats (in comparison to mouse), are virtually without lipid
droplets (Christensen & Gillim, 1969), imply that cholesteryl
esters may not play as significant a role in testes as the
source of cholesterol for steroid synthesis as in the adrenals
(Dailey et al., 1963) and corpus luteum (Robinson & Stevenson,
1971). In this regard it is of interest to note that the rat
adrenal cortex (Werbin & Chaikoff, 1961), like many other tissues
of the body (Morris & Chaikoff, 1959), make virtually none of
their own free cholesterol, but take it up from the plasma.
In contrast the rat testicular interstitial cells rely far more
heavily on endogenous synthesis - from acetate in the endoplasmic
reticulum (Christensen, 1965; Christensen & Gillim, 1969).
The nature and size of the cholesterol pool associated with
steroidogenesis in testicular mitochondria is not known.
However, on the basis of the total cholesterol content (76.5
nmoles/mg protein) and cytochrome P450 content (see section 9.4)
in the mitochondria of adult rat testis it was estimated that
there are potentially about 7,000 nmoles of cholesterol/kidoIg
of cytochrome P450. This extremely high cholesterol to
cytochrome P450 ratio could therefore account for the very low
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rates of cholesterol side-chain cleavage observed. It must be
assumed that the cholesterol which is available for steroido¬
genesis is only a small portion of the total cholesterol pool
of the mitochondria. As demonstrated in Chapter 6.3, the trans¬
location of cholesterol to the cytochrome P450 in the mitochondria
appears to be a cycloheximide sensitive process. The pretreatment
of rats with cycloheximide decreased the rate of the cholesterol
side-chain cleavage activity and also reduced the proportion of
the cholesterol which was bound to the mitochondrial cytochrome
P450 (by half). Thus there was less "reactive" cholesterol in
these mitochondria. Davis and Garren (1966) postulated that for
the transport of cholesterol to the cytochrome P450 site, a new
protein is required, the synthesis of which is inhibited by
cycloheximide and stimulated by LH. A similar cholesterol
transport step is therefore one of the mechanisms and probable
sites for the control of steroid syrythesis.. in testes.
(B) OXYGEN
No attempt was made to investigate the supply of oxygen
for practical reasons. It is interesting to note however that
the Leydig cells are generally found in the testis in clusters
around blood vessels, thus ensuring a constant supply of oxygen
(C) NADPH
It was observed (see Chapter 4) that the rat testis
cholesterol side-chain cleavage enzyme system had an absolute
requirement for NADPH - a characteristic shared by most other
mammalian mixed function oxidases. NADPH generated extramito-
chondrially involves glucose-6-phosphate dehydrogenase. Contrary
to earlier reports (Menon et aL ., 1967), in the present study
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FIGURE 9,2 A SCHEMATIC REPRESENTATION OF POSSIBLE PATHWAYS FOR
THE PRODUCTION OF NADPH IN RELATION TO CHOLESTEROL
SIDE-CHAIN CLEAVAGE
+
(1) Via NADP -linked substrates (isocitrate or
malate.
(2) Via NAD dependent dehydrogenase coupled with
NADPH:NADH transhydrogenase.
(3) Via flavoprotein dehydrogenases - involving
reverse electron transport from succinate
and transhydrogenation.
Arrows (—indicate direction of electron flow
and // site of inhibition,
NHI = nonheme iron protein; Fp various flavoproteins;
isocitrate dehydrogenase, malate dehydrogenase,
a Ketoglutarate dehydrogenase and malic enzyme are
designated ICDH, MDH, aKGDH and ME respectively.
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with the mitochondrial fraction. Since this dehydrogenase is
not a mitochondrial enzyme, and as mitochondria are relatively
impermeable to pyridine nucleotides, the physiological supply
of intramitochondrial reducing power for cholesterol side-chain
cleavage could arise from some other sources. Based on studies
in other steroidogenic organs the production of intramito¬
chondrial NADPH could occur via three possible pathways as
depicted in Figure 9.2.
On the basis of studies on adrenal cortex, Hall (1969)
and Scoon and Major (1972) implied that malate and isocitrate
were not likely to supply reducing equivalents for cholesterol
side-chain cleavage in testes. However, the studies with rat
testis mitochondria demonstrated that the Krebs cycle intermediate
may be the main source of supply of reducing equivalents for
cholesterol oxidation. Isocitrate, malate, and to a lesser
extent succinate, were able to replace the requirement for
extramitochondrially generated NADPH. Isocitrate was found to
be the most effective electron donor. The marked stimulation
r +
of cleavage activity observed when isocitrate and NADP were
both present in the incubation indicated the presence of an
"J"
active NADP dependent isocitrate dehydrogenase. Spectrophoto-
metric assay confirmed the presence of such an enzyme in these
testis mitochondria (Stevenson, unpublished results). In this
regard the reported histological observations that the Leydig
cells are the principal sites of isocitrate dehydrogenase
(Hitzeman, 1962; Ito, 1966) and malate dehydrogenase (Ambadkar
& George, 1964) are of interest.
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9.9 NATURE OF STEROID PRODUCTS FORMED FROM CHOLESTEROL
When NADPH-generating system was used as the electron
source for cholesterol side-chain cleavage, the products formed
were testosterone, androstenedione and 17<*-hydroxyprogesterone,
progesterone and pregnenolone. The latter two products generally
constituted a smaller proportion of the total products. When
NADPH was replaced by isocitrate as the electron donor the
products now were mainly pregnenolone and progesterone. The
yield and ratio of steroids accumulating were found to be further
influenced by the presence of certain factors in the incubations
such as NADP , Ca++, BSA, ADP and cyanide (see Chapter 4, Figure
4.8). These substances could therefore, by their respective
influences, provide a possible mechanism of control of steroid
synthesis by regulating the accessibility of NADPH and other
substrates to the cholesterol side-chain cleavage enzyme complex.
The observations that magnesium and other reagents which uncouple
the mitochondria stimulate cholesterol side-chain cleavage
activity, suggest that the integrity of the mitochondria could
also contribute to the regulation of steroid biosynthesis. It
is of interest that coupling could only be demonstrated when
potassium phosphate, ethylenediamine tetraacetic acid and bovine
serum albumin were present in the medium together. Since the
cholesterol side-chain cleavage enzyme has been reported to be
located in the inner mitochondrial membrane (Yago & Ichii, 1969),
the influence of the above factors on cholesterol oxygenase
activity could be highly significant.
On the basis of studies discussed in Chapter 4, the differen
effects of cations, anions, pyridine nucleotides and BSA can be
A. With NADPH-qeneratina system as the electron source
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FIGURE 9.3 Schematic representation of the influence of various






schematically represented as set out in Figure 9.3. From the
multiple nature of steroid products formed it can be inferred
that rat testis heavy mitochondrial fraction may, in addition
to the cholesterol oxygenase enzyme, also contain the enzymes
involved in the conversion of pregnenolone to testosterone.
These latter enzymes are usually assumed to be microsomal
enzymes. However, since repeated washings of the ficoll
fractionated mitochondrial pellet did not influence the nature
of the reaction products formed, there may well be two sets of
dehydrogenase-isomerase, 17a-hydroxylaseand C-17, 20 lyase
enzyme systems - one associated with the mitochondrial and the
other with microsomal components of rat testes. Such a dual
existence of distinct dehydrogenase-isomerase enzymes have been
reported in immature rat ovarian mitochondria and microsomes
(Sulimovici & Boyd, 1969b). However, the possibility that the
testicular mitochondrial fractions could be contaminated by a
small amount of active enzymes of microsomal origin, which may
be closely adhering to the mitochondria, cannot be ruled out.
Furthermore, the possibility that seminiferous tubules may-
possess different enzyme systems to that of interstitium must
also be considered. Investigations involving kinetic studies
and enzyme purification will need to be carried out with a
homogeneous population of cells to confirm or rule out these
possibilities.
9.10 CONCLUSIONS
The results presented in this thesis establish that the
first step in steroid biosynthesis in testes, namely the sice-
chain cleavage of cholesterol, occurs exclusively in the "heavy"
mitochondria derived solely from the interstitial tissue. The
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presence of cytochrome P450 was demonstrated in these mito¬
chondria for the first time and shown to be involved in
cholesterol hydroxylation. Evidence also indicated that the
regulation of the synthesis of a labile carrier protein, which
participates in the translocation of cholesterol to the cyto¬
chrome P450 sites, appears to be one of the possible modes of
action of gonadotrophins in the control of steroidogenesis.
A regulatory influence on the synthesis of steroids could also
be exerted by altering the nature of the electron donor,
cofactors, ions such as calcium and magnesium, pH around the
mitochondrion and in the immediate vicinity of cholesterol
side-chain cleavage cytochrome P450, and/or integrity of the
mitochondrial membrane. These factors markedly affected the
activity of the cholesterol side-chain cleavage complex in vitro.
It is hoped that the work presented in this thesis will
aid and pave the way to further investigations on steroido¬
genesis in testes. Although some answers have been obtained in
this present study there are many points that still need to be
clarified and investigated further:-
1. Alternative pathway
(a) Identity and nature of compound X
(b) Can metyrapone also induce the formation of X?
(c) Is cholesterol sulfate a precursor?
(d) If there are two pathways of androgen biosynthesis
from cholesterol, does one pathway predominate
over the other with respect to the development
and maturation of the testis?
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2. Components of the cholesterol side-chain cleavage
enzyme complex
(a) The presence of flavoprotein and non heme iron
have yet to be demonstrated
(b) Can metyrapone also inhibit cholesterol side-chain
cleavage activity?
3. Can foetal and postnatal testes convert cholesterol
to pregnenolone?
4. Is cytochrome P450 present in foetal and postnatal
testis, and if so when does it appear?
5. During development of the testes is the cholesterol
oxygenase enzyme or its components, such as cytochrome
P450, in any way affected or altered?
6. What is the part played by gonadotrophic hormones
during the development and maturation of the testis?
Do they:
(a) Stimulate net synthesis of particular enzymes,
cytochrome P450 or cholesterol carrier protein?
(b) Stimulate cofactor generation systems (NADPH)?
(c) Remove inhibitor(s) of cholesterol metabolism?
(d) Alter cyclic AMP activity?
Since the changes in the histology of Leydig cells observed
during early development of the testis reflect gonadotrophin
activity, age studies could provide a useful and natural model
for the investigation of the mechanisms of control of steroido¬
genesis . Such information will be of interest not only from the
viewpoint of basic endocrinology, but also for sciences related
to clinical endocrinology and reproduction.
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APPENDIX
The following chemicals were purchased from the Sigma
Chemical Company Ltd., London:- NADP monosodium salt,
glucose 6-phosphate disodium salt; glucose-6-phosphate
dehydrogenase (type XII), NADH, NAD 5 ATP, ADP, bovine serum
albumin (free of fatty acids - Type F), bovine plasma albumin
(fraction V), steroids, DL isocitrate, L-malate,succinate,
EDTA, EGTA, Trizma HC1, Trizma base and Pseudomonas testosteroni
(Type I). Sucrose, phosphate salts, magnesium chloride,
potassium cyanide and potassium chloride were purchased from
BDH Chemicals Ltd., Poole, England.
Silica gel G and thin layer chromatography silica gel
precoated plates were obtained from E. Merck A.G., Darmstadt,
Germany.
/4-14c7 Cholesterol, /4C)? pregnenolone and other labellec
steroids were purchased from the Radiochemical Centre,
Araersham, Bucks., England.
PPO and POPOP (Scintillation grade) and Soluene 100
were from Packard Instrument Co. Inc. , U.S.A..
Aminoglutethimide (Elipten) and metyrapone (SU 4885) were
obtained from CIBA.
Ficoll (M wt 400,000) was purchased from Pharmacia Fine
Chemicals, Uppsala, Sweden.
Cycloheximide-l-P was from Koch-Light Laboratories Ltd.,
Bucks., England.
Cyanoketone was a gift from Dr. J. L. McCarthy, Southern
Methodist University, Dallas, Texas. j
- 186 -
APPENDIX - Cont'd
Gas chromatography column packing was obtained from
Applied Science Laboratories Inc., U.S.A.
Ethanol, methanol and acetone were redistilled before
use. Ethanol and methanol were refluxed for 2 hours with
0,1% KOH and acetone with 0.1% potassium permanganate before
redistillation.
All other reagents and solvents were of analar grade.
Hemoglobin solution was prepared from 1.0 ml heparinized
rat blood by washing the red blood cells with isotonic saline,
lysing in 3.0 ml distilled water and sedimenting the erythrocyte
ghosts at 10,000 x g.
- 187 -
ACKNOWLEDGEMENTS
The author would like to express his gratitude to
Professor G. S. Boyd and Dr. P. M. Stevenson for their
excellent advice and supervision throughout this investigation.
My thanks are due to Dr. C. Jefcoate for his interest in
this study.
I am indebted to the Faculty of Medicine for the award of
a Graduate Research Scholarship (1972-1973) which enabled me
to complete this work.
Finally, I would like to express my thanks to my wife
for the patience shown throughout the course of this study
and to my colleagues, especially Mr. J. Arthur and Miss M. Laws
for their invaluable technical assistance in dissecting the
testes.
Part of this research was financed by the Ford Foundation.
The work was initially carried out at the Medical Research
Council's Clinical Endocrinology Unit, Forrest Road, Edinburgh,




Aakvaag, A., Hagen, A.A. & Eik-Nes, K.B. (1964). Biochim.
Biophys. Acta, 86, 622.
Abbot, C.R. (1959). J. Endocr .. 19, 33.
Acevedo, H.F., Axelrod, L.R., Ishikawa, E. & Takaki, F. (1961).
J. Clin. Endocrinol. Metab., 21, 1611.
Acevedo, H.F., Axelrod, L.R., Ishikawa, E. & Takaki, F. (1963).
J. Clin. Endocrinol. Metab., 23, 885.
Allmann, D.W. , Munroe, J., Wakabayashi, T. & Green, D.E. (1970a).
Bioenergetics 1^, 331.
Allmann, D.W., Munroe, J., Wakabayashi, T., Harris, A. &
Green, D.E. (1970b). Bioenergetics _1, 87.
Ambadkar, P.M. & George, J.C. (1964). J. Histochem. Cytochem.
12, 587.
Anliker, R., Perelman, M., Rohr, O. & Ruzicka, L. (1957).
Helv. Chim. Acta 40, 1517.
Armstrong, D.T. (1968a). Rec. Prog. Horra. Res. 24, 255.
Armstrong, D.T. (1968b). J. Anim. Sci., Suppl. 27
Ashbel, R., Cohen, R.D. & Seligman, A.M. (1951). Endocrinology
49, 265.
Attal, J. (1969). Endocrinology 85, 280.
Avigan, J., Steinberg, D., Vroman, H.E., Thompson, M.J. &
Mosettig, E. (I960). J. Biol. Chera. 235, 3123.
Axelrod, L.R. (1965). Biochim. Biophys. Acta 97, 551.
Baillie, A.H. (1961). J. Anat. 95, 357.
Baillie, A.H. (1964). J. Anat. 98, 403.
Baillie, A.H., Ferguson, M.M. & Hart, D.M. (1966). In:
Developments In Steroid Histochemistry, N.Y. Acad. Press.
Baillie, A.H. & Mack, W.S. (1966). J. Endocr. 35, 239.
- 189 -
Baird, D.T. , Galbraith, A., Fraser, I.S. & Newsam, J.E.
(1973). J. Endocr. 57, 285.
Baird, D.T., Horton, R. , Longcope, C. & Tait, J.F. (1969).
Rec. Prog. Horm. Res. 25, 611.
Bardin, C.W. & Peterson, R.E. (1967). Endocrinology, 80, 38.
Baron, J., Taylor, W.E. & Masters, B.S.S. (1972). Arch. Biochem.
Biophys. 150, 105.
Bartke, A. (1971). J. Reprod. Pert. 24, 153.
Bass, J.J., Bell, J.B.G. & Lacy, D. (1973). J. Endocr. 56, 321.
Baulieu, E.E. (1960). J. Clin. Endocr. Metab. 20, 900.
Baulieu, E.E. (1970). Eur. J. Clin. Biol. Res. jL5, 723.
Beall, D. (1940). Biochera. J. 34, 1293.
Becker, W.G. & Snipes, C.A. (1968). Biochem. J. 1Q7, 35.
Bedrak, E. & Samuels, L.T. (1969). Endocrinology 85, 1186.
Bedrak, E., Samoiloff, V. & Sod-Moriah, U.A. (1973). J. Endocr.
58, 207.
Behrman, H.R. & Armstrong, D.T. (1969). Endocrinology 85, 474.
Behrman, H.R., Armstrong, D.J. & Greep, R.O. (1970). Canad. J.
Biochem. 48, 881.
Behrman, H.R. & Greep, R.O. (1972). Horm. Metab. Res. 4, 206.
Bell, J.B.G. & Vinson, G.P. (1968a). Biochem. J. 107, 8P.
Bell, J.B.G., Vinson, G.P., Hopkin, D.J. & Lacy, D. (1968b).
Biochim. Biophys. Acta 164, 412.
Bell, J.B.G., Vinson, G.P. & Lacy, D. (1971). Proc. Roy. Soc.
London, Ser. B. 176, 433.
Bergstrbm, S. (1967). Science 157, 382.
Berthrong, M., Goodwin, W.S..& Scott, W.W. (1949). J. Clin*
Endocrin. £, 579.
Betz, Go & Michels, D. (1973a). Steroids 21^, 785.
Betz, G. & Michels, D. (1973b). Biochem. Biophys. Res. Comm.
50, 134.
- 190 -
Beyer;, K.F. & Samuels, L.T. (1956). J. Biol. Chem. 219, 69.
Bjbrntorp, P., Ellis, H.A. & Bradford, R.H. (1964).
J. Biol. Chem. 239, 339.
Blackshaw, A.W. & Elkington, J.S,H. (1970). J. Reprod. Fert.
22, 69.
Bloch, E. (1964). Endocrinology 7j4, 833.
Bloch, E. (1967). Steroids j?, 415.
Bloch, E. , Lew, M. & Klein, M. (1971). Endocrinology _89, 16.
Boime, I., Smith, E.E. & Hunter, F.E. (1968). Arch. Biochem.
Biophys. 128, 704.
Boyd, G.S. & Trzeciak, W.H. (1973). Ann. N.Y. Acad. Sci.
212, 361.
Brady, R.O. (1951). J. Biol. Chem. 193, 145.
Brown, J., McLean, P. & Greenbaum, A.L. (1966). Biochem. J.
lOl, 197.
Brownie, A.C. & Grant, J.K. (1954). Biochem. J. 57, 255.
Brownie, A.C., Simpson, E.R., Jefcoate, C.R., Boyd, G.S.,
Orme-Johnson, W.H. & Beinert, H. (1972). Biochem.
Biophys. Res. Comm. 46, 483.
Bryson, M.J. & Sweat, M.L. (1968). J. Biol. Chem. 243. 2799.
Burstein, S., Co, N., Gut, M., Schleyer, H., Cooper, D.Y. &
Rosenthal, O. (1972). Biochemistry 11, 573.
Burstein, S. & Dorfman, R.I. (1963). J. Biol. Chem. 238, 1656.
Burstein, S. & Dorfman, R.I. (1962). Acta Endcorinol. 40, 188.
Burstein, S. & Fajer, A.B. (1965). Endocrinology 77, 361.
Burstein, S. & Gut, M. (1969). Steroids-14, 207.
Burstein, S. & Gut, M. (1971). Rec. Prog. Horm. Res. E7, 303.
Burstein, S. , Kimball, H.L. & Gut, M. (1970a). Steroids JL5, 809
Burstein, S., Zamoscianyk, H., Co, N., Adelson, M., Prasad, D.S.
Greenberg, A. & Gut, M. (1971). Biochim. Biophys. Acta
231, 223.
- 191 -
Burstein, S. , Zamoscianyk, H., Kimball, H.L., Chaudhuri, N.K.
& Gut, M. (1970b). Steroids 15, 13.
Cammer, W. & Estabrook, R.W. (1967a). Arch. Biochem. Biophys.
122, 735.
Camner, W. & Estabrook, R.W. (1967b). Arch. Biochem. Biophys.
_ 122, 721.
Cammer, W. , Schenkman, J.B. & Estabrook, R.W. (1966). Biochem.
Biophys. Res. Comm. 23, 264.
Cardini, G. & Jurtshuk, P. (1970). J. Biol. Chem. 245, 2789.
Carpenter, M.P. (1971). Biochim. Biophys. Acta 231, 52.
Carpenter, M.P. & Wisman, B. (1970). Fed. Proc. 2j), 248.
Cash, R., Brough, A.J., Cohen, M.N.P. & Satoh, P.S. (1967).
J. Clin. Endocrinol. 27, 1239.
Chance, B. (1956). Advan. Enzymol. 17, 65.
Chance, B. & Hess1, B. (1959). J. Biol. Chera. 234. 2413.
Chance, B. & Williams, G.R. (1955). J. Biol. Chem. 217, 395.
Chance, B. & Williams, G.R. (1955b). J. Biol. Chem. 217. 383.
Chart, J.J. & Sheppard, H.J. (1959). Med. Pharm. Chem. jL, 407.
Cheng, S.C. & Harding, B.W. (1973). J. Biol. Chem. 248, 7263.
Christensen, A.K. (1965). J. Cell Biol. 26, 911.
Christensen, A.K. &.Gillim, S.W. (1969). In: The Gonads
(K. W. McKerns, ed.), North-Holland Publ. Co., Amsterdam, p41!
Christensen, A.K. & Mason, N.R. (1965). Endocrinology 7j6, 646.
Claesson, L. (1954). Acta Physiol. Scand. 31 (Suppl. 113), 53.
Clegg, E.J. (1966). J. Anat. lOO, 369.
Clermont, Y. & Harvey, S.C. (1967). Ciba Foundation Colloq.
Endocrin. 1_6, 173.
Clermont, Y. & Morgentaler, H. (1955). Endocrinology 57, 369.
Coffey, J.C., French, F.S. & Nayfeh, S.N. (1971). Endocrinology
89, 865.
- 192 -
Connell, G.M. & Eik-Nes, K.B. (1968). Steroids 12, 507.
Conrad, H.E., Dubus, R. , Namtiredt, M.J. & Gunsalus, I.C.
(1965). J. Biol. Chem. 240, 495.
Constantopoulos, G., Satoh, P.S. & Tchen, T.T. (1962).
Biochem. Biophys. Res. Comm. 8, 50.
Constantopoulos, G.,& Tchen, T.T. (1961). J. Biol. Chem.
236, 65.
Cooke, B.A., Van Beurden, W.M.O., Rommerts, F.F.G. &
Van der Molen, H.J. (1972a). FEBS Letts. 25, 83.
Cooke, B.A., De Jong, F.H., Van der Molen, H.J. & Rommerts, F.F.G
(1972b). Nature New Biology 237, 255.
Cooper, D.Y., Schleyer, H., Estabrook, R.W. & Rosenthal, O.
(1968). Progress in Endocrinology, Proc. Illrd Internat.
Congr. Endocrin. (C. Gual, ed.). Amsterdam: Excerpta
Medica Found., p.784.
Cooper, D.Y. , Narasimhulu, S. , Slade, A., Raich, VJ. , Foroffy 0.
& Rosenthal, O. (1965). Life Sci. 4, 2109.
Dailey, R.E., Swell, L. & Treadwell, C.R. (1963). Arch. Bio'chem.
Biophys. IPO, 360.
D'Angelo, S.A. & Grodin, J.M. (1964). Endocrinology 74, 509.
Davis, T.E., Lipsett, M.B. & Korenman, S.G. (1965). J. Clin.
Endocrinol. 2_5, 476.
Davis, W.W. & Garren, L.D. (1966). Biochem. Biophys. Res.
Comm. 24, 805.
Deane, H.W., Shaw, J.H. & Greep, R.O. (1948). Endocrinology
43, 133.
De Kretser, D.M., Catt, K.J. & Paulsen, C.A. (1971).
Endocrinology f38, 332.
Dexter, R.N., Fishman, L.M., Ney, R.L. & Liddle, G.W. (1967).
J. Clin. Endocrin. 27, 473.
Dixon, R., Vincent, V. & Kase, N. (1965). Steroids _6, 757.
Dominguez, O.V., Samuels, L.T. & Huseby, R.A. (1958). Ciba
Found. Colloq. Endocr. 12, 231.
- 193 -
Dorfman, R.I. (I960). In: Biological Activities of Steroids
In Relation to Cancer (G. Pincus & E. P. Vollmer, eds.),
Academic Press, N.Y., p.445.
Dorfman, R.I. & Shipley, R.A. (1956). Androgens, Wiley, New York.
Dorfman, R.I. & Ungar, F. (1965). In: Metabolism of Steroid
__ Hormones, N.Y. Academic Press, p.414.
Dorrington, J.H., Vernon, R.G. & Fritz, I.B. (1972). Biochem.
Biophys. Res. Comm. 46^, 1523.
Drosdowsky, M., Menon, K.M.J., Forchielli, E. & Dorfman, R.I.
(1965). Biochim. Biophys. Acta 104, 229.
Drucker, W.D. & Christy, N.P. (1963). Med. Clin. N. Amer.
47. 663.
Dufau, M.L., Catt, K.J. & Tsuruhara, T. (1971a). Biochim.
Biophys. Acta 252, 574.
Dufau, M.L., Catt, K.J. & Tsuruhara, T. (1972). Endocrinology
A
90, 1032.
Dufau, M.L., De Kretser, D.M. & Hudson, B. (1971b).
Endocrinology 8j3, 825.
Eik-Nes, K.B. (1962). Endocrinology 7_1, 101.
Eik-Nes, K.B. (1964a). Physiol. Rev. 44_, 4849.
Eik-Nes, K.B. (1964b). Canad. J. Physiol. Pharmacol. 42, 671.
Eik-Nes, K.B. (1967). J. Reprod. Fert., Suppl. 2. 125.
Eik-Nes, K.B. (1969). Gen. Comp. Endocrinol., Suppl.2. 87.
Eik-Nes, K.B. (1971). Rec. Prog. Horm. Res. 27, 517.
Eik-Nes, K.B. & Brizzee, K.R. (1956). Amer. J. Physiol. 184, 371
Eik-Nes, K.B. & Hall, P.F. (1965a). Vitamins & Hormones 23, 153.
Eik-Nes, K.B. & Hall, P.F. (1965b). J. Reprod. Fert. 9, 233.
Eik-Nes, K.B. & Kekre, M. (1963). Biochim. Biophys. Acta
78, 449.
Ellis, L.C. (1969). In: The Gonads (K.W. McKerns, ed.).
North-Holland Publ. Co., Amsterdam, p.54Q.
- 194 -
Ellis, L.C. (1972). Endocrinology 90, 17.
Ellis, L.C. & Berliner, D.L. (1965). Endocrinology 7j6, 591.
Ellis, L.C. & Berliner, D.L. (1969). In: The Gonads
(K.W. McKerns, ed.). North-Holland Publ. Co., Amsterdam,
pp.739, 740, 775.
Ellis, S. (1961). Endocrinology 6iS, 334.
Ericsson, R.J. & Dutt, R.H. (1965). Endocrinology 77, 203.
Estabrook, R.W. (1967). In: Methods in Enzymology
(R.W. Estabrook & M.E. Pullman, eds.). Academic Press,
N.Y., lO, p.41.
Estabrook, R.W., Baron, J., Franklin, M.R., Mason, I., Waterman M
& Peterson, J. (1972b). Molecular Basis of Electron
Transport 4, 197.
Estabrook, R.W., Baron, J. & Hildebrandt, A.G. (1971c).
Chem. Biol. Interaction 3, 260.
Estabrook, R.W., Baron, J., Peterson, J. & Ishimura, Y. (1972a).
"Biological Hydroxylation Mechanism", In: Biochemical
Society Symposium No.34 (G.S. Boyd &K.M.S. Smellie, eds.).
Academic Press, London, p.159.
Estabrook, R.W., Cooper, D.Y. & Rosenthal, O., (1963).
Biochem. Z., 338, 271; 741.
Estabrook, R.W., Franklin, M.R., Cohen, B., Shigamatzu, A.
& Hildebrandt, A.G. (1971b). Metabolism 20, 187.
Estabrook, R.W., Hildebrandt, A.G., Baron, J., Netter, K.J.
& Leibman, K. (1971a). Biochem. Biophys. Res. Comm. 42, 132
Estabrook, R.W. & Holowinsky, A. (1961). J. Biophys. Biochem.
Cytol. £, 19.
Estabrook, R.W., Matsubara, T., Mason, I., Werringloer, J. &
Baron, J. (1973). Drug Metab. & Disposition 1_, 98.
Everett, J.W. (1945). Amer. J. Anat. 77, 293.
Ewing, L.L., Green, P.M. & Stebler, A.M. (1965). Proc. Soc.
Exptl. Biol. Med. 118, 911.
- 195 -
Farese, R.V.,(1970). Steroids L5, 245.
Fariss, B.L. , Hurley, T.J., Hane, S. & Forsham, P.H. (1969).
Endocrinology 84, 940.
Fawcett, D.W., Heidger, P.M. & Leak, L.V. (1969). J. Reprod.
Fert. 19, 109.
-Fawcett, D.W. , Leak, L.V. & Heidger, P.M. (197Q). J. Reprod.
Fert. Suppl. IP, 105.
Fawcett, D.W., Long, J.A. & Jone, A.L. (1969). Rec. Prog.
Horm. Res. 2jj, 315.
Ferrari, R.A. & Arnold, A. (1963). Bioc'nim. Biophys. Acta
77, 349 and 357.
Ficher, M. & Steinberger, E. (1968). Steroids 1_2, 491.
Ficher, M. & Steinberger, E. (1971). Acta Endocrin. (Kbh)
68, 285.
Fishman, L.M. , S?;rfaty, G.A. , Wilson, H. & Lipsett, M.B.
(1967). Ciba Found. Colloq. Endocr. 16, 156.
Flint, A.P.F. & Armstrong, D.T. (1971a). Nature 231, NB 60.
Flint, A.P.F. & Armstrong, D.T. (1971b). Biochem. J. 123, 143.
Flint, A.P.F., Grindwich, D.L. & Armstrong, D.T. (1973).
Biochem. J. 132, 313.
Forchielli, E. (1969). In: Methods in Enzymology
(R.W. Estabrook & M.E. Pullman, eds.). Academic Press,
New York, 15, 585.
Forchielli, E. , Menon, K.M.J. & Dorfman, R.I. (1969). In:
The Gonads (K.W. McKerns, ed.). North-Holland Publ. Co.,
Amsterdam, p.519.
Frowein, J. (1973). J. Endocrinol. 57, 437.
Garren, L.D., Gill, G.N., Masui, H. & Walton, G.M. (1971).
Rec. Prog. Horm. Res. 27^, 433.
Garren, L.D., Ney, R.L. & Davis, W.W. (1965). Proc. Nat.
Acad. Sci. 53;, 1443.
- 196 -
Gaunt, R., Gisoldi, E., Smith, N., Steinetz, E.G. & Chart, J
(1970). Endocrinology 87, 1088.
Gaunt, R., Steinetz, E.G. & Chart, J.J. (1968). Clin. Pharm
Therap. 9, 657.
Goldberg, B., Jones, G.E.S. & Borkowf, H.I. (1964).
J. Histochem. Cytochem. JL2, 880.
Goldman, A.S. (1967). J. Clin. Endocr. 27, 320.
Goldman, A.S. (1970). 21 Colloq. des Desellschaft fur
Biologische Chemie, Springer Verlag, Berlin, p.389.
Goldman, A.S., Bongiovanni, A.M. & Yakovac, W.C. (1966a).
Proc. Soc. Expt. Biol. 121, 757.
Goldman, A.S., Yakovac, W.C. & Bongiovanni, A.M. (1965).
Endocrinology 77_, 1105.
Goldman, A.S., Yakovac, W.C. & Bongiovanni, A.M. (1966b).
J. Clin. Endocrin. 2_6, 14.
Goldzieher, J.W., Rawls, W.B. & Goldzieher, M.A. (1953).
Endocrinology 52, 586.
Goldzieher, J.W. & Roberts, I.S. (1952). J. Clin. Endocrin.
Metab. 12, 143.
Gomari, G. (1942). J. Lab. Clin. Med. 27, 955.
Goodman, D.S. & Shiratori, T. (1964). J. Lipid Res. _5, 575,
Gorski, J. & Padnos, D. (1966). Arch. Biochem. Biophys.
113, lOO.
Graham, J.M. & Green, C. (1970). Europ. J. Biochem. _12, 58
Green, D.E. (1963). J. Biol. Chem. 238, 975.
Greengard, P., Psychoyos, S., Tallan, H.H., Cooper, D.Y.,
Rosenthal. O. & Estabrook, R.W. (1967). Arch. Biochem
Biophys. 121, 298.
Greep, R.O. & Fevold, H.L. (1937). Endocrinology _2l, 611.
Greep, R.O., Fevold, H.L. & Hisaw, F.L. (1936). Anat. Rec.
65, 261.
- 197 -
Griffin, B.W. & Peterson, J.A. (1972). Biochem. JLl, 4740.
Grosso, L.L. & Ungar, F. (1964). Steroids 3, 67.
Grota, L.J. & Eik-Nes, K.B. (1967). J. Reprod. Fert. 13, 83.
Gual, C., Sanchez, J., Dorfman, R.I. & Rosenthal, I.M. (1962).
J. Clin. Endocrin. £2, 1040.
Gunsalus, I.C., Tyson, C.A., Tsai, R. & Lipscomb, J.D. (1971).
Chem. Biol. Interactions, 41^, 75.
Gunsalus, I.C., Tyson, C.A. & Lipscomb, J.D. (1973). In:
Oxidases and Related Redox Systems (T.E. King, H.S. Mason
& M. Morrison, eds.). Proc. 2nd Int. Symp., University
Park Press, Baltimore, Md., p.583.
Gurpide, E. , Macdonald, P.C., Chapdelaine, A., Vande Wiele, R.L.
& Lieberman, S. (1965). J. Clin. Endocr. Metab. 25, 1537.
Hafie?, A.A«>, Philpott, J.E. & Bartke, A.' (1971).; J. Endocr.
12, 619. *
Hagen, A.A. & Eik-Nes, K.B. (1964). Biochim. Biophys. Acta
86, 372.
Haksar, A. & Peron, F.G. (1972). Biochem. Biophys. Res. Comm.
47, 445.
Halkerston, I.D.K., Eichhorn, J. & Hechter, O. (1961).
J. Biol. Chem. 236, 374.
Hall, P.F. (1964). Endocrinology 74, 201.
Hall, P.F. (1966). Endocrinology 78, 690.
Hall, P.F. .(1967a). Biochem. Biophys. Res. Comm. 26, 320.
Hall, P.F. (1967b). Biochemistry 6, 2794.
Hall, P.F, (1969). In: The Gonads (K.W. McKerns, ed.).
North-Holland Publ. Co., Amsterdam, p.15.
Hall, P.F. (1970a). In: The Testes (A.D. Johnson, W.R. Gomes
& N.L. Vandemark, eds.). Academic Press, New York,
11, p.1-70.
Hall, P.F. & Eik-Nes, K.B. (1962). Biochim. Biophys. Acta
63, 411.
- 198 -
Hall, P.F., Irby, D.C. & de Kretser, D.W. (1969).
Endocrinology 8_4, 488.
Hall, P.F. & Koritz, S.B. (1964a). Biochim. Biophys. Acta
93, 441.
Hall, P.F. & Koritz, S.B. (1964b). Biochemistry 3, 129.
Hall, P.F., Sozer, C.C. & Eik-Nes, K.B. (1964). Endocrinology
74, 35.
Hall, P.F. & Young, D.G. (1968). Endocrinology 82, 559.
Harding, B.W., Bell, J.J., Oldham, S.B. & Wilson, L.D. (1968).
In: Functions of the Adrenal Cortex (K.W. McKerns, ed.).
Appleton, N.Y., II, p.831.
Harding, B.W., Bell, J.J., Wilson, I.D. & Whysner, J.A. (1969).
Adv. Enzy. Reg. 7_, 237.
Harding, B.W., Rutherford, E.R. & Nelson, D.H. (1961).
43rd Endocrine Soc. meeting, New York, Abs. 84.
:d)
Harding, B.W., Wilson, L.D., Wong, S.H. & Nelson, D.H. (1965).
Steroids, Supp1. II, 51.
Harding, B.W. , Whysner, J., Cheng, S.C. & Ramseyer, J. (1970).
Proc. 3rd Int. Congr. Hormonal Steroids, Hamburg, Ser. 219,
p.294. Excerpta Medica Foundation, N.Y.
Harding, B.W., Wong, S.H. & Nelson, D.H. (1964). Biochim.
Biophys. Acta 92_, 415.
Harding, B.W. & Nelson, D.H. (1966). J. Biol. Chem. 241, 2212.
Hashimoto, I. & Suzuki, Y. (1968). Endocr. Jap. ]L3, 326.
Haynes, R.C. (1958). J. Biol. Chem. 233, 1220.
Helinski, D.R.-& Cooper, O. (I960). J. Biol. Chem. 235, 3573.
Heller, C.G., Lalli, M.F., Pearson, J.E. & Leach, D.R. (1971).
J. Reprod. Fert. 2_5, 177.
Hermier, C. & Jutisz, M. (1969). Biochim. Biophys. Acta
192, 96.
Hermier, C., Combarnous, Y. & Jutisz, M. (1971). Biochim.
Biophys. Acta 244, 625.
- 199 -
Hildebrandt, A.G. (1972). In; Biological Hydroxylation
Mechanisms; Biochemical Society Symposium No.34.
(G.S. Boyd & M.S. Smellie, eds.). Academic Press,
London, p.79.
Hildebrandt, A.G. & Estabrook, R.W. (1971). Arch. Biochem.
Biophys. 143, 66.
Hildebrandt, A.G., Leibman, K.C. & Estabrook, R.W. (1969).
Biochem. Biophys. Res. Comm. 37, 477.
Hirshfield, I.N. & Koritz, S.B. (1964). Biochemistry 3, 1994.
Hirshfield, I.N. & Koritz, S.B. (1966). Endocrinology 7£5, 165.
Hitzeman, J.W. (1962). Anat. Rec. 143, 351.
Hochberg, R.B., Mickan, H. & Lieberman, S. (1971). Biochim.
Biophys. Acta 231, 208.
Hochberg, R.B., McDonald, P.D., Feldman, M. & Lieberman, S.
(1974). J. Biol. Chem. 249, 1277.
Horie, S. , Kinoshita, T. & Shimazono, N. (1966). J. Biochem.
(Tokyo), 60, 66G.
Horton, R. & Tait, J.F. (1967). J. Clin. Endocr. 27, 79.
Hoschoian, J.C. & Brownie, A.C. (1967). Steroids lO, 49.
Hrycay, E.G. & O'Brien, P.J. (1971). Biochem. J. 125, 12P.
Huggins, C. & Moulder, P.V. (1945). Cancer Res. fj, 510.
Huhtaniemi, I., Ikonen, M. & Vihko, R. (1970). Biochem.
Biophys. Res. Comm. 38, 715.
Ibayashi, H., Nakamura, M., Uchikawa, T., Murakawa, S.,
Yoshida, S., Nakao, R. & Okinawa, S. (1965). Endocrinology
76, 347.
Ichii, S. , Forchielli, E. & Dorfman, R.I. (1963). Steroids
2, 631.
Ichii, S. , Omato, S. & Kobayashi, S. (1967). Biochim.
Biophys. A.cta 139, 308.
- 200 -
Ichii, S. , Yago, N., Kobayashi, S. & Omato, S. (1967).
J. Biochem. (Tokyo) _62, 740.
Ichikawa, Y. & Yamano, T. (1967). Arch. Biochem. Biophys.
121 , 742.
Ichikawa, Y. & Yamano, T. (1967b). Biochim. Biophys. Acta
131, 490.
Imai , Y. & Sato, R. (1966). Biochem. Biophys. Res. Comm.
22, 620.
Inaba, M. , Nakao, T. & Kamata, K. (1967). Endocr. Jap. 14_, 1.
Inano, H., Egusa, M. & Tamaoki, B. (1967a). Biochim. Biophys.
Acta 144, 165.
Inano, H., Hori, Y. & Tamaoki, B. (1967c). Ciba Found. Colloq.
Endocr. _16, 105.
Inano, H., Inano, A. & Tamaoki, B. (1970). J. Steroid Biochem.
1, 83.
Inano, H., Machino, A., Tamaoki, B. & Tsubura, Y. (1968).
Endocrinology j83, 659.
Inano, H., Nakano, H., Shikita, M. & Tamaoki, B. (1967b).
Biochim. Biophys. Acta 137, 540.
Inano, H. & Tamaoki, B. (1966). Endocrinology 79^, 579.
Inano, H. & Tamaoki, B. (1968a). Endocr. Jap. 1_5, 197.
Ishimura, Y., Ulbrich, V. & Peterson, J.A. (1971). Biochem.
Biophys. Res. Comm. 42, 140.
Ito, M. (1966). Radiat. Res. 28., 266.
Jao, J. & Koritz, S.B. (1962). Metab. Clin. Exptl. 11, 1302.
Jeanes, A., Wise, C.S. & Dimler, R.S. (1951). Anal. Chem.
23, 415.
Jefcoate, C.R. & Boyd, G.S. (1971). FEBS Letts. 12, 279.
Jefcoate, C.R., Hume, R. & Boyd, G.S. (1970). FEBS Letts.
9, 41.
Jefcoate, C.R. & Gaylor, J.L. (1970). Biochemistry £, 3816.
- 201 -
Jefcoate, C.R., Gaylor, J.L. & Calabrese, R.L. (1969).
Biochemistry 8, 34-55.
Jefcoate, C.R., Simpson, E.R. & Boyd, G.S. (1974). Eur. J.
Biochem. 42, 539.
Jefcoate, C.R., Simpson, E.R., Boyd, G.S., Brownie, A.C. &
— Orme-Johnson, W.H. (1973). Ann. N.Y. Acad. Sci. 212,243.
Johnsen, S.G. (1969). Acta Endocr. <51, 111.
Johnson, A.D. (1970). In: The Testis (A.D. Johnson,
W.R. Gomes & N.L. Vandemark, eds.). Acad. Press, New York,
II, p.224.
De Jong, F.H. , Hey, A.H. & Van der Molen, H.J. (1973).
J. Endocr. 57_, 277.
Jost, A. (1965). In: Organogenesis (R. L. De Hann &
H. Ursprung, eds.). Halt, Rinehart & Winston, New York,
p.611.
f ■
Jungmann, R.A. (1968a). Biochim. Biophys. Acta 164, HO.
Jungmann, R.A. (1968b). Ster oids 205.
Jungmann, R.A. & Scheppe, J.S. (1969). 3rd Int. Congr.
Hormonal Steroids, abstract 215, p.107.
Kadioglu, D. & Harrison, R.G. (1971). J. Anat. 110, 283.
Kahnt, F.W. & Neher, R. (1966). Helv. Chim. Acta 49, 725.
Kahnt, F.W., Neher, R., Schmid, K. & Wettstein, A. (1961).
Experientia 17, 19.
Kahnt, F.W. & Wettstein, A. (1951). Helv. Chim. Acta 34, 1790.
Kahnt, F.W., Milani, A., Steffen, H. & Neher, R. (1974).
Eur. J. Biochem. 44_, 243.
Kaplan, N.O., Colowick, S.P. & Neufeld, E.F. (1952). J. Biol.
Chem. 195, 107.
Kaplan, N.O., Colowick, S.P. & Neufeld, E.F. (1953). J. Biol.
Chem. 205, 1.
Kelch, R.P., Jenner, M.R., Weinstein, R., Kaplan, S.L. &
Grumbach, M.M. (1972). J. Clin. Invest. 51, 824„
- 202 -
Kimura, T. & Suzuki, K. (1967). J. Biol. Chem. 242, 485.
Kimura, T. & Suzuki, K. (1965). Biochem. Biophys. Res. Comm.
2Q, 373.
Kinoshita, T., Horie, S., Shimazono, N. & Yohro, T. (1966).
J. Biochem. (Tokyo) 60, 391.
Knorr, D.W., Vanha-Perttula, T. & Lipsett, M.B. (1970).
Endocrinology 86, 1298.
Kobayashi, I. & Ichii, S. (1967). Endocrinol. Jap. 14, 134.
Kodani, M. & Kodani, K. (1966). Proc. Natl. Acad. Sci. j56, 1200.
Koritz, S.B. (1962). Biochim. Biophys. Acta 5_6, 63.
Koritz, S.B. (1966). Biochem. Biophys. Res. Comm. 23, 485.
Koritz, S.B. & Hall, P.F. (1964a). Biochim. Biophys. Acta
93, 215.
Koritz, S.B. & Hall, P.F. (1964b). Biochemistry 3, 1298.
Koritz, S.B. & Peron, F.G. (1958). J. Biol. Chem. 23Q, 343.
Koritz, S.B. & Kumar, A.M. (1970). J. Biol. Chem., 245, 152.
Kowal, J. (1969a). Endocrinology 8_5, 270.
Kowal, J. (1970). Rec. Prog. Horm. Res. 26, 623.
Kowal, J., Simpson, E.R. & Estabrook, R.W. (1970). J. Biol.
Chem. 245, 2438.
Kraaipoel, R.J., Denenhart, H.J,, Leferink, J.G., Van Beck, V.,
de Leeuw-Boon, H. & Visser, H.K.A. (1974). J. Steroid
Biochem. _5, 308 (Abstract) .
Krum, A.A., Morris, M.D. & Bennett, L.L. (1964). Endocrinology
74, 543.
Kuehl, F.A., Patanelli, D.J., Tarnoff, J. & Humes, J.L. (1970).
Biol. Reprod. 2_, 154.
Lacy, D. (1967). Endeavour 2j6, 101.
Lacy, D. & Pettitt, A.J. (1970). Br. Med. Bull. 26, 87.
- 203 -
Lacy, D., Vinson, G.P., Collins, P., Bell, J., Fyson, P.
& Pettitt, A.J. (1968). Proc. 3rd. Int. Congr. of
Endocr., Mexico, p.1019.
Lazarow, A. (1954). In: Glutathione (S. Colowick, ed.).
Academic Press, N.Y., p.231.
Leach, R.B. , Maddock, W.O., Tokuyama, I., Paulson, C.A. &
Nelson, W.O. (1956). Rec. Prog. Horm. Res. L2, 377.
Lehninger, A.L. (1965). In: The Mitochondrion
(W.A. Benjamin, ed.). N.Y., Amsterdam, Chapter 7.
Levin, S.S., Touchstone, J.C. & Murawec, T. (1969). J. Chromatog,
42, 129.
Levy, H., Deane, H.W. & Rubin, B.L. (1959). Endocrinology,
65, 932.
Lewis, L.G. & Stockard, C.G. (1950). J. Urol. 64, 518.
Lieberman, S., Bandy, L., Lippman, V. & Roberts, K.D. (1969).
Biochem. Bio'phys. Res. Comm. 34, 367.
Liddle, G.W., Island, D., Lance, E.M. & Harris, A.P. (1958).
J. Clin. Endocr. 1_8, 906.
Limanowski, A. & Miskowiak, B. (1972). Polish Endocrin. 23^, 186.
Lindner, H.R. (1966). Proc. 2nd Int. Congr. Hormonal Steroids,
Excerpta Medica Int. Congr. Ser. No.132, 821.
Lindner, H.R. (1968). Proc. 3rd Int. Congr. Endocrin., Mexico.
Excerpta Medica Int. Congr. Ser. No.184, 999.
Lindner, H.R. (1969). In: The Gonads (K.W. McKerns, ed.).
North-Holland Publ. Co., Amsterdam, p.615.
Lindner, H.R. (1961a). J. Endocr. 23, 171.
Lindner, H.R. (1961b). J. Endocr. 23, 139.
Lindner, H.R. & Mann, T. (I960). J. Endocr. 2JL, 341.
Lindenmayer, A. & Smith, L. (1964). Biochim. Biophys. Acta
93, 445.
Lipsett, M.B. (1970). In: The Human Testis (E. Rosenberg &
C.A. Paulsen, eds.). Plenum Press, New York, p.407.
- 204 -
Lipsett, M.B. & Tullner, W.W. (1965). Endocrinology 77, 273.
Lisboa, B.P. (1963). Acta Endocrin. 43, 47.
Lisboa, B.P. (1965). J. Chromatog. lj), 333.
Lisboa, B.P. & Palmer, R.F. (1967). Anal. Biochem. 20, 186.
Longcope, C. , Kato, T. & Horton, R. (1969). J. Clin. Invest.
48, 2191.
Lowry, O.H. , Rosebrough, N.J., Farr, A.L. & Randall, R.J.
(1951). J. Biol. Chem. 193, 265.
Ludwig, D.J. (1950). Endocrinology 46, 453.
Luttrel, B. , Hochberg, R.B., Dixon, R.W., McDonald, P.D. &
Lieberman, S. (1972). J. Biol. Chem. 247, 1462.
Lynn, W.S. & Brown, R.H. (1958). J. Biol. Chem. 232, 1015.
McCarthy, J.L., Rietz, C.W. & Wesson, L.K. (1966).
Endocrinology 7_9, 1123.
MacDonald, P.C. (1971). In: Control of Gonadol Steroid
Secretion (D.T. Baird, J.A. Strong, eds.). Edinburgh
University Press, Edinburgh, p.157.
MacDonald, P.C., Rombaut, R.P. & Siiteri, P.K. (1967).
J. Clin. Endocr. Metab. 27, 1103.
"
- ■- ■ tr*.. dr
Mcintosh, E.N., Uzgiris, V.I., Alonso, C. S< Salhanick, H.A.
(1971). Biochemistry 10, 2909.
Mcintosh, E.N. & Salhanick, H.A. (1969). Biochem. Biophys. Res.
Comm. 3j6, 552.
McKerns, K.W. (1964). Biochim. Biophys. Acta 90, 357.
McKerns, K.W. (1969). In: The Gonads (K.W. McKerns, ed.).
Appleton-Century Crofts, N.Y., pi.137.
Machino, A. ,.Inano, H..& Tamaoki, B. (1969). J. Steroid
Biochem. 1^, 9.
Maddock, W.O. & Nelson, W.O. (1952). J. Clin. Endocr. Metab.
12, 985.
- 205 -
Mann, T., Rowson, L.E.A.&Hay, M.F. (I960). J. Endocrin.
21, 361.
Manners, M.J., Kidder, D.E. & Parsons, P.M. (1969).
J. Chroraatog. <L3, 276.
Marcus, P.I. & Talalay, P. (1956). J. Biol. Chem. 218, 661.
Marsh, J.M. (1970). FEBS Letts. 7, 283.
Mason, J.I. (1970). Ph.D. Thesis, University of Edinburgh.
Mason, J.I. & Boyd, G.S. (1971). Eur. J. Biochem. 21, 308.
Mason, J.I., Estabrook, R.W. & Purvis, J.L. (1973). Ann. N.Y.
Acad. Sci. 212, 406.
Mason, H.S., North, J.C. & Vanneste, M. (1965). Fed. Proc.
24, 1172.
Mason, K.E. & Shaver, S.L. (1952). Ann. N.Y. Acad. Sci. _55, 585.
Mason, N.R. & Savard, K. (1964). Endocrinology, 7_4, 664.
Masters, B.S.S., JBaron, J., Taylor, W.E., Isaacson, E.L. &
Lo Spalluto, J. (1971). J. Biol. Chem. 246, 4143.
Matsuyama, H., Ruhmann-Wennhold, A. & Nelson, D.H. (1971).
Endocrinology J38, 692
Meigs, R.A. & Ryan, K.J. (1968). Biochim. Biophys. Acta
165, 476.
Menard, R.H. & Purvis, J. (1972). Endocrinology 9JL, 1506.
Menon, K.M.J., Dorfman, R.I. & Forchielli, E. (1967).
Biochim. Biophys. Acta 148, 486.
Menon, K.M.J., Dorfman, R.I. & Forchielli, E. (1965a).
Steroids. Suppl. 2, 165.
Menon, K.M.J., Drosdowsky, M., Dorfman, R.I. & Forchielli, E.
(196 5b). Steroids., Suppl. 1, 95.
Michael, C.M. (1973). Lipids,*?, 92.
Mitani, F. & Horie, S. (1969). J. Biochem. (Tokyo) 6(3, 139.
Mitton, J.R. (1967). Ph.D. Thesis, University of Edinburgh.
- 206 -
Morris, L.J. (1963). J. Lipid Res. 4, 357.
Morris, M.D. & Chaikoff, I.L. (1959). J. Biol. Chem. 234, 1095.
Morrison, G., Meigs, R.A. & Ryan, K.J. (1965). Steroids 6,
Suppl. II, 177.
Moudga.1, N.R., Moyle, W.R. & Greep, 0. (1971). J. Biol. Chem.
_ 246, 4983.
Moyle, W.R. & Armstrong, D.T. (1970). Steroids _15, 681.
Moyle, W.R., Jungas, R.L. & Greep, O. (1973). Biochem. J.
134, 407 & 415.
Moyle, W.R., Moudgal, N.R. & Greep, R.O. (1971). J. Biol.
Chem. 246, 4978.
Moyle, W.R. & Ramachandran, J. (1973). Endocrinology 93, 127.
Murad, F., Strauch, B.S. & Vaughan, M. (1969). Biochim.
Biophys. Acta 177, 591.
Murota, S., Shik:Vta, M. & Tamaoki, B. (1965). Steroids, 5, 409.
Musto, N., Hafiez, A.A. & Bartke, A. (1972). Endocrinology
91, 1106.
Nakano, H., Inano, H., Sato, H, Shikita, M. & Tamaoki, B.
(1967). Biochim. Biophys. Acta 137, 335.
Nakano, H., Sato, H. & Tamaoki, B. (1966). Biochem. "Biophys.
Res. Comm. 2_2, 425.
Nakano, H. , Takemoto, C., Sato, H. & Tamaoki, B. (1968).
Biochim. Biophys. Acta 152, 186.
Nayfeh, S.N., Barefoot, Jr., S.W. & Baggett, B. (1966).
Endocrinology 78, 1041.
Neher, R. & Kahnt, F.W. (1965). Experientia 21, 310.
Neville, A.M. & Engel , L.L. (1968). J. Clin. Endocrin. 29, 49.
• Niemi, M, & Ikonen,.M,. (1963). Endocrinology 72_, 443.
Niemi, M. & Ikonen, M. (1961). Nature, 189, 592.
Niemi, M. & Ikonen, M. (1962). Endocrinology 70, 167.
- 207 -
Niemi, M. & Kormano, M. (1964). Endocrinology 7_4, 996.
Niemi, M. & ICormano, M. (1965). Anat. Rec. 151, 159.
Notation, A.D. & Ungar, F. (1968). Canad. J. Biochem. 46, 1185.
Notation, A.D. & Ungar, F. (1969a). Biochem. £3, 501.
Notation, A.D. & Ungar, F. (1969b). Steroids 14, 151.
Notation, A.D. & Ungar, F. (1972). Endocrinology 90, 1537.
Noumura, T., Weisz, J. & Lloyd, C.W. (1966). Endocrinology
78, 245.
Oakberg, E.F. (1959). Radiat. Res. 11, 700.
Oh, R. & Tamaoki, B. (1970). Acta Endocr. (Kbh) 64, 1.
Oh, R. & Tamaoki, B. (1971). Acta Endocr. (Kbh) 67, 665.
Oh, R. & Tamaoki, B. (1973). Acta Endocr. (Kbh) 72, 366.
Ohno, H., Suzuki, K. & Kimura, T. (1967). Biochem. Biophys.
Res. Comm. 2_6, 651.
Oleinick, N.L. & Koritz, S.B. (1966). Biochim. Biophys. Acta
122, 333.
Omura, T., Sanders, E., Estabrook, R.W., Cooper, D.Y. &
Rosenthal, O. (1966). Arch. Biochem. Biophys. 117, 660.
Omura, T. & Sato, R. (1964a). J. Biol. Chem. 239, 2370.
Omura, T. & Sato, R. (1964b). J. Biol. Chem. 239, 2379.
Omura, T. Sato, R. , Cooper, D.Y., Rosenthal, 0. & Estabrook, R.
(1965). Fed. Proc. 24, 1181.
Oshima, H., Sarada, T., Ochiai, K. & Tamaoki, B. (1970).
Endocrinology 86, 1215.
Packer, L. & Utsumi, K. (1969). Arch. Biochem. Biophys.
131, 386.
Parvinen, M., Hurme, P. & Niemi, M. (1970). Endocrinology
87, 1082.
Payne, A.H. & Jaffe, R.B. (1970). Endocrinology 87_, 316.
- 208 -
Payne, A.H. & Kelch, R.P. (1973). Endocrinology 92, Suppl.
(55th Annual Meeting of the Endocrine Society).
Payne, A.H. & Mason, M. (1965a). Steroids 6^, 323.
Payne, A.H. & Mason, M. (1965b). Steroids .5, 21.
Payne, A.H., Mason, M. & Jaffe, R.B. (1969). Steroids 14, 685,
Peron, F.G. & McCarthy, J.L. (1968). In: Functionsof the
Adrenal Cortex (K.W. McKerns, ed.). Appleton-Century
Crofts, New York, Vol. 1, p.261.
Peterson, J.A. (1970). J. Bacteriol. 103, 714.
Peterson, J.A. (1971). Arch. Biochem. Biophys. 144, 678.
Peterson, J.A., Ullrich, V. & Hildebrandt, A.G. (1971). Arch.
Biochem. Biophys. 145, 531.
Pierrepoint, C.G., Galley, J.M., Griffiths, K. & Grant, J.K.
(1967). J. Endocr. 3£3, 61.
Pierrepoint, C.G., Griffiths, K., Grant, K. & Stewart, J.S.So
(1966). J. Endocr. .35, 409.
Plager, J.E. & Samuels, L.T. (1954). J. Biol. Chem. 211, 21.
Pressman, B.C. & Lardy, H.A. (1956). Biochem. Biophys. Acta
21, 458.
Price, D. & Oritz, E. (1965). In: Organogenesis (R.L. De Hann
& H. Ursprung, eds.). Holt Rinehart & Winsten, New York,
p.629-652.
Pulsinelli, W.A. & Eik-Nes, K.B. (1970). Fed. Proc. Fed. Amer.
Soc. Exp. Biol. 29, 918.
Purvis, J.L., Battu, R.G. & Peron, F.G. (1968). In: Functions
of the Adrenal Cortex (K.VJ. McKerns, ed.). Appleton-Cehturj
Crofts, New York, Vol. II, p.1007.
Rabinowitz, J.L. (1956). Arch. Biochem. Biophys. 64, 285.
Rabinowitz, J.L. & Ragland, J.B. (1958). Fed. Proc. 17,
Abstract 1158.
Racela, A., Azarnoff, D. & Svoboda, D. (1969). Lab. Invest.
21, 52.
- 209 _
Raeside, J.I. (1969). Canad. J. Biochem. 47, 811.
Raheja, M.C. & Lucis, O.J. (1970). J. Endocr. 46, 21.
Ray, J.W. (1967). Biochem. Pharmacol. L6, 99.
Rebello, P.P., Pogell, B.M. & Mukherjee, P.P. (1969). Biochim.
Biophys. Acta 117, 468.
Remmer, H., Schenkman, J.B., Estabrook, R.W. , Sesame, H. ,
Gillette, J.R., Narosimhube, S., Cooper, D.Y. &
Rosenthal, 0. (1966). Mol. Pharmacol. 2, 187.
Reslco, J.A. & Eik-Nes, K.B. (1966). J. Clin. Endocr. Metab.
26, 573.
Resko, J.A., Feder, H.H. & Goy, R.W. (1968). J. Endocrin.
40, 485.
Ritter, M.C. & Dempsey, M.E. (1973). Proc. Nat. Acad. Sci.
70, 265.
Rivarola, M.A. &jPodesta, E.J. (1972). Endocrinology 90, 618.
Rivarola, M.A. & Podesta., E.J. (1973). Endocrinology 92
Suppl. (55th Annual Meeting of the Endocrine Society).
Robinson, G.A., Butcher, R.W. & Sutherland, E.W. (1971).
In: Cyclic AMP. Academic Press, New York, p.36.
Robinson, J. (1971). Ph.D. Thesis, University of Edinburgh.
Robinson, J. & Stevenson, P.M. (1971). Eur. J. Biochem. 2_4, 18.
Rommerts, F.F.G., Cooke, B.A., Van der Kemp, J.W.C.M. &
Van der Molen, H.J. (1972). FEBS Letts. 25, 83.
Roosen-Runge, E.C. & Anderson, D. (1955). Anat. Rec. 123, 385.
Roosen-Runge, E.C. & Anderson, D. (1956). Fertil. Steril. 7, 251
Roosen-Runge, E.C. & Anderson, D„ (1959). Acta Anat. 37, 125.
Rosner, J.M., Hall, P.F. & Eik-Nes, K.B. (1965). Steroids 5_, 19S
Rosner, J.M., Horita, S. & Forsham, P.H. (1964). Endocrinology
75, 299.
Rosner, J.M. & Macome, J.C. (1970). Steroids 15^, 181.
Rubin, R. , Carchman, R.A. & Jaanus, S.D. (1972). Nature 240, 15<
Rugh, R. & Grupp, E, (I960). Amer. J. Physiol. 198, 1352.
- 2 10 -
Russell, D.W. (1971). J. Biol. Chem. 246, 3870.
Ryan, K.J. & Engel, L.L. (1957). J. Biol. Chem. 225, 103.
Samuels, L.T. (1952). Ciba Found. Colloq. Endocr. 2_, 236.
Sandler, R. & Hall, P.F. (1966). Endocrinology 79, 647.
Sanzari, N.P. & Peron, F.G. (1966). Steroids 8_, 929.
Satoh, P., Constantopoulos, G. & Tchen, T.T. (1966).
Biochemistry _5, 1646.
Satre, M. , Vignais, P.V. & Idelman, S. (1969). FEBS Letts. J5, 135,
Sauer, L.A. & Mulrow, P.J. (1969). Arch. Biochem. Biophys.
134, 486.
Savard, K. & Casey, P.J. (1964). Endocrinology 74, 599.
Sayers, G. , Beall, R.J. & Seelig, S. (1972). Science 175, 1131.
Schenkman, J.B., Remitter, H. & Estabrook, R.W. (1967). Molec.
Pharmacol. 3, 113.
"7T
Schoen, E.J. (1964). Endocrinology 75, 56.
Schoen, E.J. & Samuels, L.T. (1965). Endocrinology 50, 365.
Scoon, V. & Major, P.W. (1972). J. Endocr. 54, 161.
Serra, G.B., Perez-Palacios, G. & Jaffe, R.B. (1970). J. Clin.
Endocr. 30, 128.
Settlemire, C.T., Hunter, G.R. & Brierley, G.P. (1968).
Biochim. Biophys. Acta 162, 487.
Sharma, D.C. & Gabrilove, J.L. (1971). Acta Endocr. (56, 737.
Sharma, D.C., Joshi, S.G. & Dorfman, R.I. (1967).
Endocrinology 80, 499.
Shikita, M. & Hall, P.F. (1967). Biochim. Biophys. Acta 136, 484
Shikita, M., Kakizaki, H. & Tamaoki, B. (1964). Steroids 4, 521,
Shikita, M. & Tamaoki, B. (1965),. Endocrinology 76_, 563.
Shimizu, K., Hayano, M., Gut, M. & Dorfman, R.I. (1961).
J. Biol. Chem. 236, 695.
Shimizu, K., Gut, M. & Dorfman, R.I. (1962). J. Biol. Chem.
237, 699.
- 211 -
Shimizu, K. , Shimao, S. & Tanaka, M, (1965). Steroids
Suppl. 1, 85.
Simpson, E.R. & Boyd, G.S. (1966). Biochem. Biophys. Res.
Comm. 2A_, lO.
Simpson, E.R. & Boyd, G.S. (1967a). Eur. J. Biochem. 2_, 275.
Simpson, E.R. & Boyd, G.S. (1967b). Biochem. Biophys. Res.
Comm. 2j3, 945.
Simpson, E.R., Jefcoate, C.R. & Boyd, G.S. (1971). FEBS Letts.
15, 53.
Simpson, E.R., Jefcoate, C.R., Brownie, A.C. & Boyd, G.S. (1972).
Eur. J. Biochem. 2j8, 442.
Simpson, E.R., Jefcoate, C.R., McCarthy, J.L. & Boyd, G.S.
(1974). Eur. J. Biochem. 45, 181.
Simpson, E.R., Trzeciak, W.H., McCarthy, J.L., Jefcoate, C.R.
& Boyd, G.S. (1972b). Proc. Roy. Soc. (Aberdeen).
527, 10. *
Slaunwhite, W.R. , Jr. & Burgett, M.J. (1965). Steroids (b, 721.
Slaunwhite, W.R., Jr. & Samuels, L.T. (1956). J. Biol. Chem.
220, 341.
Smilo, R.P., Earll, J.M. & Forsham, P.H. (1967). Metabolism
16, 374.
Snipes, C.A., Becker, W.G.,& Migeon, C.J. (1965). Steroids
6, 771.
Sottocasa, G.L. & Sandri, G. (1970). Biochem. J. 116, 16P
Speroff, L. & Ramwell, P.W. (1970). J. Clin. Endocr. Metab.
30, 345.
Stahl, E. (1965). In: Thin Layer Chromatography, Academic
Press, New York, p.262.
Staple, E., Lynn, W.S. & Gurin, S. (1956). J. Biol. Chem.
219, 845.
Starka, L. & Hampl, R. (1963). J. Chromatog. 12, 347.
Steinberger, A. & Steinberger, E. (1966). Expt. Cell Res. 44,
443.
- 212 -
Steinberger, E. & Ficher, M. (1968). Steroids 1_1, 351.
Steinberger, E. & Ficher, M. (1969). Biol. Reprod. ]L, 119.
Steinberger, E. & Ficher, M. (1971). Endocrinology 8_9, 679.
Steinberger, E., Steinberger, A. & Ficher, M. (1970).
Rec. Prog. Horm. Res. _26, 547.
Steinberger, E., Steinberger, A. & Vilar, 0. (1966).
Endocrinology 79_, 406.
Steinber^er, E., Steinberger, A., Vilar, 0., Salamon, I.I. &
Sud, B.N. (1967). Ciba Found. Colloq. Endocr. 1_6, 56.
Strashimirov, D., Bohus, B. & Lissak, K. (1968). Acta Physiol.
Acad. Sci. Hungaricae 33, 51.
Strehler, B., Gold, P.H., Batra, P. & Nordgren, R. (1966).
Fed. Proc. 25, 413.
Stylianou, M., Forchielli, E. & Dorfman, R.I. (1961).
J. Biol. Chem. 236, 1318.
Sulimovici, S. (1968). Ph.D. Thesis, University of Edinburgh.
Sulimovici, S.I. & Boyd, G.S. (1968a). Eur. J. Biochem. 3, 332.
Sulimovici, S.I. & Boyd, G.S. (1968b). Steroids lj2, 127.
Sulimovici, S.I. & Boyd, G.S. (1969). Vitamins & Hormones
27, 199.
Suzuki, K. & Kimura, T. (1965). Biochem. Biophys. Res. Comm.
19, 340.
Sweat, M.L. & Lipscomb, M.D. (1955). J. Amer. Chem. Soc.
77, 5185.
Sweat, M.L., Young, R.B. & Bryson, M.J. (1969). Arch. Biochem.
Biophys. 13Q, 66.
Sweat, M.L., Young, R.B. & Bryson, M.J. (1970). Biochim.
Biophys. Acta 223, 105.
Swerdoff, R.S., Walsh, P.O., Jacobs, H.S. & Odell, W.D. (1971).
Endocrinology 8_8, 120.
- 213 -
Tamaoki, B. & Shikita, M. (1966a). Eur. J. Steroids _1, 351.
Tamaoki, B. & Shikita, M. (1966b). In: Steroid Dynamics
(G. Pincus, J. Tait & T. Nakao, eds.). Academic Press,
New York, p.493.
Teilum, G. (1949). J. Clin. Endocr. Metab. j?, 301.
-Ihorsoe, H. (1961). Acta Endocrin. 37, 199.
Toren, D., Henon, K.M.J., Forchielli, E. & Dorfman, R.I. (1964)
Steroids 3, 381.
Trzeciak, W.H. & Boyd, G.S. (1973). Eur. J. Biochem. 87, 327.
Tsaiy R.L., Yu, C.A., Gunsalus, I.C., Peisach, J., Blumberg, W.
Orme-Johnsen, W.H. & Beinert, H. (1970). Proc. Nat. Acad.
Sci. U.S.A. 66, 1157.
Tuleisnik, S., Caligaris, L. & Astrada, J.J. (1966).
Endocrinology 7_9, 49.
Uzgiris, V.I., Mcintosh, E.N., Alonso, C. & Salhanick, H.A.
(1971). Biochemistry lO, 2916.
Van den Bergh, S.G. (1967). Methods Enzymol. 10, 749.
Van der Molen, H.J., Bijleveld, M.J., Van der Vusse, G.J. &
Cooke, B.A. (1973). J. Endocrin. 57, VI.
Van der Vusse, G.J., Kalkraan, M.L. & Van der Molen, H.J. (1973)
Biochim. Biophys. Acta 297, 179.
Vanha-Per ttula, T. (1971). I-Iistochem. J. 3, 151.
Van Lier, J.E. & Kan, G. (1971). Biochem. J. 125, 47.
Van Lier, J.E., Kan, G., Langlois, R. & Smith, L.L. (1972).
In: Biochemical Society Symposia No.34. Biological
Hydroxylation Mechanisms (G.S. Boyd & R.M.S. Smellie, eds.
Academic Press, p.21.
Van Lier, J.E. & Smith, L.L. (1970a). Biochem. Biophys. Res.
Comm. 40, 510.
Van Lier, J.E. & Smith, L.L. (1970b). Biochim. Biophys. Acta
210, 153.
- 214 -
Van Lier, J.E. & Smith, L.L. (1970c). Steroids 15, 485.
Van Lier, J.E. & Smith, 'l.L. (1970d). Biochim. Biophys. Acta
218, 320.
Wakabayashi, K. & Tamaoki, B. (1966). Endocrinology 79, 477.
Walsh, E.L., Cuyler, V.P. & McCullagh, D.R. (1934). Amer. J»
Physiol. 107, 508.
Ward, M.G. & Engel, L.L. (1966). J. Biol. Chem. 241, 3147.
Warren, D.W., Haltmeyer, G.C. & Eik-Nes, K.B. (1972). Biol.
Reprod. 7, 94.
Warren, D.W., Haltmeyer, G.C. & Eik-Nes, K.B. (1973). Biol.
Reprod. j3, 560.
Watari, H. & Kimura, T. (1966). Biochem. Biophys. Res. Comm.
24, 106.
Wattenberg, L.W. (1958). J. Histochem. Cytochem. £>, 225.
Werbin, H. & Chaikoff, i.l. (1961). Arch. Biochem. Biophys.
93, 476.
Whysner, J.A. & Harding, B.W. (1968). Fed. Proc. 27, 349.
Whysner, J.A., Ramseyer, J. & Harding, B.W. (1970). J. Biol.
Chem. 245,.5441.
Whysner, J.A., Ramseyer, J., Kazmi, G.M. & I-Iarding, B.W.
(1969). Biochem. Biophys. Res. Comm. 36_, 795.
Wilson, L.D. & Harding, B.W. (1970). Biochemistry _9, 1615.
Wilson, L.D. , Oldham", S.B. & Harding, B.W. (1969). Biochemistry
8, 2975. -
*
Witschi, E. & Mengert, W. F. (1942). J. Clin. Endocrin. 2, 279.
* •
Woods, J.E. & Domm, L.V. (1966). Gen. Comp. Endocr. 7, 559.
♦ >.
Woods, M.C. & Simpson, M.E. (1961). Endocrinology 69^, 91.
Wurtman, R.J. (1964).' Endocrinology 75, 927.
Yago, N., Dorfman, R.I. & Forchielli, E. (1967a). j. Biochem.
(Tokyo) 62, 345.
Yago, N. & Ichii, S. (1969). J. Biochem. 65, 215.
- 215 -
Yago, N., Nightingale, M.S., Dorfman, R.I.,& Forchielli, E.
(1967b). J. Biochem. (Tokyo) 62, 274.
Yamada, M. & Matsumoto, K. (1974). Endocrinology 94, 777.
Yamaji, T., Motohashi, K., Tanioka, T. & Ibayashi, H. (1968).
Endocrinology 83, 992.
^Yohro, T. & Horie, S. (1967). J. Biochem. (Tokyo) j61, 515.
